Systems biological study of Drosophila immune signaling by Kallio, Jenni
JENNI KALLIO
Systems Biological Study of 
Drosophila Immune Signaling
ACADEMIC DISSERTATION
To be presented, with the permission of
the board of Institute of Biomedical Technology of the University of Tampere,
for public discussion in the Jarmo Visakorpi Auditorium,
of the Arvo Building, Lääkärinkatu 1, Tampere, 
on April 15th, 2011, at 12 o’clock.
UNIVERSITY OF TAMPERE
Reviewed by
Docent Sampsa Matikainen
University of Helsinki
Finland
Professor Ulrich Theopold
Stockholm University
Sweden
Distribution
Bookshop TAJU
P.O. Box 617
33014 University of Tampere
Finland
Tel.  +358 40 190 9800
Fax  +358 3 3551 7685 
taju@uta.fi
www.uta.fi/taju
http://granum.uta.fi
Cover design by
Mikko Reinikka
Acta Universitatis Tamperensis 1599
ISBN 978-951-44-8388-2 (print)
ISSN-L 1455-1616
ISSN 1455-1616
Acta Electronica Universitatis Tamperensis 1057
ISBN 978-951-44-8389-9 (pdf )
ISSN 1456-954X
http://acta.uta.fi
Tampereen Yliopistopaino Oy – Juvenes Print
Tampere 2011
ACADEMIC  DISSERTATION
University of Tampere, Institute of Biomedical Technology
Tampere University Hospital, Pediatric Research Center 
Finland
Supervised by
Professor Mika Rämet
University of Tampere
Finland
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life isn't about waiting for the storm to pass, 
it's about learning to dance in the rain  
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1 ABSTRACT 
The development of systems biological high-throughput methods such as microarray 
analysis and genome-wide screens based on ribonucleic acid interference (RNAi) 
opened many doors for scientific research. Vast amounts of data can be obtained 
from a biological system and processed, while the system functions. . The ambitious 
goal of systems biological studies is to characterize the entire biological system: to 
identify all of its components and to determine how the system is regulated. 
However, a large scale systems biological study requires careful planning prior to 
experiments and taking into account any problems that might be related to the assay.  
 
In this study, we used two systems biological methods, an oligonucleotide-
microarray assay and a genome-wide RNAi screen, to characterize the Drosophila 
melanogaster immune response. Drosophila provides an excellent model for 
studying the principles of innate immunity. The fruit fly’s evolutionary conserved 
immune system lacks adaptive immunity, so it relies solely on its innate immunity 
for defending against pathogens. In addition, many genetic and molecular 
techniques, including in vivo RNAi, are available for Drosophila enabling effective 
exploitation of the data obtained from in vitro studies. Also, Drosophila are cheap 
and easy to maintain, and RNAi in Drosophila is effective and straightforward to 
carry out. 
 
In our systems biological study of the Drosophila innate immunity, we first used a 
microarray analysis to identify new gene products involved in innate immune 
signaling and phagocytosis. A microarray analysis was carried out for the genes 
induced in response to E. coli in Drosophila S2 cells. This was followed by an 
RNAi-based functional analysis of the up-regulated genes. Second, we carried out 
two separate genome-wide RNAi in vitro screens to identify gene products 
necessary for Drosophila immune signaling: the Drosophila nuclear factor kappa B 
(NF-ĸB) signaling and the Drosophila Janus tyrosine kinase/signal transducer and 
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activator of transcription (JAK/STAT) signaling pathway. We identified ten novel 
regulators of the Drosophila NF-ĸB signaling and five novel regulators of the 
Drosophila JAK/STAT pathway. 
 
One gene from both RNAi screens was subjected to further functional studies. We 
carried out the in vitro characterization of G protein-coupled receptor kinase 2 
(Gprk2) identified in the NF-ĸB screen. Similarly, we also characterized Eye 
transformer (ET), which was identified in the JAK/STAT screen. We were able to 
confirm both original phenotypes with targeted RNAi treatments. Furthermore, we 
validated these results by quantitative reverse transcription polymerase chain 
reaction (RT-PCR). Thereafter, we characterized both genes in vivo. 
 
In our Drosophila in vivo RNAi assays, transgenic upstream activating sequence 
(UAS)-RNAi flies were crossed with selected GAL4 driver flies, generating RNAi 
silencing of the target gene in the offspring.  These flies were infected with E. 
cloacae to induce immune signaling and the RNAi phenotypes were validated by 
qRT-PCR from RNAs extracted from the flies. We concluded that Gprk2 has an 
essential role in the Drosophila Toll pathway mediated immunity in vivo, and that 
ET is a negative regulator of Drosophila Tot gene expression in vivo. 
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2 TIIVISTELMÄ 
Systeemibiologiset menetelmät, kuten microarray analyysi ja genomin laajuinen 
kaksijuosteiseen ribonukleiinihappo(RNA)-häirintään perustuva seulonta-analyysi 
ovat kehittyneet huimasti viime vuosikymmenien aikana. Näiden menetelmien 
avulla tutkittavasta biologisesta systeemistä saadaan valtava määrä tietoa 
reaaliajassa systeemin yhä toimiessa. Systeemibiologisen tutkimuksen tavoitteet 
ovatkin aina melko kunnianhimoisia. Tutkimuksen avulla pyritään karakterisoimaan 
koko biologinen systeemi, eli selvittämään, mitkä proteiinit systeemiin osallistuvat 
ja miten sitä säädellään. Suuren luokan systeemibiologinen tutkimus edellyttää 
tarkkaa suunnittelua ja ongelmien kartoitusta ennen kokeiden toteutusta.  
 
Tässä työssä pyrittiin karakterisoimaan banaanikärpäsen immuunivastetta kahden 
systeemibiologisen menetelmän, microarray-analyysin ja genominlaajuiseen RNA -
häirintään perustuvan seulonta analyysin avulla. Banaanikärpänen on erinomainen 
mallieläin tutkittaessa synnynnäistä immuniteettia. Sen immuniteetti on säilynyt 
evoluutiossa melko muuttumattomana. Lisäksi siltä puuttuu hankittu immuniteetti, 
jolloin sen immuunipuolustus perustuu ainoastaan synnynnäiseen immuniteettiin. 
Banaanikärpäselle on saatavilla monia käteviä genetiikan ja molekyylibiologian 
työkaluja, kuten in vivo RNA-häirintä. Lisäksi kärpäsia on helppo ja halpa ylläpitää, 
ja RNA-häirintä on mentelmänä tehokas ja helppo toteuttaa.  
 
Banaanikärpäsen immuniteetin systeemibiologinen tutkimus aloitettiin microarray 
analyysillä. Sen avulla pyrittiin selvittämään, mitkä geenituotteet osallistuvat 
banaanikärpäsellä synnynnäisen immuniteetin signalointiin ja fagosytoosiin. 
Analyysi toteutettiin banaanikärpäsen S2-soluissa, jotka oli altistettu kolibakteerille. 
Microarray-analyysin avulla selvitettiin, mitkä geenit aktivoituvat banaanikärpäsen 
S2-soluissa vasteena kolibakteeri-infektiolle. Näiden geenien toimintaa ja 
merkitystä immuunivasteelle pyrittiin kartoittamaan RNA-häirintään perustuvan 
analyysin avulla. Tässä työssä esitellään lisäksi kaksi genomin laajuista RNA-
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häirintään perustuvaa analyysiä, joiden avulla pyrittiin selvittämään, mitkä 
geenituotteet osallistuvat banaanikärpäsen immuunisignalointiin. Genomin laajuiset 
analyysit tehtiin banaanikärpäsen NF-ĸB- sekä JAK/STAT -signalointireiteille. 
Näiden seulonta-analyysien avulla pystyimme tunnistamaan kymmenen ennestään 
tuntematonta säätelytekijää, jotka osallistuvat banaanikärpäsen NF-ĸB -
signalointiin, sekä viisi uutta JAK/STAT - signalointireitin säätelijää.  
 
Näistä geenituotteista valitsimme kaksi, Gprk2-proteiinin NF-ĸB -signalointireitiltä 
ja ET-proteiinin JAK/STAT -signalointireitiltä, joiden toimintaa halusimme tutkia 
tarkemmin. Alkuperäiset tulokset pystyttiin toistamaan molempien geenituotteiden 
osalta kohdennetun RNA-häirinnän avulla. Tulokset validoitiin lisäksi 
kvantitatiivisella käänteistranskriptiopolymeraasiketjureaktion (qRT-PCR) avulla. 
Tämän jälkeen molempien geenien toiminta pyrittiin myös karakterisoimaan 
banaanikärpäsellä in vivo. 
 
In vivo analyysissä hyödynnettiin kaupallisia kärpäsiä, joiden perimään on istutettu 
RNA-häirintäominaisuus. RNA-häirintä näillä kärpäsillä toimii siten, että 
perimässään UAS-RNA - häirintägeeniä kantava kärpänen risteytetään GAL-geeniä 
kantavien kärpästen kanssa. Tuloksena syntyy jälkeläiskanta, jolla GAL4 aktivoi 
UAS-RNA -häirinnän ja kohdegeenin ilmentäminen estyy. Nämä kärpäset 
infektoitiin E. cloacae -bakteerilla immuunivasteen käynnistämiseksi. RNA 
eristettiin ja analysoitiin qRT-PCR menetelmän avulla. Näiden systeemibiologisten 
tutkimusten perusteella tulimme siihen johtopäätökseen, että Gprk2 on välttämätön 
banaanikärpäsen Toll-signaloinnille. Lisäksi pystyimme osoittamaan, että ET - 
proteiini on banaanikärpäsen Turandot - geenin negatiivinen säätelijä. 
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4 ABBREVIATIONS 
Act = Actin 
AMP = antimicrobial peptide 
aop = anterior open 
Att = Attacin 
β-gal = beta-galactosidase 
bp = base pair 
bsk = basket 
CBM = cytokine binding module 
cDNA = complementary DNA 
CNTF = ciliary neurotrophic factor  
CT-1 = cardiotrophin-1 
C-terminal = carboxy-terminal 
DAP = diaminopimelic acid 
DD = death domain 
Dif = Dorsal-related immunity factor 
DNA = deoxyribonucleic acid 
Dome = Domeless 
dPIAS = Drosophila Protein Inhibitor of Activated Stat 
Dredd = Death-related ced-3/Nedd2-like protein 
Drs = Drosomycin 
ds = double stranded  
enok = enoki mushroom 
ET = Eye Transformer 
EtOH = ethanol 
FADD = Fas associated death domain 
G-CSF = granulocyte colony-stimulating factor  
GFP = Green Fluorescence Protein 
GNBP-1 = gram-negative bacteria binding protein  
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Hep = hemipterous 
Hop = hopscotch 
Hsp = heat-shock protein 
Iap = inhibitor of apoptosis 
IкB = inhibitor of кB 
IKK = IкB kinase 
IL = interleukin 
Imd = Immune defiency 
IRC = immune responsive catalase 
Ird5 = immune responsive deficient 5 
JAK = Janus tyrosine kinase 
JNK = Jun kinase 
Jra = Jun-related antigen 
kay = kayak, Drosophila Fos 
kb = kilobase 
key = Kenny, Drosophila, IKKɣ 
LB = Luria Bertani broth 
LIF = leukemia inhibitory factor 
LPS = lipopolysaccharide 
LRR = leucine rich repeat 
luc = luciferase 
MAMP = microbe-associated molecular pattern 
MAPKKK = Mitogen-Activated Protein Kinase Kinase Kinase 
MBL = mannose binding lectin 
Med27 = Mediator complex subunit 27 
mRNA = messenger ribonucleic acid 
MyD88 = myeloid differentiation factor 88 
NFкB = nuclear factor kappa B 
n.s. = non-significant 
N-terminal = amino-terminal 
OSM = oncostatin M 
PAMP = pathogen associated molecular patterns 
PBS = phosphate-buffered saline 
PCR = polymerase chain reaction 
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PGN = peptidoglycan 
PGRP = peptidoglygan recognition protein 
Pirk = poor Imd response upon knock-in 
PLB = passive lysis buffer 
PRR = pattern recognition receptor 
PTP61F  = protein tyrosine phosphatase 61F 
puc = puckered, Drosophila Jun kinase phospatase 
qRT-PCR = quantitative reverse transcription PCR 
RHD = REl homology domain 
RHIM = RIP homotypic interaction 
RING = really interesting new gene 
RISC = RNA-induced silencing complex 
RNA = ribonucleic acid 
RNAi = ribonucleic acid interference 
ROS = reactive oxygen species 
S2 = Schneider-2 
SH3 = Src homology 3 
SCID = Severe combined immunodeficiency 
siRNA = small interfering RNA 
SOCS = suppressor of cytokine signaling proteins 
SODD = silencer of deth domain 
SP-A = surfactant apoprotein A 
STAM = Signal Transducin Adaptor Molecule 
STAT = signal transducer and activator of transcription 
Su(var)2-10 = Suppressor of variegation 2-10 
Tab2 = Tak1-associated binding protein 2 
Taf1 = TBP-associated factor 1 
Tak1 = TGF-β-activated kinase 1 
TEP = thioester-containing protein 
TGF = transforming growth factor 
TIR = Toll/interleukin-1 receptor 
TLR = Toll-like receptor 
TNF = tumor necrosis factor 
TNFR = tumor necrosis factor receptor 
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Tot = Turandot 
TRADD = TNF receptor accociated death domain 
TRAF = TNF associated factor 
UAS = upstream activating sequence 
Upd = Unpaired 
UTR = untranslated region 
Wg/Fz = Wingless-Frizzled 
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5 INTRODUCTION 
Systems biology is a concept that can be seen as a way of scientific thinking. It 
began in the 20
th
 century as a result of the discovery of many basic methods, such as 
PCR and DNA sequencing. The holistic perspective of systems biology quickly 
replaced the old practices of studying the characteristics of isolated parts of a cell or 
organism. Instead, increasing automation and computerization combined with a 
growing availability of genomic sequences allow processes of interest to be 
monitored in a functioning biological system.  
 
Today, many high-throughput systems biological method are readily accessible, of 
these DNA microarray analysis is an eminent example.  It comprises a series of 
thousands of microscopic spots of DNA oligonucleotides, which allows the 
examination of the entire genome in a single reaction. Microarrays can be used to 
detect temporal changes in expression levels in different cells or tissue samples.  
 
Another example of a systems biological methods is a genome-wide RNAi based 
screen. It uses RNAi, an ancient gene silencing mechanism for host defense against 
parasitic nucleic acids such as viral genes and transposons. In the RNAi machinery, 
dsRNA, which is detected as foreign, activates a complex RNAi pathway. The 
RNAi pathway signals the degradation of the corresponding mRNA causing the 
expressional silencing of the target gene. RNAi was first observed by plant scientists 
attempting to alter flower colors in petunias, but was better understood when 
Andrew Fire and Craig C. Mello published their work on RNAi in C. elegans in 
Nature in 1998. A genome-wide RNAi based screen is an extremely powerful 
method for identifying gene products that are necessary for physiological events of 
interest. In a genome-wide RNAi screen, the systematical suppression of each gene 
in the cell by targeted dsRNA treatments can be used to identify the components 
necessary for different cellular processes.  
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The Drosophila immune system is well conserved through out evolution. This 
makes Drosophila an excellent model for studying the basic mechanisms of host 
defense, since the results obtained may be comparable to the human immune 
system. Although Drosophila lacks the adaptive immune system, it is highly 
resistant to microbial infections due to innate immune reactions. These include the 
encapsulation and phagocytosis of invading pathogens (cellular response), blood 
clotting, melanin formation and opsonization (local response) and the synthesis of 
potent antimicrobial peptides (AMPs) (humoral response). In addition, Drosophila 
resists viruses through the degradation of viral RNA by its RNAi machinery and via 
cytokine-mediated induction of many stress genes, which counter the viral infection. 
 
There are at least four signaling pathways that regulate the immune responses in 
Drosophila. Drosophila immunity distinguishes between Gram-negative and Gram-
positive bacteria through the Imd and the Toll pathways, respectively. In addition to 
NFк-B signaling pathways, the JNK- and JAK/STAT pathways seem to have a role 
in regulating gene expression after septic injury and during viral infections. 
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6 REVIEW OF THE LITERATURE 
6.1 Systems biology 
For many decades the traditional approach of scientific study was to investigate the 
characteristics of isolated parts of a cell or organism. The discovery of many basic 
methods, such as PCR and DNA sequencing during the 80’s paved the way to a 
whole new way of addressing scientific questions called systems biology. The 
beginning of the Human Genome Project in 1990 was one of the starting points of 
this revolution, which permanently changed the way of scientific thinking. 
!ncreasing automation and computerized systems combined with the availability of 
the genomic sequences of many species, including humans, allow processes of 
interest to be monitored in a functioning biological system  (Kohl et al., 2010; Pitteri 
and Hanash, 2010; Schadt et al., 2010; Sharon et al., 2010).  
6.1.1 Systems biology: history and practice 
Systems biology is a scientific approach that applies a holistic perspective to the 
investigation of complex interactions in biological systems. This approach has been 
widely used in biosciences particularly from the year 2000 onwards.  The basic 
goals of systems biology are to gain new insights into the functional interactions of 
macromolecules in a biological system of interest, and to better understand the 
entirety of the processes that take place in biological systems (Kohl et al., 2010; 
Pitteri and Hanash, 2010; Sharon et al., 2010). 
 
The roots of the holistic thinking of systems biology can be seen as early as in  1950 
when theoretician Ludwig von Bertalanffy published his book entitled "General 
Systems Theory in Physics and Biology". Two years later, neurophysiologists and 
Nobel prize winners Alan Lloyd Hodgkin and Andrew Fielding Huxley published a 
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mathematical model that explained the interaction between a potassium and sodium 
channel, giving rise to computational systems biology. The discovery of two major 
techniques, DNA sequencing in 1975 and PCR in 1985, further contributed to the 
beginning of this new scientific approach to biology. The scientific community 
started to increasingly acknowledge the digital nature of DNA and biology was 
redefined as an informational science (Bertalanffy, 1949; Bertalanffy, 1950; 
Hodgkin and Huxley, 1952)  
The formal study of systems biology was launched in the 1990s when functional 
genomics made large quantities of data available, and computerized systems enabled 
the automation of their analysis. The scientific revolution started in 1990 in the form 
of The Human Genome Project. The first research institutes focusing entirely on 
systems biology were founded in 2000 in Seattle and in Tokyo (Sauer et al., 2007) 
and many more have been established since.. 
A holistic perspective of biological systems provides information about a system’s 
structure, dynamics and control, all at the same time. The information controlling all 
biological systems can be divided into two main types. The most important aspect is 
the digital nature of DNA, i.e. of the genes which encode the proteins (Sauer et al., 
2007). The expression of these genes in time and space is tightly controlled by a 
second level of biological information, the complex regulatory networks. Since vast 
amounts of data are obtained by high-throughput methods, such as large-scale DNA 
sequencing, microarrays and mass spectrometry, the aims of systems biological 
studies are always quite ambitious (Kohl et al., 2010; Nita-Lazar). The underlying 
goal of any systems biological study is to determine how the biological system of 
interest works and how it is regulated (Kohl et al., 2010; Nita-Lazar). This requires 
careful planning prior to experiments. The basic framework of a systems biological 
study is to first determine all of the components of the system and to then monitor 
the components by selected high-throughput biological tools and finally reconcile 
the original model with the results (Sauer et al., 2007; Schadt et al., 2010).  
Systems biological approaches start with the definition of all of the components of 
the system under study. This includes determining the structure of the overall 
network of genes and proteins, their interactions and regulation. Another aspect is to 
predict the system dynamics in order to determine its functional properties; how the 
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system behaves over time under various conditions. The initial model is tested by 
disturbing the system by genetic or environmental perturbations and monitoring the 
system’s response to these perturbation using large-scale discovery tools. Based on 
these experimental observations, the original hypothesis is then evaluated and 
modified to fit the results (Csete and Doyle, 2002; Davidson et al., 2002; Gardner et 
al., 2003; Ge et al., 2003; Hood, 2003a; Hood, 2003b; Ideker et al., 2001; Kitano, 
2002) 
 
Figure 1. Systems biology diagram (modified from the picture on the Institute for 
Systems theory and Automatic control website: http://www.ist.uni-
stuttgart.de/education/courses/sysbiointro/) 
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6.1.2 Microarray analysis 
Microarrays are microscope slides that contain an ordered series of gene-specific 
probes. Since the probes are arranged on the slides in an ordered fashion, data 
obtained from an analysis can be traced back to any of the genes. Microarray assays 
can contain several thousands of addressable genes. Vast amounts of data are 
produced in a single assay. 
A DNA microarray analysis is a great example of the multiplex technology used in 
systems biology. Microarrays comprise series of thousands of microscopic spots of 
DNA oligonucleotides each containing a specific DNA sequence as small as 20 base 
pairs. Microarrays can be used to detect temporal changes in the expression levels of 
different cells and tissue samples. Microarray assays are a genuine high-throughput 
method allowing the examination of the entire genome in a single reaction. A single 
microarray experiment can contain tens of thousands of probes and can therefore 
accomplish many genetic or expression analysis in parallel. Because of this, 
microarray technology has dramatically accelerated many types of biological and 
medical investigations (Schena et al., 1995). 
The first expression analysis using microarray technology was described in 1987 
when arrayed cDNAs were used to identify interferon regulated genes. In these early 
arrays the cDNA was spotted onto filter paper for analysis with a so called pin-
spotting device (Kulesh et al., 1987). The first genome wide expression analysis 
became possible in 1997 when a complete eukaryotic genome (Saccharomyces 
cerevisiae) was published on a microarray (Kulesh et al., 1987) (Lashkari et al., 
1997). 
A standard microarray analysis typically follows the five experimental steps of 
selecting the genes of interest, sample preparation and microarray synthesis, 
biochemical reactions and array hydridization, detection, data analysis and modeling 
with controls. The oligonucleotides attached to a solid surface of glass or silicon can 
be synthesized either in situ or they can be pre-synthesized and then deposited onto 
the chip by a covalent bond.  Microarrays can be used in a comparative genomic 
hybridization analysis to detect DNA or in an expression analysis to detect RNA or 
most commonly cDNA after reverse transcription.   
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Oligonucleotides on a chip can be short probes comprising a section of a gene or 
other DNA element such as a cDNA or cRNA sample target hybridized under high-
stringency conditions. Targets are usually labeled with fluorophore-, silver-, or 
chemiluminescence tags to detect the probe by hybridization. The quantification of 
label localization and intensity provide information about temporal gene expression 
and relative abundance of nucleic acid sequences in the target (Pollack et al., 1999; 
Schena, 1996; Watson et al., 1998).  
 
 
Figure 2. Example of a microarray analysis (Modified from the webpage of 
Microarray Center: http://www.microarray.lu/en/MICROARRAY_Overview.shtml) 
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6.1.3 RNA interference: Basic mechanisms of RNAi 
RNA interference is an ancient gene silencing mechanism for host defense at the 
cellular level. It has a crucial role in the immune defense against the parasitic genes 
of viruses or transposons. RNAi is triggered by a double-stranded RNA normally 
introduced into the cells by viruses. dsRNA is recognized as foreign by cells and it 
therefore activates a complex RNA interference pathway leading to degradation of 
the corresponding mRNA, which causes the expressional silencing of the target 
gene (Hammond et al., 2000) (Bernstein et al., 2001a; Zamore et al., 2000) 
(Bernstein et al., 2001b; Macrae et al., 2006; Siomi and Siomi, 2009a) (Siomi and 
Siomi, 2009b). 
  
RNAi machinery 
The detection of foreign dsRNA in cells activates a complex RNAi machinery 
initiated by a nuclease of the RNase III family called Dicer. After detection of the 
dsRNA, the activated Dicer binds to dsRNA and cleaves it into small, 
approximately 20 nucleotides long fragments called small interfering RNAs 
(siRNAs). Each of these small fragments consists of two strands called the guide 
strand and the anti-guide strand corresponding to the original gene sequence.  After 
cleavage the siRNAs are inserted into a large protein and RNA containing complex 
called the RNA-induced silencing complex (RISC). In the RISC complex one of the 
protein components, endonuclease of Argonaute AGO, cleaves off the anti-guide 
strands of the siRNAs. The remaining guide strand then attaches to the 
complementary endogenous mRNA marking it for degradation by cleavage also 
carried out by the AGO enzyme. A large number of siRNAs, each binding to the 
mRNA of the target gene, are made from a single strand of dsRNA. This generates 
the amplification effect of the pathway and only a small amount of original dsRNA 
is enough to activate the silencing effect of the target gene. Furthermore, the  
silencing is inherited by the next generation of cells (Hammond et al., 2000) 
(Bernstein et al., 2001a; Zamore et al., 2000) (Bernstein et al., 2001b; Macrae et al., 
2006; Siomi and Siomi, 2009a) (Siomi and Siomi, 2009b) . 
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Figure 3. Schematic representation of the RNAi mechanism 
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History and discovery 
RNAi was first observed by plant scientists attempting to alter flower colors in 
petunias. In order to produce darker flowers, they introduced additional copies of a 
gene encoding an enzyme responsible for flower pigmentation. This overexpression 
of chalcone synthase resulted unexpectedly in less pigmented white flowers, in 
which both endogenous and transgenes were completely downregulated. This was 
later discovered to be an outcome of post-transcriptional inhibition of gene 
expression via an increased rate of mRNA degradation, but the molecular 
mechanism remained unknown. 
RNAi became better understood when Andrew Fire and Craig C. Mello published 
their work on RNA interference in C. elegans in Nature in 1998 (Fire et al., 1998). 
By that time, RNAi was known by other names such as co-suppression of gene 
expression and post-transcriptional gene silencing. Fire and his co-workers 
discovered that these are all part of the same phenomenon named RNAi. In 2006 
Fire and  Mello shared the Nobel Prize in Physiology or Medicine for their 
discovery (Fire et al., 1998).  
RNAi is a valuable and easy-to-use research tool that can be used for large-scale 
screens (Ramet et al., 2002b).The effect of RNAi on gene expression is highly 
selective and robust and synthetic dsRNAs can be introduced into cultured cells or 
living organisms to induce the specific knock-down of a gene of interest. Systematic 
suppression of each gene in the cell by targeted dsRNA treatments can be used in 
systems biology to identify the components necessary for different cellular 
processes. The possible exploitation of RNAi in medicine is also under investigation 
(Castanotto and Rossi, 2009). 
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6.1.4 Large-scale genome-wide RNAi based screens 
 
In current experimental biology, RNAi based methods are widely used to study the 
function of genes both in cell cultures and in appropriate model animals such as 
Drosophila melanogaster. With specific primers, a complementary dsRNA targeting 
the gene of interest can be synthesized and introduced into cells. The dsRNA is 
considered as exogenous genetic material and therefore it activates the RNAi 
pathway resulting in a drastic decrease in the expression of the target gene. The 
physiological effects of this decrease can provide information about the functional 
role of this gene product (Boutros et al., 2004; Cullen and Arndt, 2005).  
 
One the most common model animals used in the functional genomics applications 
of RNAi is Drosophila. It is relatively easy to maintain, the RNAi is very effective 
and most importantly, the delivery of dsRNA into cultured Drosophila cells is 
extremely simple. Drosophila S2 cells spontaneously take up the dsRNA fragments 
so the RNAi can be accomplished simply by soaking the cells in dsRNA containing 
cell culture medium. dsRNA is subsequently taken up through scavenger receptor 
mediated endocytosis (Ulvila et al., 2006). 
 
Genome-wide RNAi based screens are an extremely powerful method for 
identifying gene products necessary for physiological events of interest with many 
advantages and few downsides (Ramet et al., 2002b). One of the most disconcerting 
problems of RNAi is off-target effects. Off-target effects occur frequently with 
dsRNAs containing repetitive sequences and it has been estimated that such 
sequences occur in about 10% of possible RNAs(Ge et al., 2003; Qiu et al., 2005). 
Off-target effects appear when a dsRNA delivered into cells has a sequence that can 
align with multiple mRNAs and therefore potentially knock-down many genes at the 
same time. Computational biologists have directed extensive efforts into 
developping software tools for designing dsRNAs that are automatically checked for 
repetitive sequences and for possible cross-reactivity that might cause off-target 
effects (Ge et al., 2003; Qiu et al., 2005).  
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Another challenge of RNAi is the delivery of siRNAs into cells.  Although 
Drosophila cells readily take up dsRNAs (Ulvila et al., 2006) delivery is more 
difficult in most other organisms. In general, large-scale genomic screening is seen 
as a promising method also when screening mammalian cells (Janitz et al., 2006). 
Designing genome-wide RNAi libraries also requires applications that are much 
more sophisticated than just the engineering of a defined set of experimental 
conditions for a single siRNA treatment. (Lu et al., 2005; Zhao et al., 2005) 
(Herranz and Cohen, 2010; Janitz et al., 2006; Wilkins et al., 2005). 
 
 
6.2 Drosophila as a model for studying the immune 
system 
 
 
The immune response of Drosophila has proven to be a useful model for studying 
the principles of the immune system (reviewed by Lemaitre and Hoffmann, Annu 
Rev Immunol (Lemaitre and Hoffmann, 2007)). Drosophila relies solely on innate 
immune reactions when defending against pathogens. This is an advantage over 
vertebrates, in which a highly sophisticated and complex immune system may 
complicate analyses. For instance, adaptive mechanisms may compensate for some 
knock-outs of innate immune mechanisms (Hoffmann et al., 1999). For this reason, 
the use of the Drosophila model facilitates the discovery of essential molecules and 
pathways involved in the innate immune response that is well-conserved from 
insects to human (Hoffmann et al., 1999; Hultmark and Ekengren, 2003), (Lemaitre 
and Hoffmann, 2007). On this premise, it is not surprising that the genetic and 
molecular techniques available for Drosophila have greatly facilitated the revealing 
of the basic mechanisms of the innate host response (Hoffmann et al., 1999; 
Hultmark and Ekengren, 2003). 
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6.2.1 The human immune system 
 
The human immune system consists of the adaptive and innate immunity. Adaptive 
immunity is based on the selection of somatically recombined B and T cell receptors 
whereas innate immunity relies on germ-line encoded PRRs that selectively bind to 
pathogens. The innate immune system has an essential role in protecting the host 
during the first hours after exposure to an infectious agent before the clonal 
expansion of T- and B-cells (Hoffmann et al., 1999).  Ligation of PRRs to microbes 
enhances phagocytosis (opsonisation), activates the complement system and/or 
activates inflammatory signal cascades that facilitate the destruction of an infectious 
agent. A highly specific immune response that is based on the selection and 
expansion of somatically recombined B and T cells is found only in vertebrates. 
Other animals and plants rely on innate immune defenses (Hoffmann et al., 1999; 
Hultmark and Ekengren, 2003; Janeway, 2005).  
 
A key question is how an innate immunity system recognizes and discriminates 
between a pathogen’s and the animal’s own tissue. The answer relies on the absence 
of microbial markers on the surface of the host cells. Innate immunity is based on 
germ-line encoded PRRs that selectively bind to pathogens (PAMPs, pathogen 
associated molecular patterns). These receptors recognize different pathogen surface 
structures such as lipopolysaccharide (gram-negative bacteria), lipoteichoic acid 
(gram-positive bacteria), peptidoglycan and mannans (yeast). In additon, PRRs bind 
and recognize the most important PAMSs, microbe originated DNA and RNA 
(Hallman et al., 2001) (Hultmark and Ekengren, 2003) (Janeway, 2005). Microbe-
specific receptors can be divided into three groups: Secreted molecules, phagocytic 
receptors and signaling molecules. One of the best-characterized secreted receptors 
is a mannose-binding lectin (MBL), which binds to carbohydrates on bacteria, yeast 
and viral surfaces. This group also includes, among many others, the surfactant 
apoproteins SP-A and SP-D and complement. Phagocytic receptors are expressed 
on the surface of phagocytes. These include, for example, a mannose receptor and a 
scavenger receptor. When these receptors recognize a pathogen, they phagocytose it 
into intracellular lysosomes, where it is destroyed. Components of the pathogen are 
moved to the surface of the antigen presenting cells for antigen presentation by 
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major histocompatibility complex molecules. This antigen presentation occurs only 
in vertebrates. Signaling receptors, including Toll receptors, originally found in 
Drosophila (Lemaitre et al., 1996),  activate inflammatory cascades that induce the 
expression of the inflammatory cytokines that are important for the acute host 
defense (Hallman et al., 2001) (Janeway, 2005) (Takeda et al., 2003). 
 
6.2.2  The Drosophila immune system 
 
The fruitfly lacks the adaptive immune system and relies only on innate immune 
reactions for its defense. Nevertheless, Drosophila is resistant to microbial 
infections. This resistance is achieved through at least three mechanisms, all of 
which take place within a short period of time after exposure to a pathogen. (1) 
phagocytosis of micro-organisms by circulating blood cells called plasmatocytes, 
(2) activation of proteolytic cascades that lead to blood clotting, melanin formation 
and opsonization and (3) transient synthesis of potent antimicrobial peptides 
(AMPs) (Brennan and Anderson, 2004) (Ferrandon et al., 2004; Lemaitre and 
Hoffmann, 2007). 
 
 
6.2.2.1 Local response  
 
The Drosophila local response includes AMP production via surface epithelial cells 
followed by clotting, opsonization and melanization inside the organism, all 
mediated by sophisticated signaling cascades.  When Drosophila epithelial cells get 
into contact with microbes, the activation of complex signaling pathways leads to 
the induction of potent AMP expression in these cells. This kind of local production 
of AMP in direct response to microbes is also seen in other animals, including 
mammals, and is considered an essential ancestral antimicrobial defense mechanism 
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(Brennan and Anderson, 2004; Ferrandon et al., 1998). Another local immune 
response event is wound healing including clotting of the hemolymph and 
melanization (Ramet et al., 2002a). Injury or invading large parasites activate a 
serine protease cascade which eventually leads to the synthesis of a large amount of 
melanin, clotting and encapsulation. Melanin formation can be detected under a 
microscope as a dark black band around the wound area (Brennan and Anderson, 
2004) (Ferrandon et al., 2004). Melanization is coupled to the simultaneous 
production of cytotoxic oxygen species against micro-organisms possibly present in 
the wound (Hoffmann and Reichhart, 2002) (Ramet et al., 2002b) (Brennan and 
Anderson, 2004) (Ferrandon et al., 2004). 
 
 
6.2.2.2 Cellular response 
The key players in the Drosophila cellular response are the cells of the 
hemolymph, Drosophila’s blood. These include lamellocytes which hunt and 
capture invading micro-organisms and encapsulate them. These large flattened cells 
comprise only a few percent of all the cells present in the Drosophila hemolymph 
(Meister and Lagueux, 2003). The most pre-dominant cell-type is plasmatocytes, 
which take care of phagocytosis. Plasmatocytes comprise over 95% of the 
hemolymph cells (Williams et al., 2007) (Meister and Lagueux, 2003). In addition, 
there are circulating hemocytes comprising approximately 5% of the hemolymph 
cells called crystal cells. These cells secrete components necessary for the 
melanization of invading organisms and wound repair (Williams et al., 2007) 
(Meister and Lagueux, 2003). 
  
 
The basic mechanism of phagocytosis is well conserved throughout the evolution 
from invertebrates to vertebrates. Macrophages in mammals and plasmatocytes in 
Drosophila share similarities both in appearance and in phagocytic receptors such as 
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the scavenger receptors on their cell surface (Pearson et al., 1995) (Ramet et al., 
2001). Drosophila phagocytic receptors have different ligand-binding properties and 
are able to phagocytose a wide spectrum of materials of different nature from 
apoptotic cells to large particles and micro-organisms. (Pearson et al., 1995) (Ramet 
et al., 2001) (Meister and Lagueux, 2003) Many recent studies have shown that 
phagocytosis is an important part of the Drosophila immune defense. Although able 
to orchestrate a normal humoral response, flies that do not express the phagocytic 
receptor eater are more sensitive to the gastro-intestinal tract infecting pathogen S. 
marcescens than are normal flies (Kocks et al., 2005). The crucial role of 
phagocytosis in the Drosophila host defense can be demonstrated by blocking 
phagocytosis with mutations or injecting polystyrene beads into the Drosophila 
body cavity (hemocoel). It has been shown by these studies that flies that are unable 
to phagocytose, and carry a mutation affecting the humoral response, are highly 
susceptible to infections (Braun et al., 1998) (Elrod-Erickson et al., 2000). 
6.2.2.3 The humoral response  
The Drosophila humoral response is based on the synthesis of potent AMPs and the 
signaling pathways that regulate their production.. AMPs act for example by 
permeabilizing the cell membranes of micro-organisms.  They are produced mostly 
in the fat body and secreted rapidly into the hemolymph. There are at least 34 AMPs 
encoded in the Drosophila genome. These include AMPs with a broad-spectrum 
such as cecropins, and more specialized peptides like attacins. Defensins have a 
wide spectra of activities directed against bacteria, fungi and some enveloped 
viruses (Hoffmann et al., 1999) (Tzou et al., 2002) (Hultmark and Ekengren, 2003) 
(Hetru et al., 2003).   
 
In past decades, scientist paid a great deal of attention to Drosophila immune 
signaling and revealed four different signaling pathways regulating innate immune 
responses after bacterial challenge or septic injury. The Toll pathway is activated 
primarily in response to gram-positive bacteria and fungi (Lemaitre et al., 1996), 
whereas the Imd (immune deficiency) pathway is activated by gram-negative 
bacteria (Lemaitre et al., 1995). Both the Toll and the Imd pathways are involved in 
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regulating gene production after septic injury (Hetru and Hoffmann, 2009). In 
addition, there is growing evidence for the involvement of the Janus tyrosine 
kinase/signal transducer and activation of transcription (JAK/STAT) and JNK 
signaling pathways in controlling immune response genes (Ramet et al., 2002a) 
(Baeg et al., 2005) (Dostert et al., 2005) (Brun et al., 2006; Galiana-Arnoux et al., 
2006; Muller et al., 2005). 
6.2.2.4 The Drosophila antiviral response 
Drosophila resists viruses through two types of responses: degradation of viral RNA 
by the RNA interference machinery and cytokine-mediated induction of many stress 
genes, which counter the viral infection. RNAi function is to limit the viral infection 
in the infected cells by preventing viral replication. There is some recent evidence, 
that Drosophila may also have a systemic RNAi response similar to vertebrate 
protein-based immunity, where the virus-specific immunity signal is systematically 
spread throughout the animal (Costa et al., 2009; Saleh et al., 2009). This defense 
mechanism is then coupled to other immune reactions induced by JAK/STAT 
signaling in uninfected cells (Galiana-Arnoux et al., 2006, {Costa, 2009 #177) 
(Jing-Huan Wang, 2010). 
Many scientists have demonstrated that RNAi has an essential role in the immune 
response against viruses and other foreign genetic material. In plants, RNAi also has 
a vital role in preventing self-propagation by transposons (Stram and Kuzntzova, 
2006). In some animals, including Drosophila, RNAi has also shown to have a role 
in initiating the antiviral response and is active against pathogens such as the 
Drosophila X virus (Zambon et al., 2006) (Wang et al., 2006). A similar antiviral 
response mechanism may be present in C. elegans, since RNAi related argonaute 
proteins are upregulated in C. elegan in response to viruses. In addition, worms that 
overexpress RNAi pathway components are more resistant to viral infections (Lu et 
al., 2005) (Wilkins et al., 2005) (Fritz et al., 2006) (Zambon et al., 2006) (Wang et 
al., 2006). 
There are relatively little data available concerning the role of RNAi in mammalian 
innate immunity in response to viral infections and it is therefore poorly understood. 
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Some evidence of an RNAi-dependent viral response in mammals comes from the 
existence of viruses encoding genes able to suppress the RNAi response in 
mammalian cells. However, this hypothesis is poorly substantiated due to the lack of 
adequate data on the mammalian RNAi-dependent viral response (Berkhout and 
Haasnoot, 2006) (Schutz and Sarnow, 2006) (Cullen, 2006). 
 
6.3 Signaling pathways regulating the Drosophila immune 
response 
 
Innate immunity is strikingly well conserved throughout evolution (Hoffmann and 
Reichhart, 2002) (Hoffmann and Reichhart, 2002). For example, mammalian Toll-
like receptors (TLRs) were discovered based on their similarity to the insect Toll 
protein (Beutler, 2009; Lemaitre and Hoffmann, 2007). The Drosophila host 
defense relies on the rapid detection of microbes by PRRs. The initial recognition by 
PRRs triggers phagocytosis, proteolytic cascades leading to coagulation and 
melanization in order to limit the infection and production of AMPs (Brennan and 
Anderson, 2004) (Ferrandon et al., 1998) (Hoffmann and Reichhart, 2002). Similar 
responses are also seen in mammalian immunity. For example, proteolytic cascades 
are used in blood clotting and the complement system. Signaling cascades leading to 
the release of antimicrobial peptides in Drosophila immunity distinguish between 
Gram-negative and Gram-positive bacteria through the Imd and the Toll pathways, 
respectively (Lemaitre et al., 1997). These two distinct pathways that are very 
similar to mammalian Toll/IL and TNF-receptor pathways are the major regulators 
of the immune response in Drosophila in vivo (Hetru and Hoffmann, 2009; Mishima 
et al., 2009).  
 
Current data suggest the involvement of two additional pathways in the Drosophila 
immune response. In addition to the Toll and Imd pathways, the JNK- and 
JAK/STAT pathways seem to have a role in regulating gene expression/protein 
production after septic injury and in viral infections. There are also indications that 
the mitogen-activated protein kinase kinase kinase (MAPKKK) Mekk1 regulates the 
34 
transcription of some genes induced by septic injury, such as the Turandot stress 
genes (Baeg et al., 2005) (Dostert et al., 2005) (Muller et al., 2005) (Brun et al., 
2006) (Galiana-Arnoux et al., 2006) 
6.3.1 The Imd pathway 
The Drosophila immune response against Gram-negative bacteria is carried out via 
peptidoglycan recognition proteins (PGRPs), a conserved family of microbial 
recognition proteins. There is a total of 13 PGRPs in Drosophila of which several 
have been implicated in immune response reactions. A transmembrane protein 
PGRP-LC has been shown to be a receptor of the Imd pathway. In addition, three 
secreted proteins, PGRP-LE, PGRP-SA and PGRP-SD, cooperate with PGRP-LC 
by binding Gram-negative peptidoglygan (Werner et al., 2000) (Choe et al., 2002) 
(Ramet et al., 2002b) (Gottar et al., 2002). 
 
The Imd pathway is a reasonably complex cascade comprising several different 
components. The pathway is initially activated by Gram-negative bacteria binding to 
the extracellular peptidoglycan recognition domain of the receptor PGRP-LC (Choe 
et al., 2002) (Ramet et al., 2002b) (Gottar et al., 2002). There are several indications 
that this binding is assisted by secreted PGRP-LE. Activated PGRP-LC then 
interacts via its intracellular domain with the C terminal death domain (DD) of Imd. 
Activated Imd delivers the signal to various other components of the pathway (fig 
4), leading finally to phosphorylation of the transcription factor Relish. As Relish 
becomes phosphorylated, its C terminal inhibitory domain is cleaved and activated, 
and it translocates into the nucleus and activates the expression of several 
antimicrobial peptides, including Attacin, Diptericin and Drosocin (Elrod-Erickson 
et al., 2000) (Rutschmann et al., 2000) (Georgel et al., 2001) (Vidal et al., 2001) 
(Wang et al., 2001) (Naitza et al., 2002) (Giot et al., 2003) (Silverman et al., 2003) 
(Kleino et al., 2005) (Zhou et al., 2005) (Aymeric et al., 2010; Beutler and Moresco, 
2008; Leulier et al., 2006; Lhocine et al., 2008; Matova and Anderson, 2010; 
Wiklund et al., 2009). 
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Figure 4. The Imd pathway.  PGRP-LC and PGRP-LE recognize Peptidoglycan (PGN) on 
Gram-negative bacteria and activate Imd via an unidentified protein. PGRP-LE is both an 
intracellular and extracellular receptor for monomeric peptidoglycan and contains both the RIP 
homotypic interaction motif (RHIM) and the PGRP domain. Activated Imd recruits FADD and 
DREDD, each containing a death domain (DD) and/or death effector domain (DED). DREDD passes 
the signal by activating TAK1. TAB2 is thought to participate in assembling the IKK signaling 
complex, which is composed of IRD5 and Kenny, the Drosophila  homologs of IKK  and IKK , 
respectively (Erturk-Hasdemir et al., 2009). IRD5 phosphorylates Relish, triggering its cleavage. The 
ankyrin repeats cleaved of Relish remain in the cytoplasm, and the REL moiety translocates to the 
nucleus and activates the ranscription of target genes (Ferrandon et al., 2007) 
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6.3.2 The JNK pathway 
The Drosophila Imd and the mammalian TLR signaling pathways both branche into 
another conserved signaling cascade, the Jun N-terminal kinase (JNK) signaling 
pathway at the level of Tak1 (Wang et al., 2001) (Silverman et al., 2003) (Park et 
al., 2004) (Bond and Foley, 2009; Stronach, 2005). The JNK pathway controls 
several biological processes from cytoskeletal remodeling, dorsal closure, tumor 
growth and invasion, stem cell regeneration and wound healing to transcriptional 
regulation of a wide variety of gene products in response to pathogens and tissue 
damage (Lesch et al., 2010). Like most of the signaling pathways involved in 
immune responses, the JNK pathway is highly conserved throughout evolution and 
has been implicated in stress responses, cell migration and proliferation, 
differentiation and morphogenesis, apoptosis as well as immune responses in both 
insects and mammals (Boutros et al., 2002) (Bond and Foley, 2009; Igaki, 2009). 
Despite of its well-known importance in immune signaling, the actual contribution 
of JNK signaling to the Drosophila immune response is more or less unclear. It has 
been shown that the JNK pathway is essential for sufficient Imd signaling and it is 
most likely involved in Dif-controlled Drosomycin expression via the Toll pathway. 
The most recent data suggest that this rather complex cascade can be activated by 
several kinases leading to various biological outcomes (Boutros et al., 2002) (Ramet 
et al., 2002a) (Park et al., 2004) (Delaney et al., 2006) (Bond and Foley, 2009; Igaki, 
2009).  
 
The JNK pathway can be activated by one of three cell surface ligand-receptor 
systems, TNF-TNFR (Eiger/Wengen), PVF/PVR (PDGF/PDGFR) or Wingless/ 
Frizzled (Wg/Fz) depending on the biological process it mediates (Igaki, 2009). The 
signal is then passed on to intracellular adaptor proteins such as small GTPases 
(Rac), Dishevelled (Dsh), the tumor necrosis factor (TNF) receptor-associated 
factors (TRAFs) and the Ste20-related kinase Misshapen (msn) (Boutros et al., 
2002) (Igaki, 2009; Ramet et al., 2002a). These adapter proteins function as 
waypoints and mediate the activation of the core JNK signaling proteins, JNKKKs 
dTAK1, DASK1, Slpr, dMekk1, JNKK hemipterous (Hep) and JNK basket (bsk). 
Activation of the Hep-Bsk cascade finally leads to the phosphorylation of the 
transcription factors DJun homologue of Jun-related antigen (Jra) and kayak (kay), 
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the Drosophila homologue of the human Fos, the transcriptional repressor anterior 
open (aop) and the dual-specificity phosphatase puckered (puc) (Igaki, 2009). Being 
a transcriptional target of the AP-1 (Jun/Fos) transcription factor, Puc forms a 
negative feedback loop and acts as a negative regulator of JNK signaling (Boutros et 
al., 2002) (Ramet et al., 2002a) (Park et al., 2004) (Delaney et al., 2006) (Igaki, 
2009). 
 
Figure 5. The JNK pathway is activated by one of tree cell surface ligand-receptor systems, 
TNF-TNFR (Eiger/Wengen), PVF/PVR (PDGF/PDGFR) or Wingless/Frizzled. These pass the signal 
to the adaptor proteins TRAFs, Dishevelled (Dsh), small GTPases or the Ste20-related kinase 
Misshapen (Msn). Adaptor proteins activate the core JNK signaling complex consisting of JNKKK 
(dTAK1, DASK1, Slpr, and dMekk1), JNKK (Hep), and JNK (Bsk). The activated JNK cascade 
triggers the phosphorylation of the transcription factors Jra and Kay (Jun and Fos homologs) (Igaki, 
2009) 
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6.3.3 The Toll pathway 
The Drosophila Toll pathway functions in response to Gram-positive bacteria and 
fungi. It also has a role in establishing the dorsal-ventral patterns of the early 
embryo (Anderson et al., 1985; Royet et al., 2005{Jin, 2008 #201)}(Lund et al., 
2010). The Drosophila Toll receptor is a cytokine receptor, thus it does not directly 
bind pathogens like do the human Toll-like receptors (Medzhitov et al., 1997) 
(Huang et al., 2010; Tabuchi et al., 2010; Tauszig et al., 2000). Recognition of 
Gram-positive bacteria is mediated via the circulating receptors PGRP-SA and 
PGRP-SD. There are some indications that PGRP-SA actually functions in a 
complex together with a lysine-type peptidoglygan processing enzyme, Gram-
negative binding protein 1 (GNBP-1). Nevertheless, bacterial and fungal recognition 
leads to serine protease activation and the cleavage of a cytokine called Spätzle. 
Once cleaved, Spätzle binds to the Toll receptor inducing Toll dimerization 
(Lemaitre et al., 1996) (Michel et al., 2001) (Wang et al., 2002) (Gobert et al., 2003) 
(Bischoff et al., 2004; Weber et al., 2003) (Pili-Floury et al., 2004) (Kambris et al., 
2006) (El Chamy et al., 2008) 
 
Activated Toll delivers the signal into the intracellular components of the Toll 
pathway. These include the DD proteins dMyd88, Tube and Pelle. After 
dimerization, Toll binds to a pre-existing Myd88/Tube complex that eventually 
recruits the Pelle kinase, homologous to the mammalian IRAK (Medzhitov et al., 
1998; Shen and Manley, 2002). This then leads to the phosphorylation and 
degradation of the NFк-B inhibitory protein Cactus. The kinase, which directly 
phosphorylates Cactus, remains to be discovered, but the degradation of Cactus 
releases DIF and /or Dorsal to translocate into the nucleus and activate the 
transcription of many immune response genes such as Defensin, Drosomycin, 
Cecropin and Metchnikowin (Medzhitov and Janeway, 1998) (Rosetto et al., 1995) 
(Horng and Medzhitov, 2001) (Bilak et al., 2003; Tauszig-Delamasure et al., 2002) 
(Tanji and Ip, 2005) (Kuttenkeuler et al., 2010; Zhang and Zhu, 2009). 
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Figure 6. The Toll pathway Gram-positive bacteria are recognized by PGRP-SA 
cooperatively with GNBP1 and PGRP-SD. Similarly, fungi are recognized by GNBP3. Mediated by 
Grass, this recognition results in the activation of a proteolytic cascade leading to the cleavage of 
Spätzle by the serine protease Spätzle Processing Enzyme (SPE). Cleaved Spätzle binds to the Toll 
receptor, causing Toll dimerization and the activation of the intracellular signaling cascade 
comprising MyD88, Tube and Pelle, and culminating in the phosphorylation and degradation of the 
NFкB inhibitory protein Cactus. This allows Dif/Dorsal to translocate into the nucleus and induce the 
transcription of immune response genes. The Toll pathway can also be activated by 
entomopathogenic fungi through virulence factors such as secreted proteases and chitinases, which 
activate the circulating serine protease Persephone.  
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6.3.4 The JAK/STAT pathway 
The Drosophila JAK/STAT pathway is involved in multiple processes, including 
embryonic segmentation, larval hematopoiesis and the development of various 
organs, the regulation of stem cell maintenance and cellular proliferation (Beebe et 
al., 2010; Bina et al., 2010; Conder and Knoblich, 2009; Flaherty et al., 2010; Wang 
and Huang, 2010). In addition, Drosophila JAK/STAT signaling has an important 
role in controlling immune and stress responses after septic injury. After septic 
injury, the activation of the JAK/STAT pathway leads to the expression of a number 
of genes including the Turandot (Tot) stress genes in the fat body. (Ekengren and 
Hultmark, 2001; Ekengren et al., 2001) (Hombria and Brown, 2002) (Muller et al., 
2005) (Baeg et al., 2005) (Dostert et al., 2005) (Singh et al., 2005) (Brun et al., 
2006). 
 
The main components of the JAK/STAT signaling cascade are well characterized 
and conserved in evolution from flies to mammals, with the exception that 
Drosophila only has one Janus tyrosine kinase (JAK), hopscotch (hop), and a single 
STAT transcription factor, Stat92E. Binding of an extracellular ligand, the cytokine-
like molecule Unpaired (Upd) to the transmembrane receptor Domeless (Dome), 
which shares homology with the interleukin 6 (IL-6) receptor family, induces a 
conformational change in the receptor (Brown et al., 2001). This leads to the 
activation of a nearby Hopscotch by auto- and/or trans-phosphorylation. Once 
phosphorylated, Hop phosphorylates tyrosine residues on the receptors thereby 
introducing docking sites for STATs, which concurrently are phosphorylated by 
JAKs as well. Phosphorylation activates STAT causing it to dimerise and 
translocate in the nucleus where STAT dimers act as transcriptional activators of 
target genes such as TotM. (Perrimon and Mahowald, 1986) (Binari and Perrimon, 
1994) (Harrison et al., 1998) (Hou et al., 2002) (Agaisse et al., 2003) (Gilbert et al., 
2005) (Hombria et al., 2005). 
 
The JAK/STAT pathway is tightly regulated by a number of cytokines and growth 
factors. There are few known regulators of the JAK/STAT pathway that are also 
found functionally unchanged in the mammalian system. These include a family of 
SOCS-like genes (Drosophila homolog of suppressor of cytokine signaling gene 
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family), dPIAS/Su(var)2-10 (Drosophila Protein Inhibitor of Activated Stat) and 
STAM (Signal Transducin Adaptor Molecule) (Hou et al., 2002) (Baeg et al., 2005) 
(Muller et al., 2005) (Arbouzova and Zeidler, 2006; Gronholm et al., 2010). 
 
 
 
Figure 7. The JAK/STAT signaling pathway in Drosophila Binding of the 
extracellular ligand Upd to the receptor Dome causes a conformational change and allows Hop 
(attached to the intracellular domain of Dome) to trans-phosphorylate. Activated Hop phosphorylates 
Dome and activates cytoplasmic STAT. Activated STAT dimers translocate into the nucleus and 
activate the transcription of Turandot genes. PIAS inhibits activated STAT by targeting it for 
degradation. STAM is predicted to act as a positive and SOCS as a negative regulator of Hop.  
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7 AIMS OF THE STUDY 
 
The overall aim of this study was to gain a detailed view of the signaling pathways 
regulating Drosophila host defense. This included determining all of the gene 
products involved in Drosophila NFк-B- and the JAK/STAT signaling. Thus, we set 
out to to validate previously characterized genes as well as to identify new gene 
products involved in signaling via these pathways. We approached this goal using 
two powerful systems biological methods: microarrays and genome-wide RNAi 
screening. 
 
 
 
More specifically, the aims were: 
 
1. To find new gene products involved in the Drosophila host response using 
microarray analysis to determine genes induced in response to microbes.  
 
2. Determine the role of unknown immune-response genes for microbial 
binding, phagocytosis and AMP release controlled by NFк-B signaling. 
 
3. To identify all of the gene products involved in both NFк-B and JAK/STAT 
signaling using genome-wide RNAi screens in Drosophila cells. And to 
determine the in vivo significance of selected genes using a UAS-GAL4-
based in vivo RNAi system. 
 
43 
8 MATERIALS AND METHODS 
8.1 Cell lines and culture 
8.1.1 S2 cells 
Drosophila Schneider-2 (S2) cells were grown in Schneider medium (Sigma-
Aldrich, St. Louis, MO) supplemented with 10% Fetal bovine serum (FBS, 
Gibco/Life Technologies, Carlsbad, CA), 100units/ml of penicillin and 100 µg/ml of 
streptomycin at +25°C.  
8.1.2 Hela cells 
Human HeLa cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
plus GlutaMAx cell culture medium (Gibco) supplemented with 10% FBS, 100U/ml 
of penicillin, 100 µg/ml of streptomycin and 1% nonessentials amino acids (Sigma) 
at +37°C. 
8.2 Oligonucleotide microarray analysis 
A 3.0 x 10
6
 culture of S2 cells was incubated with 3.0 x 10
7
 heat-killed Escherichia 
coli for 6 hours. Total RNA was extracted from S2 cells using the RNeasy Mini kit 
(Qiagen) and gene expression was analyzed using the Affymetrix (Santa Clara) 
Drosophila Genechips according to standard protocols provided by the 
manufactures. The extracted RNA was reverse transcribed into cDNA, which was 
used as template for the synthesis of labeled RNA. The labeled RNA was 
fragmented and analyzed using gene chips. Each gene is represented as a probe set 
of 10-25 oligonucleotide pairs in a single chip. The probe pair comprises a 
nucleotide sequence, which perfectly matches the gene (PM) and one that has a 
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mismatch (MM). In the experiment, biotin-labeled RNA is hybridized to the array 
which is stained with phycoerytrin-conjugated streptavidin after washing, and 
scanned using the Gene Array Scanner. A grid is automatically laid over the array 
image and the intensities of each probe pair are used to make expression 
measurements with the Affymetrix Microarray Suite. The gene expression levels of 
four uninduced and control dsRNA treated S2 cells were compared pair-wisely to 
four E. coli induced samples and to three E. coli induced and PGRP-LC RNAi 
treated samples. For more details, see Drosophila GeneChip Expression Analysis 
Technical Manual by Affymetrix (2001). 
 
8.3 Flow cytometry 
8.3.1 Synthesis of targeted dsRNAs 
Total RNA was extracted from cultured S2 cells using TRIZOL® Reagent (Gibgo). 
Thereafter, first-strand cDNA was synthesized from 1.0 µg of total RNA. Gene 
specific primers for targeted dsRNA treatments were designed based on the 
sequences found at www.fruitfly.org. The templates for dsRNA synthesis were 
generated from cDNA by a two-step PCR reaction. The first set of primers 
contained 15 base gene specific sequences and the second PCR reaction was 
performed using nested primers containing a T7 promoter sequence on its 5’-end 
(GAATTAATACGACTCACTATAGGGAGA) attached to gene-specific 
sequences. Both sense and antisense RNAs are synthesized simultaneously from a 
single PCR product using the T7 MegaScript RNA polymerase (Ambion, Austin, 
TX) (Ramet et al., 2001). dsRNA was precipitated with LiCl. The quality of 
DNAase-treated dsRNA was analyzed by agarose gel electrophoresis and the 
concentration of the RNA was measured with a spectrophotometer.  
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8.3.2 dsRNA treatments and FACS analysis 
The ability of targeted dsRNA treated S2 cells to bind and phagocytose heat-killed, 
FITC-labeled E. coli and Staphylococcus aureus (Molecular Probes, Leiden, 
Netherlands) compared to GFP dsRNA treated control cells was quantified using 
flow cytometry (Ramet et al., 2002b). For dsRNA treatment, 10 µg dsRNA per 10
6
 
S2 cells were added directly into the cell culture medium 72 h prior to 
measurements. A total of 5.0 x 10
5
 dsRNA treated S2 cells were transferred onto 48-
well plates and cells were allowed to attach onto plates for 1 h at room temperature.  
Thereafter, cells were kept at +4°C for 30min. Once cooled, cells were exposed to 
FITC-labelled E. coli or S. aureus, plates were centrifuged for 1 min at 100 x g at 
+4°C and incubated for 1 h at +4°C to allow binding to occur. An additional 
incubation at +26°C was carried out to allow phagocytosis, 16 min for E. coli and 30 
min for S. aureus. Binding and phagocytosis were stopped by placing cell plates on 
ice and plates kept on ice at all times during the analysis. For measurements, the cell 
culture medium was replaced with PBS and cells were transferred into flow 
cytometry tubes.  Flow cytometric analyses were done by FACS using the EXPO32 
program (Beckman Coulter, Ordior). For the phagocytosis analysis, 0.2% Trypan 
blue in 1 x PBS (pH 4.85) was added before the measurement to quench the 
fluorescence of non-internalized particles on cells surface.  5,000-10,000 cells were 
counted for each sample and the rate of phagocytosis was quantified as the 
percentage of fluorescence positive cells multiplied by the mean fluorescence.   
 
8.4 RNAi screens 
8.4.1 Drosophila dsRNA libraries 
For our genome-wide RNAi screen we produced a total of 16,025 dsRNAs. For 
synthesis, we used a commercial Drosophila genome RNAi library consisting of a 
set of 13,625 PCR products with dual T7 promoter sequences (Medical Research 
Council (MRC) Geneservice Ltd (Cambridge, UK)) as template for the synthesis of 
dsRNAs. In addition, we used our own S2 cell-derived cDNA library comprising of 
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2,400 plasmid templates. dsRNAs were synthesized with the T7 MegaScript RNA 
polymerase kit (Ambion, Austin, TX) according to the manufacturer’s instructions. 
The concentration of each dsRNA was measured using the PicoGreen dsDNA 
Quantitation Kit (Molecular probes) or NanoDrop (Thermo Scientific). Targeted 
dsRNAs were produced in a two-step PCR with nested primers containing a T7 
promoter sequence on its 5’-end as described above. The dsRNA targeting GFP 
used as a negative control was produced from the pMT/BiP/V5-His/GFP plasmid 
(Invitrogen). 
8.4.2 Luciferase reporter assay 
The effects of dsRNA treatments on signaling cascades were quantified by 
luciferase reporter assays. The basic idea is to transfect the cells with reporter 
plasmids containing the target gene attached to luciferase promoter sequences. The 
intensity of the light reaction generated by luciferase can be measured and it 
corresponds to the expression level of the target gene. An Attacin-luciferase 
expression vector was used for the Imd pathway, a Drosomycin-luciferase reporter 
was used for the Toll pathway and a TurandotM-luciferase reporter was used to 
monitor the activity of the JAK/STAT signaling pathway. An Actin 5C--
galactosidase reporter was co-transfected to control cell viability and transfection 
efficiency as well as to normalize results. 72 h after transfection and RNAi 
treatment, S2 cells were lysed in reporter lysis buffer (Promega) and luciferase and 
-galactosidase activities were measured using standard procedures (Ramet et al., 
2001). 
8.4.3 Reporter plasmids, transfections and dsRNA treatments 
Transfections, dsRNA-treatments and reporter assays were all performed according 
to same protocol. For the NF-кB signaling and for the Toll pathway alone, 1.0 x 106 
S2 cells were transfected with 0.1 μg (if not stated otherwise) of the Drosomycin-
luciferase (Drs-luc; (Tauszig et al., 2000)) and 0.1 μg of the Actin 5C-β-
galactosidase (Act 5C-β-gal) reporter plasmids using Fugene reagent (Roche). 0.5 
μg of dsRNAs was added into transfection mixture. 0.1 μg of the Toll10b-construct 
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was co-transfected with the reporter constructs to activate the Toll pathway. For the 
genome-wide screen, in order to screen both the Toll and the Imd pathway 
simultaneously, the Imd pathway was later activated by adding heat-killed E. coli 48 
h after transfection, 24 h prior to measurements. The transfections, dsRNA 
treatments and reporter assays were performed accordingly when assessing the Imd 
pathway, except that S2 cells were transfected with 0.1 μg of the Att-luc reporter 
construct, Ecdysone was added into the cell culture media to a 1µmol concentration 
48 h after transfection, and the pathway was activated by adding heat-killed E. coli 
as described above (Zhang and Palli, 2009). When analyzing JAK/STAT signaling, 
0.1 μg of the TotM-luc reporter was used and the pathway was activated by co-
transfecting cells with 0.1 μg of the hopTum-l reporter construct.  
 
Human HeLa cells were cultured as described above. For transfections, HeLa cells 
were seeded onto a 24-well plate, 6 x 10
4
 cells per well and incubated for 24 h.  
Thereafter,  cells were transfected with 0.1 μg of the NF-B-luciferase and 0.05 μg 
of the CMV-β-galactosidase reporter plasmid and 50pmol of siRNAs (Amersham) 
using Lipofectamine transfection reagent (Invitrogen) and OPTI-MEM medium 
(Gibco). siRNAs used were as follows: GFP siRNA (eGFP; cat# AM4626, neg. 
control), GRK5 siRNA (cat# AM16704; ID: 110898) and RelA (cat# AM16704; ID: 
216912, positive control). NF-κB signaling was induced for 48 h post transfection 
with 10 ng/ml of TNF- (Sigma). 6 h later the cells were lysed and luciferase and β-
galactosidase activities were measured from the lysates.  
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Figure 8. Schematic representation of the methods used in the systems 
biological study of Drosophila immune signaling.  
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8.5 Immunodetection 
8.5.1 Confocal microscopy with Gprk2/GRK5 constructs 
For immunodetection, the Drosophila Gprk2 was cloned into a Drosophila 
expression vector. The full length cDNA for the Gprk2 gene was first amplified by 
PCR and cloned into the KpnI site of the modified Drosophila expression vector 
pMT/GFP/V5/His, (gift from Dr. Iivari Kleino) to create a Gprk2-GFP fusion 
protein. S2 cells were seeded onto 24-well plates and transfected with 0.1 µg of the 
Gprk2-GFP fusion construct using Fugene reagent (Roche). Overexpression of the 
Gprk2-GFP fusion proteins was induced 24 h post-transfection by adding CuSO4 to 
a final concentration of 350µM. Cells were harvested 36 h later and passed 1:3 in 
Schneider’s cell culture medium onto 6-well plates. The cells were incubated for 30 
min to allow the cells to attach to coverslips on the bottom on each well. Thereafter, 
the culture medium was removed and the cells were fixed with 3.7% formaldehyde 
and 5% sucrose for 20 min. The coverslips were washed three times with PBS and 
mounted to objective slides with Vectashield mounting medium for fluorescence 
with 4_,6-diamidino-2-phenylindole (Vector Laboratories). For HeLa cell 
transfections, cells were grown on coverslips on the bottom 6-well plates for 24 h 
after which the cells were transfected with 0.1 μg of the GRK5-GFP construct. 
Transfected HeLa cells were grown for 36 h and the coverslips were collected and 
washed. Coverslips were mounted to objective slides as described above. Both S2 
and HeLa cells were imaged with a Olympus IX70 confocal microscope and 
analyzed with the Andor iQ software. 
 
8.5.2 Coimmunoprecipitation and Western blotting 
For coimmunoprecipitations and Western blotting analyss, S2 cells were transferred 
into 6-well plates and transfected with 0.5 µg of Gprk2-V5 full length or deletion 
constructs and Cactus-myc constructs in the pMT/V5/HisA vector (Invitrogen Life 
Technologies). 24 h post-transfection, the expression of the tagged proteins was 
induced by adding CuSO4 directly to cell culture medium to a final concentration of 
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250µM.. After a 48 h incubation, cells were lysed in 1% Nonidet P-40 lysis buffer 
(50 mM Tris-HCl (pH 7.4), 50 mM NaCl, 0.5% sodium deoxycholate, 20 mM NaF, 
1% Nonidet-P40, 10% glycerol, 100 µg/ml PMSF, and a Complete Mini protease 
inhibitor cocktail (Roche Applied Science)). Protein concentrations of lysates were 
measured with the BCA protein assay kit (Pierce) and a lysate volume 
corresponding to 1mg of total protein for each sample was treated with 25 µl of a 
1:1 suspension of protein GSepharose (GE Healthcare) in lysis buffer and incubated 
rotating for 50 min at 4°C. Cleared supernatants were transferred to fresh tubes in 
which 25 µl of protein G-beads were added to 1µg of anti-c-Myc rabbit IgG Ab. The 
samples were incubated overnight rotating at 4°C to allow co-immunoprecipitation 
and immunoprecipitates were washed for 4 x 10 min with PBS containing PMSF 
and protease inhibitors. Immunoprecipitates were released from the beads by adding 
25 µl of 2 x SDS loading buffer, vortex, and incubated at 95°C for 5 min and 
proteins were separated by electrophoresis in a NuPAGE 10% Bis-Tris gel 
(Invitrogen Life Technologies). Protein samples were blotted on to a nitrocellulose 
membrane and detected with a 1/5000 dilution of a mouse anti-V5 or rabbit anti-c-
Myc primary Ab and by goat anti-mouse or anti-rabbit Ab HRP conjugates 
(Invitrogen Life Technologies), respectively, and visualized with the enhanced 
chemiluminescence method (ECL) Plus Western blotting detection system (GE 
Healthcare). 
 
8.5.3 Stable S2/epidermal growth factor receptor-Toll cells 
The response of the Toll signaling pathway to EGF was analysed in stable 
S2/EGFR-Toll cells using the Drs-luc construct. For the analysis, S2 cells with a 
stable integration of a chimeric EGFR-Toll construct were established according to 
(Sun H, 2004).  Stable S2/EGFR-Toll cells were seeded onto 6-well cell culture 
plates in total volume of 3 ml and treated with 5 µg/ml of dsRNA. After 4 days, the 
Toll pathway was induced by adding 0.5 µg/ml of EGF (Molecular Probes) for 30 
min, cells were lysed and cytoplasmic extracts were separated by electrophoresis. 
The separated proteins were transferred to a Hybond-P membrane (Amersham 
Biosciences) and blocked. A polyclonal rabbit anti-Cactus antibody and a HRP-
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linked donkey anti-rabbit IgG (GE Healthcare) were used to detect the cactus 
protein on the membrane. As a loading control, we used a rabbit polyclonal anti-
GM130 antibody (Abcam) that recognises the Drosophila Golgi protein GM130. 
Signals intensities were measured on three separate Western blots and band 
quantifications were done with the Adobe Photoshop 7 software (Adobe systems, 
San Jose, CA). All experiments with the stable S2/EGFR-Toll cells were carried out 
by Ylva Engström and her co-workers at the Department of Molecular Biology and 
Functional Genomics, Stockholm University, Sweden. 
 
8.6  Quantitative RT-PCR 
8.6.1 Total RNA extraction from S2 cells and in vitro qRT-PCR 
Approximately 1.0 x 10
6
 S2 cells were seeded onto 24-well cell culture dishes and 
transfected with 0.2 g of hopTum-l and 0.5 g of control or experimental dsRNA. 
After a 72 h incubation, cells were harvested and lysed in TRIsure reagent 
(Bioline) by pipetting up and down for 10 times. Total RNAs were extracted 
essentially as stated in the manufacturer’s protocol. Quantitative RT-PCR for TotM, 
TotA, and CG14225 and Act5C levels was carried out from the dilutions of extracted 
RNAs using the QuantiTect SYBR Green RT-PCR Kit (Qiagen) and the ABI7000 
instrument (Applied Biosystems) according to the manufacturer’s instructions. qRT-
PCR to determine the expression levels of chosen genes related to NF-кB signaling 
was carried out accordingly, except that the Toll signaling cascade was activated by 
transfection of 0.1 g Toll10b. 
8.6.2 Fly RNA extraction and in vivo qRT-PCR 
For the in vivo qRT-PCR, the JAK/STAT pathway was activated by pricking flies 
with a tungsten needle dipped into a concentrated culture of E. cloacae.  16h after 
infection, flies were collected and snap-frozen in dry ice. Groups of five flies were 
homogenized manually directly into Eppendorf tubes, and total RNAs were 
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extracted from the homogenates with TriSURE reagent (Bioline) according to the 
manufacturer’s instructions. Quantitative RT-PCR for TotM, TotA and Act5C levels, 
as well as expression levels of chosen genes related to NF-кB signaling, was carried 
out as described above.  
8.7 Cloning 
8.7.1 TA-cloning and sequencing 
 
The genes identified in the genome-wide screens were sequenced in order to 
design targeted PCR primers for dsRNA synthesis to confirm the original findings. 
PCR products corresponding to the genes of interest were used as templates for Taq 
polymerase-amplified (TA) cloning using the TOPO TA Cloning® system 
(Invitrogen) according to the manufacturer’s instructions. For the sequence analysis, 
the sequence of interest was blasted with NCBI blast at the NCBI web site 
(http://www.ncbi.nlm.nih.gov/). In order to identify similar regions between ET, 
Dome and gp130, ClustalW alignments were done at the EBI web site.   
 
8.8 Drosophila in vivo experiments 
8.8.1 Fly stocks and maintenance 
Drosophila stocks were kept on a standard mashed potato diet at RT or at 25ºC. 
C564-GAL4 driver flies, a kind gift from Professor Bruno Lemaitre (CNRS, 
France), express GAL4 in the adult fatbody; the P{UAS-Tl
10b
:11} stock carries a 
Toll
10b 
insert on the X chromosome and the hml
Δ
-GAL4, UAS-eGFP stock 
constitutively expresses GFP in the majority of its blood cells (Sinenko and Mathey-
Prevot, 2004). The UAS-RNAi fly stocks were purchased from the Vienna 
Drosophila RNAi Center [VDRC, Vienna, Austria; (Dietzl et al., 2007)] or the 
Kyoto NIG-Fly stock center (Drosophila Genetic Resource Center, Kyoto Institute 
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of Technology, Japan). UAS-RNAi flies were crossed with fat body and hemocyte 
specific C564-GAL4 flies, ubiquitous GeneSwitch-GAL4 driver flies or, w
1118
 flies 
for controls. Week-old offspring carrying one copy of the UAS-RNAi construct and 
one copy of the GAL4 driver were used for infections. 
 
8.8.2 Fly infections and survival experiments 
In order to study the Toll pathway-mediated immunity, experimental fly crosses 
were first pricked with a thin tungsten needle dipped into a concentrated culture of 
M. luteus to active the Toll pathway. 24h later the flies were additionally infected 
with E. faecalis by pricking them as above and their survival was monitored for 24 h 
at RT. For Imd pathway -mediated immunity, flies were infected with the gram-
negative bacterium Enterobacter cloacae (E. cloacae) as described above, kept at 
RT and their survival was monitored for 48 h. 
 
 
 
8.8.3 Fly larvae experiments 
To assess the distribution of blood cells in Drosophila larvae in vivo, parental 
crosses of experimental flies were kept on a stained mashed potato diet, which 
permits the staging of larval progeny (Zettervall et al., 2004) at 29°C for two days. 
Fly vials were assigned with arbitrary numbers in order to blind the experiment. 
After 48 h, larvae were collected, washed gently and embedded in 50% chilled 
glycerol with their dorsal side up between an objective glass and a cover slip. Slides 
were kept at -20°C for 18 min for immobilization and examined under UV-light on 
an Axioplan microscope (Carl Zeiss Jena). Digital pictures were taken with a 
Hamamatsu C4742-95 video unit, controlled by the Openlab program (Improvision, 
Coventry, UK). 
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Twenty F1 progeny larvae from each cross were divided into four grades depending 
on the percentage of segments showing a band formed by islets of sessile hemocytes 
under the epidermis. In the grading system, larvae were graded as follows: grade 1 
larvae showed sessile hemocyte bands in 100% of the segments. Grade 2 or 3 larvae 
showed bands in less than 75 or 50% of their segments and larvae showing no 
bands, or bands only in the most posterior 25% of their segments, received grade 4. 
All crosses were repeated three times and the average grades were calculated as 
triplicates. These experiments with fly larvae were carried out in Dan Hultmark’s 
laboratory at the Department of Molecular Biology, Umeå University, Umeå, 
Sweden. 
 
8.9 Data analysis 
The statistical analyses of reporter assays, qRT-PCR and Western Blot band 
quantifications were carried out using one-way ANOVA. The statistical analysis of 
fly larvae in vivo experiments was performed using one-way ANOVA and 
Bonferroni as a post hoc method.  The statistical analysis of fly survival experiments 
was carried out using the logrank (Mantel-Cox) test. P < 0.05 was considered to be 
statistically significant. 
 
Band quantifications with stable S2/EGFR-Toll cells Western blotting were done 
with the Adobe Photoshop 7 software: To obtain the absolute intensity, the mean 
value of each band was multiplied by the pixel value. The relative intensity was 
calculated by normalizing absolute intensities with the absolute intensity of the 
negative control, which was set to1. 
 
In a microarray analyses, genes whose RNA levels were affected in response to E. 
coli were analyzed using three criteria: the majority of 16 comparisons had to be 
affected and the remaining ones had to be not affected, the relative expression levels 
had to be changed at least three fold and the increase or decrease of the relative 
expression level had to be significant in the t-test (P < 0.05).   
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9 RESULTS 
9.1 Functional analysis of Drosophila immune response 
genes 
Microarray analysis is a convenient and widely used method for analyzing a large 
number of genes simultaneously. We used oligonucleotide microarrays to identify 
genes involved in the Drosophila immune response to heat-killed E. coli. The 
significance and biological roles of these genes were further analyzed in more detail 
by targeted RNAi-based functional studies.  
9.1.1 Microarray analysis of the genes induced in response to E. 
coli in Drosophila S2 cells 
In our microarray analysis, total RNA was extracted from S2 cells after challenging 
them with heat-killed E. coli. The expression levels of more than 13, 500 
Drosophila genes were measured using Affymetrix Drosophila genechips. We 
identified 53 genes that were up-reguated/whose expression was induced in 
response to E. coli by at least three-fold compared to untreated controls. The 
induction was peptidoglycan recognition protein LC (PGRP-LC) dependent for each 
of the 53 genes. Twenty-two had already been identified as differentially expressed 
proteins involved in the Drosophila host defense (De Gregorio et al., 2002). In our 
follow up studies, we aimed to determine the role of 31 genes with unknown 
function by targeted dsRNA treatments. We carried out an RNAi-based functional 
analysis of the genes with unknown function and evaluated their role in microbial 
binding, phagocytosis and antimicrobial peptide (AMP) release as regulators of both 
the Imd- and the Toll pathway. 
 
The 53 genes up-regulated in E. coli treated S2 cells are listed in Figure 9. Ten of 
these genes code for known antimicrobial peptides: Attacin B1 and D, Cecropin A1, 
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A2 and B, Diptericin B, Drosocin, Metchnikowin, Cecropin C and Drosomycin. The 
expression levels of three PGRP genes, PGRP-SA, PGRP-SD and PGRP-like gene 
(CG4437) were also induced in our assay. However, PGRP-SB1, PGRP-SC2 and 
PGRP-LB, which all are shown to be up-regulated in septic injury in vivo, were not 
induced (De Gregorio et al., 2002) (Irving et al., 2005).  
 
Among the induced genes were five putative serine protease-coding genes 
CG16731, CG8215, CG9370, CG3505 and CG10232, which may possibly 
contribute to melanization. In addition, we found two genes coding for the 
complement-like proteins Tep4 and Tep-like CG18589 as well as one homologue of 
the vertebrate α-2-macroglobulin receptor gene (CG4823) and the transcription 
factor gene Relish significantly up-regulated in response to the Gram-negative 
bacterium, E. coli. 
 
Figure 9: Genes induced in S2 cells by E.coli  
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9.1.2 The importance of immune response genes for Drosophila 
phagocytosis and immune signaling 
In our functional analysis, we used targeted RNAi treatments to determine the 
biological role of the genes with unknown function. At first, we designed primers 
for dsRNA treatments against the genes of interest according to the sequences found 
at the www.fruitfly.org website. The templates for dsRNA synthesis were generated 
from cDNA by a two-step PCR reaction resulting in T7 promoter sequence 
containing templates. Both sense and antisense RNAs were synthesized 
simultaneously from a single PCR product using the T7 MegaScript RNA 
polymerase.  
 
The binding and phagocytosis of FITC-labeled heat-killed E. coli and S. aureus 
were quantified using flow cytometry. Labeled heat-killed bacteria were incubated 
with RNAi treated S2 cells and the amount of bound or phagocytosed microbes was 
determined using flow cytometry (Ramet et al., 2002b). Our hypothesis was that 
upon microbial challenge, some of the genes expressed in the challenged S2 cells 
would encode opsonin-like proteins with roles in either phagocytosis or binding of 
the invading microbes. However, none of the studied genes proved to be important 
for the recognition or internalization of bacteria, since RNAi against any of the 
genes had no significant affect on these processes in our experimental setting. 
 
The possible effect of targeted dsRNA treatment on AMP release was determined 
using a Luciferase reporter assays. An Attacin-luciferase (Att-luc) reporter was used 
for the Imd–pathway and a Drosomycin-luciferase (Drs-luc) reporter was used for 
the Toll-pathway. An Actin 5C -galactosidase (Act5C--gal) reporter was used to 
normalize results. S2 cells were transfected with either Attacin- or Drosomycin –
reporter plasmids together with a -galactosidase expression vector. After RNAi 
treatment, cells were lysed and luciferase and -galactosidase activities were 
measured.  
 
In our luciferase reporter assay, we found only one dsRNA treatment that affected 
the Drs-luc reporter activity like it did the the activity of the Toll pathway. RNAi 
against CG15507 caused more than a 50% reduction in luciferase activity (Fig. 10). 
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This effect was also observed in our phagocytosis assay as the dsRNA treatment 
targeting CG15507 resulted in a 42±18% reduction in phagocytosis. However, we 
came to the conclusion that this effect is not specific to either phagocytosis or Toll 
signaling, since the RNAi targeting/ CG15507 also decreased cell viability as 
measured by the Act5C--gal reporter. A microscopic examination of the CG15507 
dsRNA treated cells also reveiled them to be unhealthy. 
 
Figure 10: RNAi against the gene CG15507 caused a marked decrease in the 
Drs-luc reporter activity but it also affected cell viability (Act5C--gal activity) 
 
 
Only one dsRNA treatment strongly decreased the Att-luc reporter activity mediated 
via the Imd pathway in S2 cells without affecting cell viability. RNAi against 
CG7097, a Ste20 family kinase named happyhour (Corl et al 2009), caused a 
52±30% reduction in Att-luc reporter activity in response to E. coli (Fig. 11). 
CG7097 presumably encodes a protein highly homologous to the mammalian 
mitogen activated protein kinase kinase kinase kinase (MAP4 K) isoform 3 (e
-132
) 
and to a germinal center kinase related protein kinase (e
-132
), since it has an N-
terminal Serine/Threonine kinase domain and a C-terminal CNH domain. To test 
whether CG7097 interacts with JNK, we carried out targeted dsRNA treatments 
against several known components of the JNK pathway. As shown in figure 10, 
dsRNA treatments targeting either kayak, msn, hep or aop caused a significant 
decrease in Imd pathway activity.  
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In addition, we identified two potential negative regulators of the Imd pathway. 
RNAi silencing the expression of CG15678 and β-Tubulin 60D resulted in the 
hyperactivation of the Att-luc reporter in response to Gram-negative E. coli. dsRNA 
treatments targeting CG15678 caused on average a 284±102% induction of the Imd 
pathway compared to GFP dsRNA treated controls, and CG15678 expression was 
also highly increased (10.3 fold) in response to E. coli in our microarray assay (Fig. 
12). CG15678 encodes a protein with unknown molecular function and it has no 
close mammalian homologues. It has been shown by previous studies to be induced 
by septic injury (De Gregorio et al., 2002). In addition, dsRNA treatment against β-
Tubulin 60D caused a 370±170% increase in the activity of the Imd pathway as 
measured by the Att-luc reporter assay. We studied the  role of Tubulin-associated 
proteins for the Imd pathway signaling further by targeted dsRNA treatments 
against α-Tubulin 84D (CG1913), and detected a strong, 738±107% increase in Imd 
pathway activity. Of note, the expression of hemocytes was further demonstrated by 
Irwing et al. in their studies on whole animals.  (Irving P et al. 2005). 
 
 
Figure 11: Att-luc reporter assay (targeted RNAi against CG7097 and JNK 
pathway components, [*** p≤0.001, ** p≤0.01])  
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Figure 12: Negative regulators: Att-luc reporter assay (dsRNA treatments 
targeting CG15678, β-Tubulin 60D and α-Tubulin 84D [*** p≤0.001])  
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9.2 Genome-wide RNAi in vitro screens to identify gene 
products necessary for Drosophila immune 
signaling 
 
Based on our previous work with Drosophila melanogaster we reasoned that 
genome-wide RNAi performed in vitro would be an extremely powerful method for 
identifying gene products necessary for antimicrobial peptide release in Drosophila 
(Kleino et al., 2005; Ramet et al., 2002b). First, Drosophila makes an excellent 
model for studying innate immune signaling, since it lacks adaptive immunity and 
relies only on innate immunity for defending against pathogen. This is an advantage 
compared to vertebrates, in which a highly sophisticated and complex immune 
system can compensate for the effects of RNAi against genes of interest. Second, 
innate immunity is well-conserved throughout evolution from insects to human. 
Therefore the fruit fly can be used as a model organism to study these responses and 
the results may be comparable to humans. Third, Drosophila is cheap and easy to 
maintain, and the RNAi is relatively simple to carry out. For example, Drosophila 
S2 cells take up dsRNA from the growth medium by scavenger receptor-mediated 
endocytosis (Ulvila et al., 2006), so the delivery of dsRNA into the cells can be 
accomplished simply by soaking cells in culture media containing dsRNAs. In 
addition, there is a plethora of genetic and molecular techniques available for 
Drosophila melanogaster enabling effective exploitation of the data obtained from 
these assays.  
 
We carried out two separate genome-wide RNAi-based in vitro screens to identify 
novel genes involved in immune signaling: a screen for genes involved in NF-ĸB 
signaling and another screen for JAK/STAT signaling. Our aim was to identify all 
the gene products involved in the Toll, Imd and the JAK/STAT pathways in a 
Drosophila in vitro model. The most interesting genes were later subjected to 
further functional studies.  
 
In our genome-wide RNAi-based in vitro screens, we used commercial PCR 
products representing the entire Drosophila genome (13,607 genes, MRC 
Geneservice, Babraham Bioincubator, Cambridge) and an additional 2,418 genes 
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from an S2 cell-derived cDNA library as template for dsRNA synthesis. The second 
PCR reaction and dsRNA synthesis were performed as stated above except that both 
reactions were carried out on 96-well plates. The concentration of each dsRNA was 
measured using the PicoGreen dsRNA Quantitation Kit (Molecular probes).  
 
9.2.1 A genome-wide RNAi in vitro screen to identify 
novel regulators of Drosophila NF-ĸB signaling  
Drosophila NFĸ-B signaling comprises two signaling pathways, the Toll and the 
Imd pathway (Ganesan et al., 2010; Lemaitre et al., 1995; Tanji et al., 2010). In our 
genome-wide RNAi in vitro screen, we used our earlier finding, indicating that in 
Drosophila S2 cells RNAi mediated knock-down of the Imd pathway components 
decreases the Toll
10B
 induced Drosomycin promoter-driven luciferase activity 
(Kleino et al., 2005). In order to define the specific roles of the Toll and the Imd 
pathways in regulating Drosomycin expression, we carried out an assay to analyze 
Drs-luc expression induced by both Toll
10B
 and E. coli. The S2 cells, transfected 
with appropriate reporter constructs, were co-transfected with Toll
10B
 to induce Toll 
signaling. Later, the cells were also exposed to heat killed E. coli to activate Imd 
signaling. Drs-luc reporter activity was measured to analyze Drs expression levels 
in response to both Toll
10B
 and E. coli. Our results demonstrate that Drs expression 
is controlled by both NFĸ-B signaling pathways, the Toll and the Imd pathway,, in 
S2 cells.  Overexpression of Toll
10B
 caused the induction of Drs expression as 
expected, and Drs expression was further induced when the Imd pathway was also 
activated with E. coli (Fig. 13). This Toll and Imd pathway stimulated induction of 
Drs expression was significantly decreased by RNAi against the Toll pathway 
components, Toll, Myd88 or dorsal. Furthermore, our results indicate, that the Imd 
pathway components, PGRP-LC, Imd, Tab2 and Relish are also essential for the 
normal induction of Drs expression in this assay. Drs induction is completely 
abolished if both NFĸ-B pathways are silenced by RNAi against both Relish and 
Myd88. These results are in line with previous reports and confirm that Drs-luc 
activity can be used to discover and identify novel components of both the Toll and 
the Imd signaling pathways.  
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Figure 13. Drs-luc reporter activity in both Toll
10B
 and E. coli induced S2 cells 
(Data is shown as the mean ± SD, n≥3, [*** p≤0.001]) 
 
On this premise, we analyzed the effects of 16,025 dsRNA treatments on the Drs-
luc reporter activity in Toll
10B
 and E. coli induced Drosophila S2 cells. Our aim was 
to identify all of the gene products required for signaling via the Toll and Imd 
pathways. With a cut-off of 50%, we found twenty-three out of 16, 025 dsRNA 
treatments that repeatedly decreased the Drs-luc reporter activity without affecting 
cell viability (Fig 14).  To validate these findings and to confirm that the RNAi 
effect really was due to dsRNA targeting the identified gene and to rule out off- 
target effects, the 23 genes were TA-cloned, sequenced and targeted PCR primers 
were designed based on the sequencing results. These PCR products were used as 
templates to synthesize targeted dsRNAs against the genes. With these targeted 
dsRNA treatments, we were able to verify, that our RNAi screen effectively found 
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components of both of the Drosophila NFĸ-B signaling pathways. Five of the 
identified genes represented known components of the Toll pathway (Toll, Myd88, 
tube, pelle and dorsal) and eight were known components of the Imd pathway 
(Relish, Kenny, Fadd, Tak1, imd, Tab2, Ird5 and Iap2) (III fig. 1C). Most 
importantly, we identified ten novel regulators of the Drosophila NFĸ-B signaling 
pathways. These genes were subjected to further studies. 
 
 
Figure 14. Results of the genome-wide RNAi screen of Drosophila NFĸ-B signaling 
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To find out which pathway is affected by these ten dsRNA treatments and which 
pathway they potentially regulate, we assayed the pathways separately. We carried 
out luciferase reporter assays in dsRNA treated and induced S2 cells. We used an 
AttA-luc construct to measure the activity of the Imd pathway in dsRNA treated and 
heat-killed E. coli induced S2 cells.  Accordingly, we used a Drs-luc construct in 
Toll
10b
 induced and dsRNA treated S2 cells to measure the activity of the Toll 
pathway. 
 
Out of these ten candidate genes, only one RNAi treatment, Mediator complex 
subunit 25 (MED25), affected Imd signaling approximately at the level of RNAi 
against known components of the Imd pathway (data not shown). In addition, RNAi 
against u-shaped caused a significant decrease (52%) in Imd pathway activity, and 
RNAi targeting achaete, Gprk2, pannier, CG4325 and CG32133 caused 
hyperactivation of the Imd pathway, whereas RNAi against Spt6, CG31660 and 
CG15737 had only a minor effect on pathway activity. 
 
Nine of the original candidate genes turned out to be regulators of the Toll signaling 
pathway, since RNAi against these genes decreased the Drs-luc reporter activity in 
Toll
10b
 induced S2 cells by more than 60% (II fig. 2B).  These findings were further 
confirmed with an qRT-PCR analysis of endogenous Drosomycin expression in 
dsRNA treated S2 cells. With regard to these findings, we concluded that u-shaped, 
pannier, CG4325, Gprk2, CG15737, CG32133, CG31660, achaete and Spt6 are 
novel regulators of and are required for accurate signaling via the Drosophila Toll 
pathway in vitro in S2 cells. Of note, MED25 RNAi had no significant effect on the 
Toll pathway alone. 
 
 
Epistasis analysis of the identified regulators of the Toll pathway 
To further investigate the role of the novel regulators identified in the screen, we 
carried out a cactus RNAi based epistasis analysis of these genes. Cactus is a 
Drosophila homolog for human Iĸ-B, and silencing cactus releases the Dif/Dorsal 
complex to translocate into the nucleus resulting in over a 40-fold induction of the 
Drs-luc reporter activity (II fig. 2E). In the epistasis experiment, Drs-luc expression 
was induced by cactus RNAi instead of Toll
10b
. This induction was blocked by ten 
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dsRNA treatments, dorsal, pannier, CG15737, Relish, Spt6, Gprk2, and CG4325, u-
shaped, CG32133 and achaete, indicating that these gene products act downstream 
or independently of Cactus. In contrast, dsRNA treatments targeting Toll, tube, 
pelle, CG31660 and MyD88 had very little or no effect on this induction, therefore 
these gene products appear to act upstream of Cactus. 
 
 
9.2.2. Genome-wide RNAi analysis of the Drosophila 
JAK/STAT pathway 
 
In addition to the genome-wide analysis of the Drosophila NFĸ-B signaling 
pathways, we carried out a genome-wide RNAi-based in vitro screen to analyze 
Drosophila JAK/STAT signaling. It has been shown that under stressful conditions, 
such as after septic injury, several Turandot (Tot) stress genes are expressed in the 
Drosophila fat body, and that this expression is regulated via the JAK/STAT 
pathway (Ekengren and Hultmark, 2001; Ekengren et al., 2001) (Agaisse et al., 
2003) (Brun et al., 2006).  Based on this information, we used a Stat92E responsive 
TurandotM-luciferase (TotM-luc) reporter based assay to monitor JAK/STAT 
pathway activity in Drosophila S2 cells. Since the intracellular part of the 
JAK/STAT pathway downstream of the JAK kinase is especially well conserved, 
we decided to activate signaling using the constitutively active form of the 
Drosophila JAK kinase hopscotch (hop
Tum-l
) (Harrison et al., 1995) (Luo et al., 
1995).  
 
As shown in III fig. 1A, hop
Tum-l
-induced TotM-luc reporter activity is a valid 
means of studying the regulation of the JAK/STAT pathway in Drosophila S2 cells. 
First, TotM-luc reporter activity is induced by hop
Tum-l
 in Drosophila S2 cells in a 
STAT dependent manner, as RNAi targeting the transcription factor Stat92E almost 
completely blocks TotM expression. Second, our assay is specific for JAK/STAT 
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signaling because RNAi targeting the Imd pathway transcription factor Relish has 
no effect on hop
Tum-l
-induced TotM expression (data not shown).  
 
After validating our assay, we carried out a genome-wide RNAi analysis of the 
Drosophila JAK/STAT pathway in Drosophila S2 cells in order to identify all of the 
regulators of the JAK/STAT pathway downstream of hop. Altogether, we monitored 
the effects of 16,025 different dsRNA treatments on hop
Tum-l
-induced TotM-luc 
reporter activity in Drosophila S2 cells using the same pool of dsRNAs as described 
earlier. Again, Act5C--gal activity was used to monitor cell viability and GFP 
RNAi served as a negative control. The luciferase and -galactosidase values for 
GFP dsRNA treated cells were set to one and used as reference values for 
experimental dsRNAs. RNAi against STAT92E was used as a positive control in 
each assay.  
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Figure 15. Results of the genome-wide screen for JAK/STAT pathway signaling 
 
 
Figure 15 shows the results of 16,025 different dsRNA treatments analyzed for their 
effect on hop
Tum-l
 –induced TotM-luc activity. As expected, most dsRNA treatments 
had little or no effect. Importantly however, we found seven dsRNA treatments that 
repeatedly decreased TotM-luc activity by more than 50% without significantly 
affecting cell viability as represented by Act5C--gal activity. Out of these seven 
dsRNA treatments, two targeted known components of the JAK/STAT pathway 
(Stat92E and hop) and one targeted a previously characterized regulator of the 
JAK/STAT pathway (enok) (Baeg et al., 2005) (Muller et al., 2005),  demonstrating 
the efficiency of our screen to find components of the JAK/STAT signaling 
pathway. In addition, we found four putative novel regulators (Taf1, CG31716, 
CG14225 and Med27) essential for JAK/STAT signaling.  Again, the corresponding 
templates from the original library were TA-cloned and sequenced and gene specific 
primers were designed. Targeted independent dsRNAs were synthesized against 
these novel regulators and the reporter assays were repeated with these dsRNAs. As 
shown in III fig. 1C, all five targeted dsRNA treatments decreased TotM-luc 
reporter activity comparably to dsRNAs from the library.  
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To further confirm our findings and to ensure that the results were not due to any 
artifact related to the reporter assay, we used qRT-PCR to study endogenous TotM 
and Act5C expression levels in hop
Tum-l
 -transfected and dsRNA treated S2 cells. 
The results of this qRT-PCR assay further confirmed our findings that enok, Taf1, 
CG31716, CG14225 and Med27 are potential regulators of the Drosophila 
JAK/STAT pathway and that these genes are required for a normal hop
Tum-l
 -
induced TotM response in S2 cells. RNAi targeting any of the identified genes 
resulted in at least a 50% reduction in relative TotM expression levels (III fig 1D). 
We decided to subject these five genes to further studies. 
 
 
9.3 Functional characterization of the selected genes 
identified in the screens 
 
To gain more insight into the role of the genes identified in the RNAi screens, we 
carried out a set of functional in vitro studies of the selected genes. In addition, we 
carried out a set of functional studies for the five potential regulators of the 
JAK/STAT signaling pathway. 
 
9.3.1 Functional analysis of the G protein-coupled receptor 
kinase in Drosophila cells 
Of the genes identified in the RNAi screens, we chose to study the function of 
Gprk2 in more detail. Gprk2 has a strong in vitro phenotype and is evolutionarily 
conserved. In fact, Drosophila Gprk2 shares high sequence similarity with the 
human, mouse and zebrafish GRK5s. Drosophila Gprk2 belongs to a family of 
multifunctional GTPase-accelerating proteins (De Vries L, 2000). It is a 714-aa 
protein with three known domain structures: a regulator of G protein signaling 
(RGS) domain, a serine/threonine protein kinase catalytic domain and a kinase 
domain extension. To investigate the cellular localization of Gprk2, we 
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overexpressed a Gprk2-GFP construct in S2 cells. As shown in Figure 16A, Gprk2 
is localized on the cell membrane or in the cytoplasm. A similar localization pattern 
is observed with a GRK5-GFP construct when overexpressed in HeLa cells (Fig 
16B). On this premise, we decided to investigate whether GRK5 has the same 
evolutionary conserved role in NFĸ-B signaling. A similar RNAi-based luciferase 
reporter assay was carried out with GRK5 (II fig. 4B). HeLa cells were transfected 
with NFĸ-B luciferase and CMV-β-galactosidase reporters together with GRK5 or 
control siRNAs, and NFĸ-B signaling was induced with TNFα six hours prior to 
measurements. The relative NFĸ-B-luc activity was reduced more than 60% in 
GRK5 siRNA treated HeLa cells indicating that GRK5 is an important regulator of 
human NFĸ-B signaling in vitro. These findings were further confirmed in our in 
vivo studies with zebrafish, indicating that GRK5 is necessary for proper NFĸ-B 
signaling in the vertebrate immune system in vivo (II fig. 4D). 
 
 
Figure 16. Gprk2/GRK5 is localized on the cell membrane or in the cytoplasm 
in both Drosophila S2 cells (A) and in HeLa cells (B) 
 
 
Because we observed both sequence and functional similarities between Drosophila 
Gprk2 and vertebrate GRK5, and because of reports on mammalian GRK5 
interacting with members of the Iĸ-B family (Parameswaran et al., 2006) (Sorriento 
et al., 2008) (Patial et al.), we decided to study the potential interaction of Gprk2 
with Cactus and Dorsal. We co-immunoprecipitated myc-tagged Cactus and Dorsal 
with V5-tagged full-length Gprk2 or with three deletion constructs: a calmodulin 
(CaM) binding site deletion (ΔCaM1), an RGS-domain deletion (ΔRGS) and a 
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kinase deletion (Δkinase) in S2 cells. The full-length Grpk2 interacted with Cactus 
as did the ΔCaM1 and ΔRGS deletion constructs, indicating that these domains are 
not essential for the Grpk2 and Cactus interaction (Fig. 17). Conversely, an 
interaction between Cactus and the Δkinase construct could not be detected. This 
suggests that either the kinase domain is important for the interaction or such a large 
deletion itself causes the loss of function of the whole protein due to improper 
folding. Interactions between the V5-tagged Gprk2 constructs and Dorsal-myc were 
not detected. 
 
Figure 17. The full length Gprk2, the Calmodulin binding-site deletion 
(CaM1) and the RGS-domain deletion (RGS) constructs interact with the 
Cactus protein  
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In order to indentify the functional significance of the interaction between Cactus 
and Gprk2, we decided to investigate the potential role of Gprk2 in Cactus 
degradation. We set up an EGFR-Toll pathway induction system (Sun H, 2004) with 
S2 cells expressing a chimeric EGFR-construct. These cells were treated with GFP, 
Gprk2 and MyD88 dsRNAs and Cactus degradation was monitored by Western-blot 
(II fig. 5C). Additionally, we carried out kinase experiments with 
coimmunoprecipitated Gprk2 and Cactus. Grpk2 RNAi had no effect on Cactus 
degradation nor did the kinase experiments show any Gprk2-mediated Cactus 
phosphorylation, indicating that Gprk2 is not required for Cactus degradation upon 
signaling although it interacts directly or indirectly with the Cactus protein. 
 
9.3.2 In vitro characterization of Eye transformer 
We identified five putative regulators of the Drosophila JAK/STAT pathway in our 
genome-wide RNAi in vitro screen. Of these, CG14225, which we call Eye 
Transformer (ET), was subjected to further functional studies.  
 
ET is a negative regulator of the JAK/STAT pathway in Drosophila S2 cells 
To investigate the role of ET in a more physiological context, we overexpressed the 
natural ligand of the JAK/STAT pathway, unpaired (upd) to activate the pathway. 
TotM-luc and 10xStat92E-luc reporters were used to measure JAK/STAT pathway 
activity in ET dsRNA treated S2 cells. 10xStat92E-luc is a reporter consisting of a 
sequence containing a double Stat92E binding site from the SOCS36E enhancer 
region multiplied 10 times. This construct allowed us to study if ET is specific for 
regulating TotM expression or if it affects JAK/STAT target genes in a more general 
manner. As is shown in III fig. 2, the RNAi targeting CG14225 caused strong 
hyperactivation of both reporters compared to GFP dsRNA treated controls. These 
results are in total contrast to our results with the constitutively active hop
Tum-l
 
induction, and thus prompted us to investigate CG14225 gene more thoroughly.  
 
According to the literature, CG14225/ET is a 3.3 kb gene located next to the 
Drosophila JAK/STAT pathway receptor Domeless (Dome) and codes for a 713-aa 
type-I transmembrane protein sharing structural similarities with Dome (Hombria 
73 
and Brown, 2002; Makki et al., 2010). Intriguingly, ET’s closest human homologue 
is the signal transducing protein gp130, a protein associating with interleukin-6 (IL-
6) receptors, the mammalian receptors, which Dome resembles (Taga and 
Kishimoto, 1997). Thus, ET shares structural similarities with Dome and with 
mammalian gp130, both of which play key roles in JAK/STAT pathway regulation. 
 
In order to rule out the possibility that our results are due to unintended off-target 
effects or other artifacts of the assay, we designed an additional dsRNA targeting 
the third exon of ET (III fig. 3A). 10xStat92E-luc reporter assays were then carried 
out with both hop
Tum-l
 and upd induced S2 cells (III fig. 3B and 3C). The ET RNAi 
phenotype was confirmed with these results, since both ET-specific RNAi 
treatments caused a strong inhibition of the hop
Tum-l
 induced 10xStat92E-luc reporter 
activity and conversely, hyperactivation of upd induced the 10xStat92E-luc reporter 
activity.  The efficiency of the RNAi was further validated by analyzing ET mRNA 
levels in targeted dsRNA treated S2 cells by qRT-PCR (III fig. 3D). Both dsRNA 
treatments sufficiently suppressed ET expression compared to GFP dsRNA treated 
control cells.  
 
These RNAi phenotype results were further confirmed with our overexpression 
experiments. As shown in III fig. 3E, overexpression of ET decreased the upd-
induced 10xStat92E-luc activity, but increased hop-induced TotM-luc activity. Of 
note, since ET mRNA lacks UTR regions, we were not able to carry out any rescue 
experiments, where ET would be first silenced by dsRNAs targeting the UTR 
regions and this phenotype then rescued by overexpressing ET.  
 
Epistasis analysis of ET 
To gain more insight into the function of ET and to explain the opposite effects of 
ET RNAi in the reporter assays, depending on whether JAK/STAT signaling was 
activated using hop
Tum-l
 or upd, we performed an epistasis analysis of ET in S2 cells. 
We carried out dual RNAi treatments targeting, in addition to ET, the known 
components of the Drosophila JAK/STAT signaling pathway, hop, Stat92E or 
Dome, after which the activity of the JAK/STAT pathway was measured by the 
TotM-luc reporter. Our results indicate that ET is a negative regulator of the 
JAK/STAT pathway and functions at the level or upstream of the known 
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components, hop, Stat92E or Dome in S2 cells (III fig. 4A). ET RNAi caused a 
slight enhancement of the TotM-luc reporter activity and this activation was 
prevented by RNAi targeting any of the known Drosophila JAK/STAT pathway 
components (hop, Stat92E or Dome). These results explain the conflicting results 
gained from ET RNAi reporter assays depending on the level of JAK/STAT 
pathway activation.   
 
9.4 In vivo characterization of selected genes regulating 
Drosophila immune signaling 
  
 
To investigate if the nine candidate genes identified in the Toll screen are important 
for Toll signaling in vivo, the RNAi flies, carrying UAS-RNAi constructs targeting 
these nine genes were crossed with the C564-GAL4 driver line, which drives the 
expression of the dsRNA in the fat body. Flies that were crossed with w
1118
 i.e. flies 
without the driver, which therefore did not express any dsRNA were used as a 
negative control, and MyD88 RNAi flies crossed with the driver line were used as a 
positive control. Flies were pricked with a M. luteus contaminated needle to 
generate septic injury to activate the Toll pathway. After infection, total RNAs were 
isolated and relative Drosomycin expression levels were measured by qRT-PCR. As 
a result, we detected four in vivo RNAi fly lines with significantly decreased 
Drosomycin expression (II fig. 3). First, two Gprk2 fly lines, Gprk2 R-1 and Gprk2 
R-3, crossed with C564-GAL4 driver lines showed a significant degrease in 
Drosomycin expression. In addition, fly lines expressing the CG15737 and u-shaped 
RNAi constructs showed a statistically relevant reduction in Drosomycin expression 
compared to control flies. We decided to name the CG15737 gene Toll pathway 
activation mediating protein (TAMP). Flies carrying RNAi constructs against other 
genes identified in the screen showed no significant difference in Drosomycin 
expression compared to controls.  
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9.4.1 Gprk2 has an essential role in Drosophila Toll pathway 
mediated immunity in vivo 
To investigate the role of Gprk2 on Toll pathway mediated immunity in vivo, we 
carried out a series of experiments with Gprk2 RNAi flies.  First, we assayed the 
expression levels of Toll pathway target genes after a natural fungal infection. In 
addition, we examined the survival of Gprk2 RNAi flies upon E. faecalis infection. 
We also carried out in vivo experiments in Drosophila larvae in order to determine 
if Gprk2 RNAi can inhibit blood cell activation triggered by a constitutively 
activated Toll pathway.  
 
In order to assess the role of Gprk2 on signaling via the Toll pathway, we studied 
the expression levels of Toll pathway target genes, namely Drosomycin, IM1 and 
IM2, under a natural fungal infection. Gprk2 RNAi fly lines, Gprk2 R-1 and Gprk2 
R-3, were crossed with C564-GAL4 driver lines and these flies, as well as control 
flies, were subjected to the insect pathogen B. bassiana. After a 48 hour infection, 
total RNA was isolated and the expression of Toll pathway target genes was 
measured by qRT-PCR. w
1118
 flies crossed with C564-GAL4 flies were used as 
negative and MyD88 RNAi flies over C564-GAL4 flies as a positive control. RNAs 
isolated from the noninfected flies were used as a control for the infection. As a 
result, we discovered that Gprk2 is essential for Toll pathway-mediated immunity 
and that the expression of Toll pathway target genes is poorly activated in the 
Gprk2-silenced flies.  The expression of Toll pathway induced genes was reduced in 
both Gprk2 R-1 and Gprk2 R-3 RNAi flies crossed with the driver C564-GAL4 (II 
fig. 6). 
 
Gprk2 is also needed for a normal defense against the Gram-positive bacteria E. 
faecalis. In our survival experiment, we used septic injury with E. faecalis to 
examine if the Gprk2 silencing affects the Toll pathway enough to impair the fly’s 
survival. Both Gprk2 RNAi flies were crossed with C564-GAL4 driver flies. These 
flies were first immunized by pricking them with a needle dipped into a culture of 
M. luteus in order to activate the Toll pathway response, including Drosomycin 
expression. After a 24 hour immunization, flies were infected with E. faecalis by 
septic injury generated by pricking as above and the survival rate of the flies was 
monitored. Both Gprk2 RNAi flies crossed with the C564-GAL4 driver were more 
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susceptible to the E. faecalis infection and showed a statistically significant 
reduction in survival compared with control flies lacking the driver (II 7A and 7B).  
 
To further examine the role of Gprk2 in Toll signaling in vivo, we studied whether 
RNAi targeting Gprk2 can inhibit hemocyte activation generated by UAS-Toll
10b
. To 
do this, we combined Gprk2 R-3 RNAi fly lines and MyD88 as a control, with the 
blood-cell specific hml
Δ
-GAL4, UAS-GFP driver. Males originating from these 
stocks were crossed with females carrying UAS-Toll
10b
. As a negative control, males 
from the original driver line were crossed with females of the UAS-Toll
10b
 and with 
the w
1118
 line to gain treatment control. Progeny third-instar larvae were graded into 
four groups for the percentage of their segments. Segments showing bands were 
formed by islets of sessile hemocytes gathering under the epidermis. The 
constitutive activation of the Toll pathway in blood cells caused a largely disturbed 
sessile hemocyte banding pattern in the larvae of the negative control (II fig 7C and 
7D). This loss of the sessile hemocyte banding pattern could be rescued by reversing 
the constitutive Toll pathway activation i.e. by introducing Gprk2 or MyD88 RNAi 
constructs. In conclusion, RNAi targeting Gprk2 can rescue UAS-Toll
10b
 blood cell 
activation in Drosophila larvae in vivo.  
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9.4.2 ET is a negative regulator of Tot gene expression in vivo 
Our functional studies clearly showed, that ET negatively regulates the Drosophila 
JAK/STAT pathway signaling in vitro. In order to investigate whether ET is 
important for JAK/STAT signaling in vivo, we carried out in vivo RNAi 
experiments with fly lines carrying UAS-RNAi constructs targeting ET (ET IR
1
 and 
ET IR
2
) (Dietzl et al., 2007). RNAi flies and w
1118
 control flies were crossed with the 
C564-GAL4 driver line and flies were pricked with a E. cloacae contaminated 
needle. Thereafter, total RNA was isolated and the relative expression levels of both 
TotM and TotA were measured by qRT-PCR. As expected, the C564-GAL4 driven 
expression of UAS-Stat92E dsRNA significantly degreased both the TotM and TotA 
response compared to w
1118
 control flies. Moreover, ET RNAi flies crossed with 
C564-GAL4 driver flies showed a significant increase in both TotM and TotA 
expression in response to septic injury with E. cloacae (III fig. 6A and 6B). These 
results are in line with the earlier results from the in vitro studies and further 
confirm ET as a negative regulator of Tot gene expression in Drosophila in vivo. 
The relative expression level of ET was also measured in E. cloacae infected flies, 
but the infection showed no effect on ET expression compared to uninfected 
controls, indicating that ET expression is not regulated by the JAK/STAT or the Imd 
pathway activated in response to E. cloacae infection (data not shown).  
 
According to the literature, Tot gene expression is co-operatively regulated by the 
JAK/STAT and the Imd pathways upon septic injury in Drosophila (Agaisse et al., 
2003) (Brun et al., 2006). To this end, we tested if the effect of ET RNAi on Tot 
gene expression is mediated by the Imd pathway. ET RNAi flies were again crossed 
with C564-GAL4 driver line, pricked with a needle dipped into a E. cloacae culture, 
after which total RNAs were isolated. The relative expression level of Imd pathway 
mediated Attacin B (AttB) in response to the E. cloacae infection was measured (Fig 
18). Our results indicate, that ET does not have role in host defence regulation via 
the Imd pathway in vivo, since ET RNAi had no effect on AttB expression upon 
septic injury with the Gram-negative bacterium E. cloacae. 
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Figure 18. ET RNAi had no effect on AttB expression upon septic injury with 
the gram-negative bacterium E. cloacae, indicating that ET does not 
participate in host defence regulation via the Imd pathway in vivo. 
 
Because genetic background can have an effect on gene expression levels under 
experimental conditions, we decided to further analyze the ET RNAi in vivo 
phenotype using the GeneSwitch-GAL4 driver. GeneSwitch-GAL4 is a drug-
inducible driver, which activates the expression of a UAS-RNAi construct only 
when drug called Mifepristone is added to the fly food vials. These conditions 
provide a genetically relevant control, since the offspring from each cross can be 
monitored with and without the expression of dsRNA.  In response to septic injury 
with E. cloacae, ET RNAi flies crossed with GeneSwitch-GAL4 driver flies and 
induced by Mifepristone showed a significant increase in both TotM and TotA 
expression levels measured as above. In contrast, Stat92E RNAi strongly inhibited 
the expression of both genes, demonstrating that the GeneSwitch-GAL4 driver 
functioned as expected (III fig. 6C and 6D). Taken together, our results indicate 
that ET negatively regulates Tot gene expression in Drosophila in vivo, and 
functions independently of the Imd pathway mediated regulation. The importance of 
ET/latran was later demonstrated by another research group (Makki et al., 2010). 
 
79 
10 DISCUSSION 
Automation and computerized systems together with the availability of the genomic 
sequences of many species enabled the systems biological revolution in the 
twentieth century. With high-throughput methods, such as microarrays and genome-
wide screens, vast amounts of data can be obtained and processed. Therefore, the 
aims of systems biological studies are ambitious; the goal is to determine the basic 
mechanism of the biological system, identify all its components and define how it is 
regulated. This requires careful planning prior to experiments. It includes 
determining the hypothetical model of the system under study and defining potential 
problems related to the assay. 
 
 
Large-scale RNAi screening 
 
In the past decade, large-scale RNAi based in vitro screening has become a 
commonly used systems biological method for identifying gene products involved 
in a variety of biological processes (Ramet et al., 2002b) (Boutros et al., 2004). 
Nevertheless, one could argue whether RNAi based genome-wide in vitro screening 
is a genuine systems biological method. After all, only one gene is studied at a time. 
However, the screens do provide information on the entire system, and allow us to 
determine all of the components involved in the biological system under study, such 
as Drosophila immune signaling, as well as the regulation of the system. There are 
many benefits to Drosophila RNAi screening. The delivery of dsRNAs is easy; they 
can be introduced into S2 cells simply by soaking and S2 cells spontaneously take 
up dsRNA fragments as long as 1,000 bp from the cell culture medium (Ulvila et al., 
2006). As a technique RNAi itself is fast, effective and easy to carry out, and off-
target effects rarely present any problems.  
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However, in general, off-target effects are  a genuine problem related to RNAi based 
screening (Ge et al., 2003; Qiu et al., 2005). Off-target effects may occur, when a 
dsRNA delivered into cells contains a sequence that can bind and therefore silence 
multiple genes at the same time. In our assay set-up however, off-target effects 
presents rarely any problems. At least in one particular case, RNAi was shown, by 
microarray, to be completely specific  (Kleino et al., 2005). In our experimental 
setting, we typically deliver 700-1000bp of sequence specific dsRNA into  
Drosophila S2 cells. This gives rise to approximately 35-50 siRNAs. If one or two 
of these siRNAs are able to bind multiple genes, the remaining 33-48 siRNAs are 
likely more specific or at least do not target the same off-target gene. It is likely that 
the off-target effects are a greater problem in mammalian systems, where the 
siRNAs are delivered into cells one or only a few at a time. Nevertheless, one 
should always verify the observed phenotypes with at least two independent 
dsRNAs and if possible, carry out rescue experiments with dsRNAs that target the 
UTR of the endogenous gene (Fig 19). Of note, since ET mRNA lacks UTR regions, 
we were not able to carry out any rescue experiments, in which ET would be first 
silenced by dsRNA targeting the UTR regions and this phenotype would then be 
rescued by overexpressing ET from constructs lacking UTR regions. In addition, it 
is also important to control and monitor cell viability, especially when the rate of 
expression (in our assay luciferase expression) equals the activity of the signaling 
pathway. In our RNAi screen, the general well being of the cells was assessed using 
the Act5C--gal reporter.  
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Figure 19. Schematic representation of RNAi. The untranslated regions (UTRs) can 
be used to validate the efficiency of RNAi. The gene of interest is first silenced by dsRNA 
targeting the UTR regions and then rescued by overexpressing the same gene from 
constructs without UTR regions 
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In addition to our work, two large-scale RNAi based screens have been carried out 
earlier to identify regulators of the Drosophila JAK/STAT signaling (Baeg et al., 
2005; Muller et al., 2005). Interestingly, the findings of these three screens show 
only minor overlap (Fig 20). In fact, only one gene, enok, was identified in all three 
screens. A similar divergence of the results can be seen when comparing our RNAi 
screen for regulators of the Drosophila NF-B signaling to three corresponding 
RNAi screens (Foley and O'Farrell, 2003) (Kambris et al., 2006) (Kuttenkeuler et 
al.).  
 
 
 
Figure 20. Results of the three screens identifying regulators of Drosophila JAK/STAT 
signaling showed very little overlap. Only one gene, enok, was identified in all three 
screens. 
 
 
This can be due to variety of issues, such as biological differences between the assay 
set-ups, cell lines chosen, reporters used and means of pathway activation, as well as 
different normalization approaches. All these factors create variation in the RNAi 
phenotypes rising from the screens. The smaller number of RNAi phenotypes in our 
screen corresponds to biologically meaningful cut-offs in our assay set up. In 
addition, we were able to repeat our original findings with targeted dsRNA 
treatments and importantly, validate our results at least with the one gene we chose 
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to study in vivo, with secondary and tertiary assays.  This variation between 
independent screens underlines the importance of careful planning of the screen and 
the validation of the results obtained. To confirm our screening results, we found it 
essential to TA-clone and sequence PCR templates corresponding to interesting 
RNAi phenotypes and design gene-specific primers to carry out independent RNAi 
with targeted dsRNAs. Thereafter, RNAi phenotypes were further validated with 
qRT-PCR quantification, where expression levels of endogenous target genes (Drs 
or TotM) were measured from S2 cell lysates treated with targeted dsRNAs. 
Similarly, the efficiency of the RNAi itself was demonstrated by qRT-PCR by 
measuring the absence of endogenous transcripts in the RNA extracted from S2 
cells treated with a targeted dsRNA against the gene in question. 
 
In both genome-wide screens (Toll and JAK/STAT), we chose to activate the 
pathways with constitutively active forms of pathway components, the Toll pathway 
with  Toll
10b 
and the JAK/STAT pathway with  Hop
Tuml
 , instead of cytokine 
induction. The approach was taken to study the evolutionarily conserved 
intracellular part of these pathways and to exclude the extracellular part of the 
signaling cascade. Due to this arrangement, some of the upstream regulators of both 
pathways remain unknown, and may to some extent explain the smaller number of 
genes identified in our studies.  
 
 
In vivo validation of the results 
 
The fruit fly’s evolutionarily conserved immune system makes Drosophila 
melanogaster an excellent model for studying the principles of innate immunity. For 
our purposes, studying the innate immune reactions using RNAi, Drosophila is the 
best possible model to use. The basic mechanisms of Drosophila immunity are 
highly conserved throughout evolution and the data obtained may have relevance to 
mammalian models. Drosophila lacks adaptive immunity, so the RNAi mediated 
knock-down of the gene studied is not compensated by adaptive immune reactions. 
Finally, Drosophila is cheap and easy to maintain and there is a large amount of 
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genetic and molecular techniques available for Drosophila, enabling effective 
exploitation of the data obtained from the studies.  
 
In vivo RNAi in Drosophila provides a readily accessible tool for observing the 
functional importance of a selected gene product on the scale of  the whole 
organism., Transgenic Drosophila RNAi fly collections, namely the VDRC 
(Vienna, Austria) and NIG-fly (Kyoto, Japan) are commercially available for this 
purpose. In these flies the target gene is silenced through the production of hairpin 
dsRNAs when the flies are crossed with an appropriate GAL4 driver fly line. We 
used this approach to validate the selected RNAi phenotypes of both screens in vivo. 
For the ET in vivo validation, flies carrying UAS-RNAi constructs for ET (ET IR
1
, 
ET IR
2
) were crossed with the C564-GAL4 driver and the offspring was infected 
with E. cloacae to induce JAK/STAT signaling. Total RNA was extracted and the 
expression levels of TotM and TotA were measured by qRT-PCR. With these 
validations, we were able to demonstrate, that ET RNAi strongly increases both of 
the JAK/STAT signaling pathway target genes (TotM and TotA) in response to 
septic injury in Drosophila in vivo. Thus, we confirmed our original in vitro findings 
also in vivo.  
 
Curiously, however, we were able to confirm only three in vivo phenotypes (Gprk2, 
TAMP, u-shaped) in our Toll screen out of ten candidates originating from the 
screen. This can be due to certain limitations of the approach. It is acknowledged 
that, in some cases, silencing of the targeted gene is far from sufficient. In fact, as 
much as 35%-40% of fly-lines may give a false-negative result (Dietzl et al., 2007). 
These problems may be due to several causes related to the RNAi, the driver GAL4 
strain and/or the assay chosen (Dietzl et al., 2007). Along these lines, since we were 
able to confirm three out of ten candidates, the results of our Toll pathway in vivo 
infection assays are actually in accordance with the estimates presented by Dietzl 
and co-workers. 
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Microarray analysis  
 
Our genome-wide microarray analysis was carried out in macrophage-like S2 cells 
in contrast to earlier genome-wide microarray analyses, that were carried out with 
adult flies (De Gregorio et al., 2001; Irving et al., 2001). However, our results are in 
good agreement with these earlier studies, but also include several interesting 
differences, perhaps due to better sensitivity of our in vitro model. We analyzed 
genes that were induced in S2 cells by exposure to heat-killed E. coli and further 
evaluated the role of PGRP-LC in this response. Due to these experimental 
arrangements, the accuracy of detecting hemocyte-specific changes at the 
transcriptional level may be better compared to previous in vivo studies (De 
Gregorio et al., 2001; Irving et al., 2001). On the other hand, we were not able to 
detect events that are regulated at levels other than transcription. Furthermore, we 
carried out a targeted RNAi analysis of the up-regulated genes in order to determine 
the role of these gene products in microbial recognition, phagocytosis and signaling 
via the Imd and the Toll pathway.  
 
In this context, it is quite surprising that we failed to identify any opsonin-like 
proteins or any other gene products necessary for binding or phagocytosis in our 
functional studies of the genes induced by E. coli. We anticipated that these proteins 
would be expressed (induced?) in response to microbial challenge. However, none 
of the genes we identified appeared to be necessary for the binding or phagocytosis 
of bacteria. This led us to conclude that the most important genes for the recognition 
and engulfment of invading microbes are not transcriptionally regulated. This makes 
sense as phagocytosis is a rapid process occurring instantly after initial recognition. 
Instead of transcriptional regulation, it seems that these genes appear to be 
expressed at relatively high levels constantly, and S2 cells are always surveying 
pathogens ready to initiate immune responses. In general, the data obtained from our 
microarray study are in good agreement with earlier studies. We identified twenty-
two genes previously shown to be up-regulated upon septic injury in vivo. These 
included ten well characterized and highly conservative antimicrobial peptides, 
PGRP proteins and other recognition and receptor proteins as well as one 
transcription factor, Relish. The expression of structural proteins coding for genes 
like β-Tubulin 60D as well as Tep4 and Tep-like CG18589, putative candidates for 
86 
complement cascade, were up-regulated in our assay. In addition, the expression of 
thirty-one previously uncharacterized genes was induced in response to E. coli. 
Further functional studies identified three new gene products regulating 
antimicrobial peptide release in vitro. Silencing CG7097, a Ste20 family kinase 
named happyhour (Corl et al., 2009), caused a significant decrease in Attacin 
expression in response to E. coli. Silencing the components of the JNK pathway had 
a similar effect indicating that induction of the JNK pathway is important for a 
optimal response via the Imd pathway. In contrast, RNAi targeting CG15678 or the 
structural protein coding genes β-Tubulin 60D and α-Tubulin 84D caused a clear 
increase in the Imd pathway response. Of note, CG15678 was later confirmed to be 
a negative regulator of the Drosophila NFĸ-B signaling and was named Pirk (Kleino 
et al., 2008). None of the genes studied seem to be import for the Toll pathway 
response. This is unsurprising since Drosophila humoral immunity distinguishes 
between different classes of pathogens and the Toll response is not activated in 
response to the Gram-negative E. coli. 
 
 
 
Future perspectives 
 
The past few years have brought answers to many key questions concerning the 
Drosophila innate immunity. With powerful systems biological methods such as 
microarrays and large-scale RNAi screening, vast amounts of data can be obtained 
from biological processes, including Drosophila immunity. Genes involved in these 
processes can all be monitored simultaneously, which is a huge advantage compared 
to the traditional mutation-based genetic assays. Using these systems biological 
methods, scientists have been able to determine many of the key players in the field 
of Drosophila immunity. For example, the main phagocytic receptor, Eater, was 
eventually identified by Kocks et al in 2005 (Kocks et al., 2005). Similarly, the 
comprehesive models for the Drosophila NFĸ-B signaling pathways are coming 
together. The complexity of the Imd signaling pathway is currently well understood 
and the main components of the Toll pathway are known.  
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Our work has, for its part, provided a lot of new insight into Drosophila immunity. 
We have found new regulators of the Imd pathway in our microarray assay and 
further confirmed the involvement of the JNK pathway in the Imd response. Our 
microarray data also addresses many new questions to be answered by future 
experiments. The potential role of Tep-like proteins in the complement cascade 
remains to be shown  although recent studies on Drosophila intestine-specific 
responses have pointed in this direction (Buchon et al., 2009). Similarly, the 
molecular means of how Tubulin-associated proteins affect Imd signaling remain 
speculative. We identified five putative new regulators of the Drosophila 
JAK/STAT pathway and nine potential novel regulators of the Toll pathway. Our in 
vitro and in vivo studies confirmed ET as a negative regulator of the JAK/STAT 
pathway involved in Stat92E phosphorylation and showed that ET function is Dome 
and Hop dependent. However, the exact role of ET in Stat92E phosphorylation 
remains to be discovered. We have also proved that Gprk2 is an evolutionary 
conserved regulator of immune signaling and is required for normal microbial 
resistance in vivo. Interestingly, although it interacts with Cactus, Gprk2 is not 
necessary for Cactus degradation. The exact molecular mechanism of the Gprk2-
Cactus interaction and its purpose will certainly be a target for great scientific 
interest in the near future. 
 
To address these questions one could use a more recent systems biological method, 
Drosophila in vivo RNAi screening (Kambris et al., 2006) (Lesch et al., 2010). This 
techique allows genes involved in designated biological processes to be inactivated 
in a tissue specific manner and at a defined time point. The method is particularly 
convenient for analysing secreted gene products (Kambris et al., 2006) (Lesch et al., 
2010). In the future, it would be interesting to carry out a Drosophila in vivo RNAi 
screen of the Toll and the JAK/STAT pathways in order to determine the upstream 
regulators that weren’t identified in this work. 
 
 
88 
11 SUMMARY AND CONCLUSIONS 
With systems biological high-throughput methods, such as microarrays and 
genome-wide screens, genes involved in several different biological processes can 
be monitored all at the same time. This is an epoch-making advantage compared to 
traditional mutation-based genetic assays. With these methods, scientists have been 
able to determine many of the key players in the field of Drosophila immunity.  Our 
systems biological studies have provided new insights into Drosophila immunity. In 
our microarray analysis, we identified new regulators for the Imd pathway and 
confirmed the involvement of the JNK pathway in the Imd response. In addition, we 
carried out two genome-wide RNAi screens and were able to identify five putative 
new regulators of the Drosophila JAK/STAT pathway and nine potential novel 
regulators of the Toll pathway. 
 
Our systems biological studies also indicate many new issues for future 
experiments. The potential role of Tep-like proteins in the complement cascade 
remains to be discovered. In addition, the exact molecular role of Tubulin-associated 
proteins in Imd signaling is yet to be determined. Furthermore, our in vitro and in 
vivo studies characterized ET as a negative regulator of the JAK/STAT pathway 
involved in Stat92E phosphorylation. We were also able to show that ET function is 
Dome and Hop dependent, but the exact role of ET in Stat92E phosphorylation 
remains to be discovered. We have also confirmed that Gprk2 is an evolutionary 
conserved regulator of immune signaling and is required for normal microbial 
resistance in vivo. We have shown that Gprk2 interacts with Cactus. Nevertheless, 
Gprk2 is not necessary for Cactus degradation. The exact molecular mechanism of 
the Gprk2-Cactus interactions and the precise function of this interaction are still to 
be discovered. Moreover, since we chose to activate the pathways with 
constitutively active forms of pathway components, instead of cytokine induction, 
some of the upstream regulators of both pathways remain uncharacterized. 
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Abstract
The templates of innate immunity have ancient origins. Thus, such model animals as the fruit fly, Drosophila melanogaster, can be used to
identify gene products that also play a key role in the innate immunity in mammals. We have used oligonucleotide microarrays to identify
genes that are responsive to Gram-negative bacteria in Drosophila macrophage-like S2 cells. In total, 53 genes were induced by greater than
threefold in response to Escherichia coli. The induction of all these genes was peptidoglycan recognition protein LC (PGRP-LC) dependent.
Twenty-two genes including 10 of the most strongly induced genes are also known to be up-regulated by septic injury in vivo. Importantly, we
identified 31 genes that are not known to respond to bacterial challenge. We carried out targeted dsRNA treatments to assess the functional
importance of these gene products for microbial recognition, phagocytosis and antimicrobial peptide release in Drosophila S2 cells in vitro.
RNAi targeting three of these genes, CG7097, CG15678 and b-Tubulin 60D, caused altered antimicrobial peptide release in vitro. Our results
indicate that the JNK pathway is essential for normal antimicrobial peptide release in Drosophila in vitro.
© 2005 Elsevier SAS. All rights reserved.
Keywords: Drosophila melanogaster; Innate immunity; JNK signaling
1. Introduction
Recent progress in understanding the basic templates of
innate immunity has revealed striking conservation in the first-
line host defense from insects to human [1,2]. This similarity
is clearly illustrated by the role of Toll-like receptors and
related intracellular pathways in acute humoral response to
microbial infection [3,4]. Consequently, genetically tractable
model organisms like Drosophila, in particular, have been
widely used to dissect genes and pathways that are of impor-
tance in innate immune response of the host.
Upon microbial challenge, both cellular and humoral arms
of the Drosophila innate host defense are required for opti-
mal immune competence in vivo [5]. Invading microbes are
phagocytosed by circulating macrophages and the antimicro-
bial peptides are synthesized by both hemocytes and the fat
body, a functional equivalent of the mammalian liver. In addi-
tion, proteolytic cascade that leads to activation of phenoloxi-
dase, which catalyses the conversion of dopamine to micro-
bicidal melanine, is activated. Drosophila humoral immunity
distinguishes between different classes of pathogens through
the immune defiency (Imd) and the Toll pathways. These two
pathways, which are very similar to mammalian Toll/IL and
Abbreviations: aop, anterior open; dSR-CI, Drosophila scavenger recep-
tor CI; GNBP, Gram-negative bacteria-binding protein; hep, hemipterous;
Imd, immune defiency; kay, kayak; MAPK, mitogen-activated protein kinase;
msn, misshapen; PAMP, pathogen associated molecular pattern; PGRP, pep-
tidoglycan recognition protein; PRR, pattern recognition receptor; TNF,
tumor necrosis factor.
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tumor necrosis factor (TNF)-receptor pathways [2], are the
major regulators of the immune response in Drosophila in
vivo [6]. Remarkable conservation between human and
Drosophila pathways points to an evolutionary link from
insects to man.
Earlier we have shown that Drosophila S2 cells are
macrophage-like [7,8], which makes them a valid in vitro sys-
tem to study hemocyte-mediated response to microbial chal-
lenge. In these cells, exposure to Gram-negative bacteria leads
to rapid transcriptional induction of several well-characterized
antimicrobial peptide genes including Attacin, Cecropin and
Metchnikowin via the Imd pathway [8]. In addition, S2 cells
recognize and phagocytose efficiently both Gram-negative and
Gram-positive bacteria. In contrast, the activation of the Toll
pathway, which is initiated by Gram-positive bacteria through
a circulating peptidoglycan recognition protein (PGRP) SA
in vivo [9], requires introduction of the active form of Spätzle
by transfection in these cells [10]. Therefore, S2 cells pro-
vide an opportunity to study the Imd pathway mediated
response to Gram-negative bacteria.
2. Materials and methods
2.1. Cell cultures
S2 cells were maintained as described earlier [11].
2.2. Microbial challenge, RNA isolation
and oligonucleotide microarray analysis
3.0 × 106 S2 cells were incubated for 6 h with 3.0 × 107
heat-killed Escherichia coli and thereafter total RNA was
extracted using the RNeasy Mini kit (Qiagen) according to
the manufacturer’s instructions. Gene expression analysis was
performed using the Affymetrix (Santa Clara) Drosophila
Genechips according to the standard Affymetrix Genechip
protocol as outlined in the GeneChip Expression Analysis
Technical Manual byAffymetrix (2001). Gene expression lev-
els of four unchallenged, control dsRNA treated S2 cells were
compared pair-wisely to four E. coli exposed samples (alto-
gether 16 comparisons) and to three E. coli exposed,
PGRP-LC dsRNA treated samples (12 comparisons).
2.3. Data analysis
We identified the genes whose RNA levels are affected by
an exposure to E. coli using the following criteria. First, the
majority of the 16 comparisons had to be called increased (or
decreased) and none of the remaining ones was called
decreased (or increased). Second, there must be at least a
threefold increase (or decrease) in the relative expression level.
Finally, the t-test was used to measure statistical signifi-
cance. A P-value of < 0.05 was considered to be significant.
Those genes that fulfilled all of these criteria are shown in
Table 1.
2.4. dsRNA treatments
Total RNA was isolated with TRIZOL® Reagent (GIBCO
BRL, Gaithersburg, MD) and first-strand cDNA was synthe-
sized from 1.0 µg of total RNA. The templates for dsRNA
synthesis were generated from cDNA by a two-step PCR reac-
tion. The first primers consisted of 15 base gene-specific
sequences designed for each gene of interest. A second PCR
reaction was performed using primers containing a
T7 promoter sequence (GAATTAATACGACTCACTATAGG-
GAGA) attached to the 5′-end of the gene-specific sequences.
Both sense and antisense RNAs were synthesized simulta-
neously from a single PCR product using the T7 MegaScript
RNA polymerase (Ambion, Austin, TX) as recommended by
the manufacturer. dsRNA was precipitated with LiCl and
treated with DNAase. Quality of dsRNA was analyzed by
agarose gel electrophoresis and the concentration was mea-
sured by spectrophotometer. The concentration of dsRNA was
10 µg per 106 S2 cells in each experiment (if not stated oth-
erwise). Cells were incubated with dsRNA for 72 h.
2.5. FACS analysis to quantify phagocytosis and microbial
binding
Flow cytometry was used to analyze the ability of the
dsRNA treated cells to bind and phagocytose heat-killed,
FITC-labeled E. coli and Staphylococcus aureus (Molecular
probes, Leiden, the Netherlands) compared to GFP dsRNA
treated control cells. A total of 5.0 × 105 dsRNA treated
S2 cells were plated onto 48-well plates and incubated for 1 h
at room temperature. Thereafter the cells were cooled down
to 4 °C for 30 min, and heat-killed, FITC-labeled E. coli or S.
aureus was added. Plates were centrifuged for 1 min at 100 ×
g (at 4 °C) and incubated for 1 h at 4 °C to let S2 cells bind
bacteria. To allow phagocytosis, the plates were incubated at
26 °C (16 min for E. coli and 30 min for S. aureus). There-
after plates were placed on ice, medium was replaced with
ice-cold PBS and cells transformed into flow cytometry tubes.
Samples were analyzed with FACS using EXPO32 program
(Beckman Coulter, Ordior). The fluorescence of extracellu-
lar particles was quenched by adding 0.2% Trypan blue in 1×
PBS (pH 4.85) shortly before the actual measurement. The
amount of phagocytosis was quantified as the percentage of
fluorescence-positive cells multiplied by the mean fluores-
cence of these cells. 5000–10,000 cells were counted from
each sample. The ability of dsRNA treated cells to bind bac-
teria was measured accordingly except plates were kept
at +4 °C at all times and no Trypan blue was added prior to
measurements.
2.6. Luciferase reporter assay
A luciferase reporter assay was used to analyze the effect
of dsRNA treatments on antimicrobial peptide release by both
the Imd and the Toll pathway. The S2 cells were transfected
either with 0.5 µg of Attacin-reporter plasmid (the Imd path-
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Table 1
Microarray analysis of genes induced by E.coli
Gene Name or function Naïve expression E. coli stimulated Fold change P-value Decrease by PGRP-LC RNAi
Antimicrobial peptides
CG7629 a Attacin-D 162 ± 113 43788 ± 11750 281.6 <0.001 92 ± 1%
CG1367 a Cecropin A2 229 ± 538 42282 ± 16122 184.5 0.002 77 ± 9%
CG8175 a Metchnikowin 436 ± 224 49119 ± 15181 112.7 <0.001 82 ± 8%
CG10816 a Drosocin 162 ± 138 14728 ± 2913 90.7 <0.001 84 ± 5%
CG10794 a Diptericin B 1206 ± 577 67329 ± 23964 55.8 0.001 85 ± 7%
CG1878 a Cecropin B 143 ± 128 6266 ± 2333 43.7 0.002 87 ± 3%
CG1365 a Cecropin A1 2210 ± 1044 90405 ± 26110 40.9 <0.001 78 ± 6%
CG18372 a Attacin-B 624 ± 102 23692 ± 7418 38.0 <0.001 78 ± 5%
CG10810 a Drosomycin 540 ± 72 6266 ± 87 5.0 <0.001 79 ± 14%
CG1373 a Cecropin C 451 ± 29 2707 ± 391 3.80 <0.001 85 ± 17%
Recognition molecules, Receptors and Transporters
CG7496 a PGRP-SD 736 ± 118 12466 ± 2376 16.90 <0.001 69 ± 3%
CG11709 a PGRP-SA 1252 ± 206 16496 ± 5352 13.20 0.001 86 ± 5%
CG11897 Transporter 1183 ± 812 11297 ± 2096 9.50 <0.001 80 ± 11%
CG6231 Transporter 4653 ± 821 25420 ± 4120 5.50 <0.001 83 ± 3%
CG7052 a Tep2 376 ± 141 2003 ± 881 5.30 0.01 55 ± 28%
CG4823 a LDL-receptor 88 ± 152 412 ± 136 4.70 0.02 73 ± 31%
CG8805 Receptor 406 ± 199 1580 ± 234 3.90 <0.001 97 ± 18%
CG16700 Transporter 280 ± 118 967 ± 163 3.50 <0.001 106 ± 11%
CG9753 Receptor 352 ± 96 1202 ± 176 3.40 <0.001 93 ± 15%
CG4437 PGRP-like 484 ± 161 1566 ± 636 3.20 0.02 58 ± 16%
CG18589 Tep-like 1192 ± 253 3726 ± 795 3.10 <0.001 39 ± 8%
CG5372 Integrin –5 ± 118 301 ± 101 ~ 0.008 66 ± 15%
Transcription factor
CG11992 a Relish 5278 ± 528 15429 ± 2478 3.00 <0.001 83 ± 22%
Serine proteases and enzymes
CG16731 Serine protease 158 ± 50 1681 ± 213 10.60 <0.001 67 ± 6%
CG8215 a Serine protease 261 ± 67 1685 ± 167 6.50 <0.001 82 ± 8%
CG9370 Serine protease 344 ± 42 1966 ± 131 5.70 <0.001 88 ± 8%
CG3505 a ProPO-AE 363 ± 362 1266 ± 179 3.50 0.004 74 ± 35%
CG10232 ProPO-AE –75 ± 31 190 ± 102 ~ 0.003 57 ± 29%
CG4837 5′-Nucleotidase 44 ± 93 267 ± 64 6.10 0.007 98 ± 68%
CG5992 Adenosine deaminase 2472 ± 491 11182 ± 1273 4.50 <0.001 89 ± 2%
CG7097 Protein kinase 130 ± 78 537 ± 116 4.10 0.001 27 ± 26%
CG10564 Adenylyl cyclase 78C 139 ± 94 555 ± 261 4.00 0.02 53 ± 43%
CG2171 Triosephosphate isomerase 633 ± 544 2088 ± 553 3.30 0.01 38 ± 21%
Structural proteins
CG3401 b-Tubulin 60D 3580 ± 727 13427 ± 1043 3.80 <0.001 88 ± 5%
CG8772 Nemy 526 ± 265 1609 ± 328 3.10 0.002 77 ± 21%
CG11312 Inscuteable –42 ± 142 382 ± 172 ~ 0.009 75 ± 61%
Uncharacterized genes induced by E. coli
CG15678 a 753 ± 136 7744 ± 473 10.30 <0.001 79 ± 8%
CG18356 153 ± 226 1173 ± 75 7.60 <0.001 73 ± 27%
CG17218 75 ± 149 514 ± 126 6.90 0.004 62 ± 25%
CG10006 125 ± 88 833 ± 189 6.70 0.02 89 ± 3%
CG6804 56 ± 128 348 ± 57 6.20 0.006 53 ± 33%
CG3831 153 ± 134 729 ± 123 4.80 <0.001 71 ± 37%
CG3304 104 ± 171 491 ± 95 4.70 0.008 84 ± 40%
CG1572 1922 ± 356 8629 ± 1009 4.50 <0.001 77 ± 4%
CG5847 335 ± 233 1507 ± 114 4.50 <0.001 89 ± 11%
CG9815 836 ± 446 3602 ± 163 4.30 <0.001 90 ± 15%
CG15507 221 ± 76 862 ± 296 3.90 0.006 78 ± 30%
CG14253 4074 ± 768 14142 ± 679 3.50 <0.001 69 ± 10%
CG7778 a –594 ± 440 1469 ± 207 ~ <0.001 57 ± 4%
CG4250 a –693 ± 626 562 ± 436 ~ 0.02 66 ± 73%
CG13654 –205 ± 232 695 ± 187 ~ <0.001 59 ± 14%
CG17124 6 ± 93 566 ± 213 ~ 0.003 78 ± 16%
CG6051 –93 ± 40 436 ± 186 ~ 0.001 80 ± 62%
a Induced also in vivo [12].
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way) or with 0.4 µg of Drosomycin-reporter plasmid together
with 0.4 µg of constitutively active form of Toll (Toll10B)
(the Toll pathway) using Fugene reagent (Roche). A
b-galactosidase expression vector (0.6 µg) was included in
the reaction mix to control transfection efficiency and the
viability. In addition, 2 µg of dsRNA was added directly to
the transfection medium. The Drosomycin-reporter driven
luciferase activity was measured 72 h afterwards to measure
the activity of the Toll pathway. When assessing the Imd path-
way, Ecdysone was added into the cell media to 1 µmol con-
centration 48 h after the initial transfection followed by addi-
tion of heat-killed E. coli 24 h later. After another 24 h, cells
were lyzed in reporter lysis buffer (Promega) and luciferase
and b-galactosidase activities were measured using standard
procedures.
3. Results
3.1. Genes induced in S2 cells in response to E. coli
To identify all the genes that are induced in macrophage-
like S2 cells by a 6-h-exposure to Gram-negative bacteria,
we first extracted the total RNA from both E. coli exposed
cells and control cells, and then used Affymetrix Drosophila
genechips to detect the expression level of more than 13,500
Drosophila genes. Four independent RNA preparations from
control S2 cells and E. coli induced cells were hybridized.
The data from altogether 16 pair-wise comparisons between
E. coli treated and untreated cells were analyzed as stated in
Section 2. Altogether 53 genes were induced by greater than
threefold in response to E. coli. Twenty-two genes including
10 of the most strongly induced genes were previously shown
to be up-regulated by septic injury in vivo (Table 1, [12]). All
of the 10 most strongly induced genes code for well-
characterized, immunity-related peptides. In addition, we
identified 31 genes that have not been described to be induced
in vivo (Table 1).
Eight of the most strongly induced genes are known anti-
microbial peptides. These include two Attacin (B1 and D),
three Cecropin (A1, A2 and B), Diptericin B, Drosocin and
Metchnikowin genes (Table 1). In addition, Cecropin C was
moderately induced as well as antifungal peptide Drosomy-
cin. The remaining five antimicrobial peptides, Attacin A1
and A2, Defensin, Drosomycin B and Diptericin were not sig-
nificantly up-regulated. Interestingly, our Northern blot data
indicate that Diptericin gene expression is induced by bacte-
ria in S2 cells only if the cells are pretreated with Ecdysone
(data not shown). Therefore, it is likely that in S2 cells a spe-
cific co-factor is required for efficient Diptericin response to
E. coli.
As shown in Table 1, we found three PGRP genes to be
induced by E. coli in our assay: PGRP-SA, PGRP-SD and
PGRP-like gene (CG4437). Interestingly, PGRP-SB1, PGRP-
SC2 and PGRP-LB which all are up-regulated in response to
septic injury in vivo [12,13] were not significantly induced.
None of the Gram-negative bacteria-binding protein (GNBP)
genes were up-regulated by E. coli in the present study. This
is in line with the notion that both GNBPs (CG12780 and
CG13422) are regulated in vivo selectively by the Toll path-
way [6] and as stated above, our experimental setting was to
identify genes induced by the Imd pathway in response to
Gram-negative bacteria.
In our experimental setting using macrophage-like S2 cells,
five genes coding for putative serine proteases CG16731,
CG8215, CG9370, CG3505 and CG10232, possibly involved
in melanization, were induced. The fewer number of genes
induced in our assay compared to previous in vivo studies
may indicate that at least a portion of the in vivo induced
genes that participate in melanization are induced by the
wound itself. In addition, the expression of two genes coding
for complement-like proteins, Tep4 and Tep-like CG18589,
was up-regulated. Furthermore, a homologue of vertebrate
a-2-macroglobulin receptor gene (CG4823) was among genes
up-regulated significantly by an exposure to E. coli.
PGRP-LC is important for antimicrobial peptide response
against Gram-negative bacteria both in vitro and in vivo
[8,14,15]. Furthermore, PGRP-LC deficient flies are suscep-
tible to Gram-negative, but not Gram-positive, bacterial infec-
tion [8,15]. Interestingly, however, PGRP-LC null mutant flies
are less prone to Gram-negative bacterial infection compared
to flies harboring mutation in other key gene, such as Relish,
in the Imd pathway. Therefore, it is plausible that only a sub-
set of genes that are under transcriptional control of Relish is
regulated by PGRP-LC. Our data indicate that in S2 cells,
induction of all the genes that respond to E. coli is PGRP-LC
dependent (Table 1). These results combined with the notion
that PGRP-LC mutant flies have impaired—not totally
abolished—Diptericin response to Gram-negative bacteria in
vivo argue that PGRP-LC is not absolutely required for the
activation of the Imd pathway.
3.2. Functional analysis of immune response genes
3.2.1. Microbial binding and phagocytosis
Many of the genes induced by E. coli in S2 cells fit well
into the current concept of Drosophila immunity. However,
we found transcription of several yet uncharacterized genes
to be up-regulated upon bacterial challenge in S2 cells
(Table 1). To assess functional significance of these genes,
we carried out targeted dsRNA treatments and evaluated the
role of these gene products for microbial recognition, phago-
cytosis and antimicrobial peptide release in Drosophila
S2 cells in vitro. To measure if any of the genes induced by E.
coli encode protein(s) necessary for binding or engulfment
of bacteria, we performed targeted dsRNA treatments and
measured the rate of microbial binding and phagocytosis of
both Gram-negative (E. coli) and Gram-positive (S. aureus)
bacteria by S2 cells using flow cytometry (data not shown).
We anticipated that upon microbial challenge, S2 cells might
express opsonin-like protein(s) that would have a role in bind-
ing or phagocytosis. However, none of the targeted genes stud-
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ied appeared very important for recognition or engulfment of
bacteria. RNAi targeting SCAR, known to be involved in
phagocytosis [16], was used as positive control and resulted
in 42 ± 18% reduction in phagocytosis. Of note, dsRNA treat-
ment targeting CG15507 strongly decreased the phagocyto-
sis of S. aureus. As CG15507 has been shown to be the first
exon of the kayak gene [17] we further analyzed the role of
the JNK pathway for normal phagocytosis. We carried out
targeted dsRNA treatments against several well-characterized
JNK pathway components including p21-activated kinase
(PAK), misshapen (msn), hemipterous (hep) and anterior open
(aop). None of these treatments drastically affected phagocy-
tosis (data not shown). Furthermore, RNAi targeting CG15507
decreased cell viability as measured by Actin 5C promoter-
driven b-galactosidase activity in S2 cells (Figs. 1 and 2).
This let us to conclude that the effect of RNAi targeting
CG15507 is not specific for phagocytosis.
3.2.2. Luciferase reporter assay for measuring
antimicrobial peptide release in S2 cells
In addition to binding and phagocytosis, we analyzed
whether any of the induced genes are involved in the release
of antimicrobial peptides. Again, we performed targeted
dsRNA treatments and analyzed the transcription rate of
Drosomycin (the Toll pathway) and Attacin (the Imd path-
way) genes using luciferase reporter assay (Fig. 1). There was
only one dsRNA treatment that decreased Drosomycin
reporter-driven luciferase activity by more than 50% (Fig. 1).
This dsRNA treatment targeted CG15507 and caused an aver-
age of 61% reduction in the luciferase activity. However, it
also very drastically decreased the Actin 5C promoter-driven
b-galactosidase activity indicating unhealthiness of cells.
Decreased viability was also clear by microscopic examina-
tion of CG15507 dsRNA treated cells.
There was one dsRNA treatment that decreased the Imd
pathway mediated Attacin-reporter driven luciferase activity
in S2 cells by more than 50% without affecting viability.
dsRNA targeting a putative protein kinase encoding gene
CG7097 decreased the Imd pathway activity in response to
E. coli by 52 ± 30% (Fig. 2). CG7097 is predicted to code for
a protein of 1218 amino acids, which has an N-terminal
Serine/Threonine kinase domain and a C-terminal CNH
domain. It has high homology to a mammalian mitogen-
activated protein kinase kinase kinase kinase (MAP4 K) iso-
form 3 (e–132) and to a germinal center kinase related protein
kinase (e–132). Therefore, it may have a role in activating the
JNK pathway also in Drosophila. To this end we carried out
targeted dsRNA treatments to silence several known compo-
nents of the JNK pathway. RNAi silencing either kayak, msn,
hep or aop resulted in marked decrease in the Imd pathway
activity (Table 2).
In addition, two of the genes induced by E. coli appear to
be negative regulators of the Imd pathway: CG15678 and
b-Tubulin 60D. First, silencing the expression of CG15678
caused an average of 284 ± 102% enhancement of the activ-
ity of the Imd pathway in response to Gram-negative bacte-
ria. CG15678 expression was strongly increased (10.3-fold
induction) in response to E. coli in our experimental setting.
It is also induced by septic injury in vivo [12]. CG15678 is
predicted to encode a protein of 197 amino acids with no
conserved domains and it has no close mammalian homo-
logues. Molecular function of the CG15678 gene product is
Fig. 1. The effect of dsRNA treatments targeting immune response genes on antimicrobial peptide release via the Toll pathway in S2 cells measured by a
luciferase reporter assay. The dsRNA treated S2 cells were transfected with Drosomycin–luciferase reporter plasmid to measure antimicrobial peptide release
(black columns), and Actin 5C-b-galactosidase reporter plasmid was used as a control for transfection efficiency and viability (white columns). The Drosomycin-
reporter driven luciferase activity was measured 72 h after activating the Toll pathway using a constitutively active form of Toll (Toll10B). Results are presented
as an average of independent dsRNA treatments (% of GFP dsRNA treated controls) ± S.D. Myd88 RNAi, resulting in 93 ± 1% reduction of the Toll pathway
activity, was used as a positive control. N is the number of independent dsRNA treatments.
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unknown. Second, RNAi targeting b-Tubulin 60D increased
Attacin-reporter activity by 370 ± 170%. To further evaluate
the role of Tubulin-associated proteins for the Imd pathway
signaling, we targeted-Tubulin 84D (CG1913) and observed
a striking 738 ± 107% increase in Attacin-reporter activity in
response to E. coli.
4. Discussion
In this study, we have used a genome-wide analysis of
genes that are induced by a 6-h-exposure to E. coli. Further-
more, we evaluated the role of PGRP-LC in this response. In
general, our data are in good agreement with the earlier
genome-wide analysis of immune responses in Drosophila
[12,13]. However, several interesting differences were
observed that perhaps reflect better sensitivity of our experi-
mental setting to detect hemocyte specific changes in tran-
scription levels compared to previous in vivo studies. In addi-
tion, we assessed functional importance of the up-regulated
genes in vitro by carrying out targeted dsRNA treatments and
evaluating the role of these gene products for microbial rec-
ognition, phagocytosis and antimicrobial peptide release.
Importantly, we found three new gene products that appear
to regulate significantly the antimicrobial peptide release in
S2 cells in vitro. RNAi targeting CG7097 caused a 52 ± 30%
decrease in Attacin expression in response to E. coli. In con-
trast, silencing CG15678, b-Tubulin 60D or -Tubulin 84D
(CG1913) by RNAi caused a marked increase in the Imd path-
way response. In a recent paper by Foley and O’Farrell [18],
RNAi targeting -Tubulin 84D increased the Diptericin
response via the Imd pathway in response to lipopolysaccha-
ride. The molecular mechanisms of how the Tubulin-
associated proteins affect the Imd pathway remain specula-
tive.
CG7097 codes for a protein which is very similar to a mam-
malian MAP4 K isoform 3 and to a germinal center kinase
related protein kinase. These proteins are known to be
involved in regulating the JNK pathway in mammals and it is
possible that the CG7097 gene product has a similar role in
Fig. 2. The effect of dsRNA treatments targeting immune response genes on antimicrobial peptide release via the Imd pathway in S2 cells measured by a
luciferase reporter assay. The dsRNA treated S2 cells were transfected with Attacin–luciferase reporter plasmid to measure antimicrobial peptide release (black
columns), and Actin 5C-b-galactosidase reporter plasmid was used as a control for transfection efficiency and viability (white columns). The Imd pathway was
activated by adding 1 µmol of Ecdysone to the culture medium followed by addition of heat-killed E. coli 24 h later. After another 24 h cells were lyzed in
reporter lysis buffer (Promega) and luciferase and b-galactosidase activities were measured using standard procedure. Results are presented as an average of
independent dsRNA treatments (% of GFP dsRNA treated controls) ± S.D. Relish RNAi, resulting in 96 ± 3% reduction of the Imd pathway, was used as a
positive control. Statistically significant results (P < 0.01) are marked with an asterisk (*) and N is the number of independent dsRNA treatments.
Table 2
Attacin and Drosomycin-reporter activities after dsRNA treatments of the JNK signaling pathway components
Gene Name Function Attacin reporter activity a Drs reporter activity a Act 5C reporter activity b
CG4353 hep MAPKK 53 ± 11 (5) 79 ± 14 (5) 90 ± 15 (10)
CG15509 kayak fos homologue 22 ± 10 (5) 71 ± 12 (5) 105 ± 67 (10)
CG3166 aop Transcript. repressor 59 ± 8 (5) 72 ± 19 (5) 123 ± 17 (10)
CG16973 msn MAPKKK 31 ± 1 (2) 29 ± 4 (3) 69 ± 1 (5)
a Relative luciferase activity (% of GFP dsRNA treated controls ± standard deviation (S.D.) [number of experiments]).
b Relative b-galactosidase activity (% of GFP dsRNA treated controls ± S.D. [number of experiments]).
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Drosophila. This is highly interesting as regulatory cross-
talk between the JNK and NF-jB pathways was recently iden-
tified in Drosophila [19]. In their study, rapid and transient
activation of the JNK pathway was terminated by sustained
induction of Relish-dependent genes [19]. Others have also
shown the importance of the JNK pathway in the Drosophila
immune response [20,21]. In our study, RNAis silencing the
components of the JNK signaling cascade caused decreased
Attacin promoter-driven luciferase response to E. coli. Our
results indicate that appropriate induction of the JNK path-
way is important for optimal response via the Imd pathway.
Microbial recognition by immune cells is of paramount
importance for immune response. The initial recognition is
mediated by germline encoded pattern recognition receptors
(PRRs) that are capable of selectively recognizing pathogen
associated molecular patterns (PAMPs) [22]. Currently,
PGRPs and GNBPs are regarded as the main PRRs in Droso-
phila. PGRPs were first identified as PRRs from the moth
Trichoplusia ni and the silkworm Bombyx mori [23,24]. Simi-
lar proteins are also found in flies, mice and humans [25–27].
There are altogether 13 predicted PGRP and five Gram-
negative bacteria-binding protein (GNBP) genes in the Droso-
phila genome. Today, several Drosophila PRRs are molecu-
larly characterized, including Drosophila scavenger receptor
CI (dSR-CI), PGRP-SA, PGRP-LC, PGRP-LE, PGRP-SC1b
and PGRP-LB and GNBP1 [7–9,14,15,28–30]. Seven of the
PGRP and two of the GNBP genes, including PGRP-SB1,
PGRP-SC2 and PGRP-LB, are induced upon septic injury in
vivo [12,13]. PGRP-LC was shown to be important for anti-
microbial peptide response against Gram-negative bacteria
both in vitro and in vivo [8,14,15]. dSR-CI is able to recog-
nize both Gram-positive and Gram-negative bacteria and has
a role in phagocytosis of both E. coli and S. aureus in vitro
but it is not required for antimicrobial peptide response [7].
PGRP-SA, PGRP-LC and PGRP-LE are required in vivo for
antimicrobial peptide response [8,9,14,15,29]. In addition,
PGRP-SD was recently shown to be involved in activation of
the Toll pathway [31]. As shown in Table 1, we found PGRP-
SA, PGRP-SD and PGRP-like gene (CG4437) to be induced
by E. coli in our assay, but interestingly, PGRP-SB1, PGRP-
SC2 and PGRP-LB were not significantly induced. This argues
for a difference in regulation of these PGRP genes in S2 cells.
This is likely the case also in vivo since PGRP-SA is induced
by natural fungal infection whereas PGRP-LB, for instance,
is not [12,13]. It is interesting to note that both E. coli and
natural fungal infection induce the expression of the gene that
codes for the molecule (PGRP-SA) required for antimicro-
bial peptide response to Gram-positive bacteria.
It is a longstanding observation that an injection of bacte-
ria into Drosophila larvae or adults results in synthesis of
immune proteins. More recently, Drosophila humoral immu-
nity has been shown to distinguish between different classes
of pathogens via the Imd and the Toll pathways [2,3]. Flies
harboring a mutation in a key molecule in the Toll pathway
are susceptible to certain Gram-positive bacteria and fungal
infections due to impaired antimicrobial peptide response.
Similarly, mutants having insufficient response via the Imd
pathway are susceptible to certain Gram-negative bacteria.
In this study, we performed microarray analysis of the Droso-
phila genes induced by E. coli. Eight of the most strongly
induced genes are known antimicrobial peptides. Our results
concerning antimicrobial peptides are in good agreement with
the earlier in vivo studies [6,12,13] and confirm that S2 cells
are a valid model to investigate the antimicrobial response
mediated via the Imd pathway. Furthermore, the lack of induc-
tion of several antimicrobial peptides that are induced in vivo
by the Imd pathway points to an additional level of regula-
tion beyond linear PGRP-LC/Imd/Tak1/IKK/Relish signal-
ing cascades.
Drosophila has circulating macrophages that phagocytose
microbes comparably to mammalian macrophages [7]. Phago-
cytosis appears to have an important part in Drosophila host
defense [5]. Although the exact mechanisms by which the
initial ligation of a microbe to the phagocytic receptors leads
to an engulfment of the bound particle are insufficiently under-
stood, several gene products are necessary for optimal phago-
cytosis in Drosophila, including, for instance, SCAR,Abi and
RN-tre [8,16]. The regulation of these genes is poorly under-
stood. In our experimental setting, none of these or other gene
products necessary for optimal phagocytosis in Drosophila
was induced upon exposure to Gram-negative bacteria. Our
results indicate that the most important genes for phagocyto-
sis are not transcriptionally regulated. This is not unexpected
as phagocytosis is a very rapid phenomenon occurring within
minutes after the initial recognition. Similarly, PRRs respon-
sible for binding of bacteria are not under transcriptional regu-
lation. There are two hemocyte PRRs that have a role in
phagocytosis of bacteria in S2 cells: dSR-CI and PGRP-LC
[7,8], out of which E. coli induced neither. Therefore, it seems
that phagocytic receptors are not transcriptionally regulated
upon E. coli challenge in S2 cells and these genes appear to
be expressed in relatively high levels in unchallenged cells
also. Therefore, it is likely that both dSR-CI and PGRP-LC
proteins are constantly surveying pathogens and as such,
always ready to initiate both cellular and humoral immune
responses.
Phagocytosis-capable plasmatocytes account for approxi-
mately 90% of all the hemocytes. The remaining 10% con-
sists of cells characterized by crystalline inclusions that con-
tain both substrates and enzymes for melanization. In
Drosophila-like in many other arthropods—injury triggers
proteolytic cascades that lead to blood clotting and melaniza-
tion at the site of the injury. Similar processes are also initi-
ated also by foreign particles such as microbes that contami-
nate the body cavity. Previous studies [12] have shown that
especially septic injury induces several genes that are likely
involved in these cascades. It is less clear whether these genes
are induced merely due to injury or whether septicemia is
required. In this study, five genes coding for putative serine
proteases, possibly involved in melanization, were induced.
This is much less compared to previous in vivo studies, which
may indicate that at least some of these genes are induced by
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the wound itself. In addition, it is likely that some of the pre-
viously reported genes that are up-regulated upon a septic
injury react only to Gram-positive bacteria. For example, Irv-
ing et al. [13] showed that masquerade-like gene was mini-
mally induced by Gram-negative bacteria but responded dra-
matically to both Gram-positive bacteria and fungal infection.
In addition, we have shown earlier that S2 cells are
macrophage-like and express plasmatocyte-determining fac-
tor glial cell missing but do not express crystal-cell-
determining factor lozenge [8]. Therefore, the cells used in
this study are not professional melanizers, which may well
explain the lack of induction of the genes participating in the
melanization cascade. In conclusion, our data indicate that
the transcription of certain genes coding for proteins involved
in melanization is induced by E. coli without injury. The exact
role of these proteases in host defense remains to be studied.
In mammals, complement proteins C3 and a-macro-
globulin bind covalently to conserved surface structures of
microorganisms through a thiolester bond initiating a cas-
cade that leads to lysis of the target microbe and enhanced
phagocytosis. Although no similar cascade has been detected
in insects, there are four thiolester-containing, complement-
like proteins in Drosophila [32]. Of these, Tep1, Tep2 and
Tep4 genes are strongly up-regulated after bacterial chal-
lenge in vivo [12,13,32]. In our analysis, the expression of
Tep4 and Tep-like CG18589 was up-regulated. In addition, a
homologue of vertebrate a-2-macroglobulin receptor gene
(CG4823) was among genes significantly up-regulated by an
exposure to E. coli. This gene is induced by a septic injury
also in vivo [12]. Future experiments will tell whether Tep4
gene product—or any other Tep-like molecule—has a simi-
lar role in Drosophila immunity as it appears to have in the
mosquito, Anopheles gambiae [33].
Two hundred and nine of the genes up-regulated by septic
injury in vivo were not induced in our experimental setting.
These included, for example, puckered (puc), which codes
for a well-characterized down-stream target of the JNK path-
way [34]. As discussed earlier, the JNK pathway has been
shown to be activated upon microbial challenge in Droso-
phila both in vitro and in vivo [19,20]. This discrepancy is
likely explained by the earlier time point used by Park and
colleagues [19]. In their analysis, puc was induced very rap-
idly (maximum at 2 h after induction) and transiently (induc-
tion was over by 4 h after induction). It is noteworthy that
induction of puc in vivo may also be caused by pricking—not
by the host’s response to microbial challenge itself—as the
JNK pathway was recently shown to be involved in wound
healing in Drosophila [34]. This speculation is in line with
the notion that transcription of the puc gene is not induced by
natural fungal infection in vivo [12]. Altogether, our more
moderate number of genes induced by E. coli argues that our
assay is more specific in identifying genes induced by micro-
bial challenge itself than previous in vivo studies. Alterna-
tively, fat body is the principal immune tissue in Drosophila
and thus blood cells may produce only a subset of immune
response genes in response to bacteria.
The last few years have brought a lot of new insight into
Drosophila immunity. There are, however, several key ques-
tions that remain to be solved. For example, the main phago-
cytic receptor that recognizes both Gram-negative and Gram-
positive bacteria is currently unidentified. Similarly, it is
currently unknown if there are any circulating molecules that
opsonize microbes for more efficient phagocytosis. Tep4 ex-
pression is induced by an exposure to microbes both in vivo
and in vitro. It is interesting to see whether Tep4 protein acts
as an opsonin and whether it has any role in immune response
in vivo. The fungal PRR as well as receptors that trigger mela-
nization and coagulation cascades are still unknown. Progress
in understanding Drosophila immunity will likely continue
to fuel experiments in mammalian systems.
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Genome-Wide RNA Interference in Drosophila Cells
Identifies G Protein-Coupled Receptor Kinase 2 as
a Conserved Regulator of NF-kB Signaling
Susanna Valanne,* Henna Myllyma¨ki,*,1 Jenni Kallio,*,1 Martin Rudolf Schmid,†
Anni Kleino,* Astrid Muruma¨gi,* Laura Airaksinen,* Tapio Kotipelto,*
Meri Kaustio,* Johanna Ulvila,‡ Shiva Seyedoleslami Esfahani,x Ylva Engstro¨m,x
Olli Silvennoinen,* Dan Hultmark,*,† Mataleena Parikka,* and Mika Ra¨met*,{
Because NF-kB signaling pathways are highly conserved in evolution, the fruit fly Drosophila melanogaster provides a good model
to study these cascades. We carried out an RNA interference (RNAi)-based genome-wide in vitro reporter assay screen in
Drosophila for components of NF-kB pathways. We analyzed 16,025 dsRNA-treatments and identified 10 novel NF-kB regulators.
Of these, nine dsRNA-treatments affect primarily the Toll pathway. G protein-coupled receptor kinase (Gprk)2, CG15737/Toll
pathway activation mediating protein, and u-shaped were required for normal Drosomycin response in vivo. Interaction studies
revealed that Gprk2 interacts with the Drosophila IkB homolog Cactus, but is not required in Cactus degradation, indicating
a novel mechanism for NF-kB regulation. Morpholino silencing of the zebrafish ortholog of Gprk2 in fish embryos caused
impaired cytokine expression after Escherichia coli infection, indicating a conserved role in NF-kB signaling. Moreover, small
interfering RNA silencing of the human ortholog GRK5 in HeLa cells impaired NF-kB reporter activity. Gprk2 RNAi flies are
susceptible to infection with Enterococcus faecalis and Gprk2 RNAi rescues Toll10b-induced blood cell activation in Drosophila
larvae in vivo. We conclude that Gprk2/GRK5 has an evolutionarily conserved role in regulating NF-kB signaling. The Journal
of Immunology, 2010, 184: 6188–6198.
N
uclear factor-kB signaling is involved in a variety of cel-
lular processes, including control of both the innate and
adaptive immune systems. The NF-kB/Rel family of
transcription factors consists of five members in humans. These
proteins control the expression of hundreds of target genes, including
various cytokines and chemokines, in a tightly regulated manner (1).
In mammals, immune-related NF-kB activation mainly occurs via
two signaling pathways, the TNFR pathway and the TLR pathway.
NF-kB signaling pathways are highly conserved in evolution,
and therefore, similar signaling cascades are found in lower eu-
karyotes, such as the fruit fly Drosophila melanogaster. Dro-
sophila systemic immune response is largely mediated by two
NF-kB signaling cascades, the Toll and the immune deficiency
(Imd) pathway, which closely resemble mammalian TLR and
TNFR signaling cascades, respectively (2). Both signaling cas-
cades lead to activation and nuclear localization of Drosophila
NF-kB family protein and expression of a distinct but overlapping
set of antimicrobial peptide genes (3–5). Thus, lacking adaptive
immunity, the fruit fly makes a useful and simpler model to study
the signaling cascades and their involvement in innate immune
responses.
The Drosophila Imd pathway is activated in response to Gram-
negative bacterial infection. After ligand binding to the receptor
peptidoglycan recognition protein (PGRP)-LC (6–8), the signal
proceeds via downstream components, which include the death-
domain protein Imd (9), the MAPK kinase kinase TGF-b–activated
kinase 1 (Tak1) (10), and a Drosophila homolog of Fas-associated
death domain protein (FADD) (11). The signaling leads to activation
of Drosophila IkB kinases Kenny and immune response deficient
5 (12), which phosphorylate the inhibitory domain of the NF-kB
family transcription factor Relish (13), resulting in Relish cleavage
by the caspase Dredd (14–16). Subsequently, the activated N-
terminal 68-kDa Relish is translocated into the nucleus, where it
activates transcription of antimicrobial peptide genes. In addition,
inhibitor of apoptosis 2 and TGF-b–activated kinase 1-associated
binding protein 2 (Tab2) are shown to play a key part in the regu-
lation of Relish activity (17–20).
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The Toll pathway is activated by Gram-positive bacteria and
fungi (3) recognized by several pattern recognition receptors (2)
including PGRP-SA (21), leading to proteolytic cleavage and
activation of the cytokine Spa¨tzle and its binding to the Toll re-
ceptor (22, 23). Intracellular components of Toll pathway include
the death domain proteins Drosophila MyD88 (24), Tube, and
Pelle (3). Finally, the signaling leads to degradation of the NF-kB
inhibitory protein Cactus and nuclear localization of Dorsal-
related immunity factor (Dif) and/or Dorsal (25). It has also been
shown that Toll signaling is involved in the activation of the
cellular immune system (26, 27). It is likely that components yet
to be found are involved in regulating the cascade.
To identify novel gene products involved in Drosophila NF-kB
signaling, we carried out a genome-wide screen for 16,025
dsRNAs using a Drosomycin luciferase reporter-based assay that
enables us to monitor both the Toll and Imd pathways. We iden-
tified 10 novel NF-kB regulators, of which 9 act primarily on the
Toll pathway. Furthermore, we identified G protein-coupled re-
ceptor kinase (Gprk)2/GRK5 as an evolutionarily conserved reg-
ulator of NF-kB signaling.
Materials and Methods
Drosophila dsRNA libraries and synthesis of targeted dsRNAs
The dsRNAs used in the RNA interference (RNAi) screen (16,025) were
produced from a commercial Drosophila genome RNAi library consisting
a set of 13,625 PCR products with dual T7 promoter sequences (Medical
Research Council [MRC]Geneservice, Cambridge, U.K.) and from in-house–
made S2 cell-derived cDNA library (2,400). dsRNAs were synthesized
from PCR product or plasmid templates with the T7 MegaScript RNA poly-
merase kit (Ambion,Austin, TX) according to themanufacturer’s instructions.
Concentration of each dsRNAwas measured using PicoGreen dsDNAQuan-
titation Kit (Molecular Probes, Eugene, OR) or NanoDrop (Thermo Fisher
Scientific,Waltham,MA).Targeted dsRNAswere produced using cDNAfrom
S2 cells as a template in a two-step PCR with nested primers (Supplemental
Table I), the second primers containing a T7 promoter sequence (59-TAA-
TACGACTCACTATAGGGAGA-39) at the 59 end. pMT/BiP/V5-His/GFP
plasmid (Invitrogen/Life Technologies, Carlsbad, CA) was used as a templa-
te for the production of the negative control GFP dsRNA.
S2 cell treatments and reporter assays
S2 cell culture, transfections, dsRNA treatments, and reporter assays for the
Toll and Imd pathways were performed essentially as previously described
(17, 28). For the genome-wide screen, S2 cells were transfected with 0.1
mg Drosomycin luciferase (29) and 0.1 mg Actin 5C–b-galactosidase
(Act5C–b-gal) reporter plasmids. In addition, the cells were treated with
0.5 mg dsRNAs. To screen both Toll and Imd pathways simultaneously,
the Toll pathway was first activated by transfecting S2 cells with 0.1 mg
Toll10b construct. Forty-eight hours posttransfection and 24 h prior to
measurements, the Imd pathway was activated by adding heat-killed Es-
cherichia coli.
S2 cell transfections for quantitative RT-PCR
For quantitative RT-PCR (qRT-PCR) experiments, S2 cells were seeded on
24-well plates and transfected with 0.1 mg Toll10b construct and 0.5 mg
dsRNA. Seventy-two hours later, cells were harvested and lysed in TRIsure
reagent (Bioline, London, U.K.) by pipetting up and down 10 times. Total
RNAs were extracted according to the manufacturer’s instructions and
RNAs subjected to quantitative RT-PCR analysis as detailed below.
HeLa cell culture and transfections
HeLa cells were grown in DMEM plus GlutaMAX (Gibco/Life Technol-
ogies, Carlsbad, CA) with 10% FBS, 1% nonessential amino acids (Sigma-
Aldrich, St. Louis, MO), 100 U/ml penicillin, and 100 mg/ml streptomycin.
For transfection, 6 3 104 cells per well were seeded onto 24-well plate.
Twenty-four hours later, the cells were transfected with 0.1 mg NF-kB
luciferase, 0.05 mg CMV–b-galactosidase reporter plasmid, and 50 pmol
small interfering RNAs (siRNAs) (Ambion, Austin, TX) using Lipofect-
amine transfection reagent (Invitrogen/Life Technologies) and Opti-MEM
medium (Life Technologies). siRNAs used were as follows: GFP siRNA
(Silencer GFP [eGFP]; catalog number AM4626, negative control), GRK5
siRNA (catalog number AM16704; ID 110898), and RelA (catalog number
AM16704; ID 216912, positive control). Forty-eight hours post-
transfection, NF-kB signaling was induced with 10 ng/ml TNF-a (Sigma-
Aldrich), and 6 h later, luciferase and b-galactosidase activities were
measured from the cell lysates.
Immunohistochemistry with Gprk2/GRK5 constructs
To create a Gprk2-GFP fusion protein, the full-length cDNA for Drosophila
Gprk2 gene was amplified by PCR and cloned into the KpnI site of the
modified Drosophila expression vector pMT/GFP/V5/His, a kind gift from
Dr. I. Kleino (University of Helsinki, Helsinki, Finland). S2 cells were
transfected with the Gprk2-GFP fusion construct essentially as described
previously (30). Overexpression of Gprk2-GFP fusion protein in S2 cells
was induced with 350 mM CuSO4 for 36 h. For HeLa cell transfection, cells
were seeded onto coverslips on six-well plates, and 24 h later, the cells were
transfected with 0.1 mg GRK5-GFP construct. Thirty-six hours later, the
coverslips were mounted to slides with Vectashield mounting medium for
fluorescence with 49,6-diamidino-2-phenylindole (Vector Laboratories,
Burlingame, CA). Cells were imaged with an Olympus IX70 confocal
microscope (Olympus, Tokyo, Japan) and analyzed with Andor iQ software
(Andor Technology, Belfast, U.K.).
Zebrafish maintenance and morpholino gene silencing
AB wild-type zebrafish strain was maintained according to standard protocols
(31). Translation-blocking morpholinos targeting zebrafish GRK5 (ZDB-
GENE-060929-1198) (59-GGCCACGATATTCTCAATCTCCATT-39) and
MyD88 (ZDB-GENE-040219-3) (59-GGTCTATACTTAACTTTGATGC-
CAT-39), as well as a mismatch-GRK5 control morpholino (59-GCCCAC-
CATATTGTCAATGTCGATT-39),wereobtained fromGeneTools (Philomath,
OR). A total of 1 nl 250 mMmorpholinos in 0.2 M KCl was injected into the
yolk sacs of AB wild-type embryos at the 1-2 cell stage.
Zebrafish infections
For infection experiments, E. coli was grown in Luria-Bertani broth until
OD of 0.3 at 600 nm. Bacterial cells were pelleted by centrifugation
(10,000 3 g, 5 min), washed with 0.2 M KCl, pelleted, and diluted 1:2 in
0.2 M KCl. Prior to injection, 70 kDa rhodamine dextran tracer was added
to the bacterial suspension. Morpholino-injected zebrafish larvae were
manually dechorionated at 24–28 h postfertilization, after which 1 nl
prepared E. coli suspension was injected into the yolk. Before and after
the injections with each needle, one injection dose was plated for checking
the bacterial quantity. Infected larvae were kept at 28˚C for 2–24 h post-
infection, after which they were snap-frozen for total RNA extraction.
Total RNAs were extracted according to standard procedures.
Coimmunoprecipitation
S2 cells were transfected with Gprk2-V5 full-length or deletion constructs
and Cactus-myc constructs in pMT/V5/HisA vector (Invitrogen/Life
Technologies) and coimmunoprecipitated, separated, transferred on the
membrane, and detected essentially as described (30).
Stable S2/epidermal growth factor receptor-Toll cells, Western
blotting, and quantification
S2 cells with stable integration of a chimeric epidermal growth factor receptor
(EGFR)-Tollconstructweremadeaccording toRef.32,and the response toToll
signaling by EGF was verified with Drosomycin luciferase construct. Stable
S2/EGFR-Toll cells were grown in six-well culture dishes and treated with 15
mg dsRNA in a total volume of 3 ml medium for 4 d. Induction of the Toll
pathway was done by addition of EGF (0.5 mg/ml) (Molecular Probes) for 30
min. Cytoplasmic extracts of S2-EGF/Toll cells were separated by electro-
phoresis, transferred to aHybond-Pmembrane (GEHealthcareLife Sciences),
and blocked. Cactus protein on the membrane was detected with polyclonal
rabbit anti-Cactus Ab andHRP-linked donkey anti-rabbit IgG (GEHealthcare
Life Sciences, Uppsala, Sweden). Rabbit polyclonal anti-GM130Ab (Abcam,
Cambridge, MA) targeting a Drosophila Golgi protein GM130 was used as
a loading control. Band quantifications were done with Adobe Photoshop 7
software (Adobe Systems, San Jose, CA) as follows: to obtain the absolute
intensity, the mean value of each band was multiplied by the pixel value. The
relative intensity was calculated by normalizing absolute intensities with the
absolute intensity of the negative control, which was set to the value of 1.
Quantifications were carried out on three separate Western blots.
Fly stocks and maintenance
Drosophila stocks were kept on a standard mashed potato diet at room
temperature or at 25˚C. C564-GAL4 flies express GAL4 in the adult
fatbody; the P{UAS-Tl10b:11} stock carries a Toll10b insert on the X
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chromosome and the hemolectinD (hmlD)-GAL4, UAS-GFP stock consti-
tutively expresses GFP in the majority of blood cells (33). The upstream
activating sequence (UAS)-RNAi fly stocks listed in Supplemental Table I
were obtained from the Vienna Drosophila RNAi Center [VDRC; Vienna,
Austria (34)] or the Kyoto Fly Stocks of the National Institute of Genetics
(NIG-FLY) (Drosophila Genetic Resource Center, Kyoto Institute of
Technology, Kyoto, Japan). The C564-GAL4 flies were crossed with UAS-
RNAi flies, and the adult flies carrying one copy of the UAS-RNAi construct
and one copy of the GAL4 driver were used in infections. UAS-RNAi flies
crossed to w1118 were used as controls in infection experiments.
Fly infection and RNA extraction
To produce induced Drosomycin expression via septic injury, flies were
pricked with a thin tungsten needle previously dipped in a concentrated
culture of Micrococcus luteus and grown at 25˚C. Twenty-four hours later,
five flies per sample were collected and snap-frozen in dry ice. Alternatively,
expression of Toll pathway target genes was induced by natural fungal in-
fectionwithBeauveria bassiana at 29˚C for 48 h as previously described (35),
after which the flies were collected as mentioned above. Total RNAs were
extracted according to standard procedures and RNAs subjected to qRT-PCR
analysis as detailed below.
qRT-PCR
Extracted total RNAs from S2 cells, zebrafish embryos, or flies were used in
qRT-PCR experiments. qRT-PCR for expression levels of chosen genes was
carried out from dilutions of the extracted RNAs using the QuantiTect
SYBR Green RT-PCR Kit (Qiagen, Hilden, Germany) and the ABI7000
instrument (Applied Biosystems, Foster City, CA). Primers and sizes of
PCR products are listed in Supplemental Table II.
Fly survival experiments
To assess Toll pathway-mediated immunity, flies were first immunized by
pricking them with M. luteus as described above (M. luteus infection acti-
vates the Toll pathway). Twenty-four hours later, the flies were infected with
Enterococcus faecalis by pricking as above. The infected flies were kept at
room temperature, and their survival was monitored for 24 h. For Imd
pathway-mediated immunity, flies were pricked with a thin tungsten needle
previously dipped in a concentrated culture of Enterobacter cloacae (a
Gram-negative bacterium), and their survival was monitored for 48 h.
Fly larvae in vivo experiments
To assess the distribution of blood cells in Drosophila larvae in vivo, parental
crosses were kept for 2 d at 29˚C in stained mashed potato food, which per-
mits the staging of larval progeny as described previously (27). The experi-
ment was blinded by assigning arbitrary numbers to the fly bottles. Collected
larvaewere gently washed and embeddedwith the dorsal side up in 50% chilled
glycerol between a glass slide and a coverslip. For immobilization, slides
were kept at220˚C for 18min before examining underUV light on anAxioplan
microscope (Carl Zeiss, Jena, Germany). Digital pictures were taken with a
Hamamatsu C4742-95 video unit (Hamamatsu Photonics, K.K., Hamamatsu
City, Japan), controlled by the Openlap program (Improvision, Coventry, U.K.).
For each cross, 20 F1 progeny larvae were graded for the percentage
of their segments showing a band formed by islets of sessile hemocytes
under the epidermis. In the grading system, grade 1 larvae showed sessile
hemocyte bands in 100% of the segments. Larvae receiving grade 2 or 3
showed bands in ,75 or 50% of their segments, respectively. Larvae
showing no bands or bands only in the most posterior 25% of their seg-
ments received grade 4. All crosses were repeated three times and the
average grades of three independent experiments calculated.
Data analysis
Statistical analyses of reporter assays, qRT-PCR, and Western blot band
quantification were carried out using one-way ANOVA. Statistical analysis
of fly larvae in vivo experiments was performed using one-way ANOVA and
Bonferroni as post hoc method. Statistical analysis of fly survival experi-
ments was carried out using the log-rank (Mantel-Cox) test; p , 0.05 was
considered to be statistically significant.
Results
Drosomycin expression is controlled by both the Toll and Imd
pathways in Drosophila S2 cells
Drosomycin promoter-driven luciferase activity has been used to
monitor the Drosophila Toll pathway activity (29). However, we
have observed earlier (17) that in S2 cells, RNAi targeting compo-
nents of the Imd pathway decreased the Drosomycin luciferase ex-
pression induced by the constitutively active form of Toll (Toll10b).
To investigate the respective roles of the Toll and Imd pathways to
the regulation of Drosomycin, we analyzed the Drosomycin lucif-
erase activity in S2 cells activated with both Toll10b overexpression
and heat-killed E. coli. As shown in Fig. 1A,Drosomycin expression
was induced by Toll10b, and this induction was further enhanced if
the Imd pathway was also activated by E. coli. This induction,
stimulated by both pathways, can be drastically decreased by si-
lencing known components of the Toll pathway, namely Toll,
MyD88, or dorsal. Imd pathway components, namely PGRP-LC,
Imd, Tab2, and Relish, are also required for normal induction in this
assay. If both pathways are silenced by targeting both Relish and
MyD88, Drosomycin activation is totally blocked (Fig. 1A). These
results are in line with previous studies indicating that Drosomycin
expression can be induced by both the Toll and Imd pathways in vivo
and in vitro (5, 36). These results also show that Drosomycin lucif-
erase activity can be used in screening for components of both the
Toll and Imd signaling cascades in Drosophila S2 cells.
Genome-wide analysis of the Toll and Imd pathways in
Drosophila S2 cells
To identify gene products required for signaling via the Toll and Imd
pathways, we examined the effect of 16, 025 dsRNA treatments for
Drosomycin luciferase reporter activity in response to inductionwith
Toll10b andE. coli inDrosophila S2 cells. The dsRNA collection was
obtained by transcribing PCR products from the commercial Dro-
sophila genome-wide library (MRC Geneservice) to dsRNAs
(13,607) and transcribing dsRNAs (2,418) from S2 cell-derived
cDNA library (37).
Drosophila S2 cells were transfected with Drosomycin luciferase
and Act5C–b-gal reporter constructs, Toll10b, and dsRNAs. dsRNAs
targetingMyD88 and Relishwere used as positive controls andGFP
as a negative control in each experiment.E. coliwas added 24 h prior
to luciferase and b-galactosidase measurements. Out of 16,025
dsRNA treatments, 23 repeatedly decreased the Drosomycin lucif-
erase reporter activity.50%without considerably affecting the cell
viability as measured by Act5C–b-gal reporter activity (Fig. 1B).
Corresponding templates were sequenced and targeted PCR primers
for dsRNA synthesis designed to confirm that the effect had been due
to dsRNA according to the library data and not due to contaminating
dsRNAs. As shown in Fig. 1C, five dsRNA treatments representing
known components of the Toll pathway (Toll, MyD88, tube, pelle,
and dorsal), and eight dsRNA treatments representing known Imd
pathway components (Relish, kenny, FADD, Tak1, imd, Tab2, Ird5,
and inhibitor of apoptosis 2) were identified, indicating that our
screen effectively found components of both of the Drosophila NF-
kB signaling pathways. Importantly, 10 novel regulators of NF-kB
signaling were identified (Fig. 1C). Corresponding genes were
subjected to further studies.
Nine of the identified regulators are required for signaling via
the Toll pathway
Our RNAi screen effectively identified components of both the
Toll and Imd signaling cascades. To find out which pathway is af-
fected by these regulators, we carried out separate assays for the Toll
and Imd pathways in S2 cells with targeted dsRNAs. Imd pathway
activitywasmeasuredwitha reporter assay inwhichAttacinA-driven
luciferase (AttA-luc) construct, Act5C–b-gal, and dsRNAs were
transfected into S2 cells, cells treated with E. coli, and reporter ac-
tivities measured (Fig. 2A). Out of the 10 novel candidate genes,
mediator complex subunit 25 (MED25) RNAi was shown to affect
Imd pathway at the same level as RNAi to known Imd pathway
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FIGURE 1. Genome-wide RNAi screen to identify genes required for NF-kB signaling in Drosophila S2 cells. A, Drosomycin luciferase reporter activity
is regulated by both the Toll and Imd pathways in S2 cells. S2 cells were transfected with Drosomycin luciferase and Act5C–b-gal reporters. Toll pathway
was induced by overexpression of Toll10b and the Imd pathway by heat-killed E. coli treatment for 24 h. RNAi targeting known components of the Toll
pathway (Toll, MyD88, or dorsal) or components of the Imd pathway (Tab2, PGRP-LC, imd, or Relish) caused a strong reduction in the Drosomycin
luciferase/Act5C–b-gal activity. Relish + MyD88 RNAi completely blocked the relative Drosomycin activation. Data are shown as mean 6 SD; n $ 3. B,
Results of the genome-wide RNAi screen of the Drosophila NF-kB signaling. The 16,025 independent dsRNA treatments were analyzed for effect on
Drosomycin luciferase reporter activity induced via both the Toll and Imd signaling pathways. S2 cells were transfected with Drosomycin luciferase and
Act5C–b-gal reporters, Toll10b, and dsRNAs and treated with heat-killed E. coli. Luciferase and b-galactosidase values were plotted on a log-scale.
Negative control samples (GFP RNAi) are illustrated with light blue crosses. Toll pathway positive controls (MyD88 RNAi) are shown in purple, and Imd
pathway positive controls (Relish RNAi) are shown in yellow. Samples with values in the top left corner of the plot include the most potential regulators of
NF-kB signaling in Drosophila S2 cells. C, Targeted dsRNA treatments of potential regulators of the Drosophila NF-kB signaling confirm 23 dsRNA
treatments that decrease Drosomycin luciferase reporter activity by .40%. Drosomycin luciferase and Act5C–b-gal values of induced GFP dsRNA-treated
cells were set to 1. Data are shown as mean 6 SD; n $ 3. Statistics refer to Drosomycin luciferase values.
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FIGURE 2. MED25 affects mainly the Imd signaling cascade, U-shaped affects both Toll and Imd signaling, and the other eight identified novel NF-kB
regulators affect mainly Toll signaling. Data are shown as mean6 SD; n$ 3. In each panel, statistics refer to white bars. A, For Imd pathway, S2 cells were
transfected with AttA-luc reporter, Act5C–b-gal reporter, and indicated dsRNAs and induced with heat-killed E. coli. In addition to known Imd pathway
components (kenny, Tab2, Imd, Tak1, FADD, and Relish), MED25 RNAi decreased the AttA-luc reporter activity comparably to the known components.
u-shaped RNAi also significantly affected the AttA-luc reporter activity. B, For Toll pathway activity, S2 cells were transfected with Toll10b, Drosomycin
luciferase reporter, Act5C–b-gal reporter, and indicated dsRNAs. Of the novel regulators, pannier, CG4325, CG32133, u-shaped, CG15737, achaete,
Gprk2, CG31660, and Spt6 dsRNAs considerably decreased the Drosomycin luciferase reporter activity. Also, most of the Imd pathway components/
regulators (kenny, Tab2, imd, Tak1, MED25, and Relish) affected the Drosomycin luciferase activity. C, Drosomycin expression is inhibited by dsRNA
treatments targeting all of the known tested components of Toll pathway and 10 dsRNAs identified from our collections. Endogenous Drosomycin ex-
pression in Toll10b-transfected dsRNA-treated S2 cells was analyzed using qRT-PCR and normalized to Act5C expression values. D, Schematic repre-
sentation of the Drosophila Toll pathway. E, Epistasis analysis of the identified regulators of Toll signaling. Drosomycin luciferase expression was induced
by cactus RNAi. Ten dsRNA treatments (dorsal, pannier, CG15737, Relish, Spt6, Gprk2, CG4325, u-shaped, CG32133, and achaete) blocked this in-
duction and therefore appear to act downstream or independently of Cactus. Five dsRNA treatments (Toll, tube, pelle, CG31660, and MyD88) did not
considerably affect this induction, indicating that these gene products act upstream of Cactus.
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components (21% of pathway activity left; Fig. 2A). Also, u-shaped
RNAi decreased significantly the Imd pathway activity (48% of
activity left). Spt6, CG31660, and CG15737 RNAi had little effect
on Imd pathway activity, whereas RNAi targeting achaete, Gprk2,
pannier, CG4325, and CG32133 resulted in hyperactivation of the
pathway (Fig. 2A, on the right with a separate scale).
Outof the10novelcandidategenes,9dsRNAtreatmentsdecreased
theDrosomycin luciferase activity of Toll10b-induced S2 cells.60%
(Fig. 2B). TheDrosomycin luciferase activity of S2 cells treatedwith
these dsRNAs was also reduced by at least 50% when the Toll
pathway was activated by overexpression of the cleaved, active
Spa¨tzle ligand (SpzC106; data not shown). MED25 dsRNA treatment
did not have as strong an effect on Toll pathway alone (Fig. 2B), so it
was omitted from further analyses.
To ensure that our results were not due to an artifact related to the
use of a reporter construct, we analyzed the relative endogenous
Drosomycin expression levels of Toll10b-induced S2 cells by qRT-
PCR. In this assay, Toll10b transfection to S2 cells induced the rel-
ative endogenousDrosomycin expression (Drosomycin/Act5C) in S2
cells ∼25-fold (Fig. 2C). Treating cells with dsRNAs targeting the
known components of the Toll pathway, Toll,MyD88, tube, pelle, or
dorsal, decreased the pathway activity by .55%. Similarly, RNAi
targeting all of the nine novel Toll pathway regulators identified in
the reporter assay, namely u-shaped, pannier, CG4325, Gprk2,
CG15737, CG32133, CG31660, achaete, and Spt6 caused a statisti-
cally significant reduction in endogenousDrosomycin expression. Of
note, RNAi targeting Relish, the NF-kB factor in the Imd pathway,
also caused a statistically significant reduction in Toll10b-induced
Drosomycin expression.
To gain more insight into the mechanism of how the novel reg-
ulators are functioning on the Toll pathway, we silenced cactus, the
Drosophila homolog of human IkB, by RNAi (Fig. 2D, 2E). Si-
lencing cactus results in Dif/Dorsal translocation into the nucleus
(Fig. 2D) and .40-fold induction of the Toll pathway in a Droso-
mycin luciferase reporter assay (Fig. 2E). RNAi targeting known
components of the pathway upstream of Cactus, namely Toll, tube,
pelle, and MyD88 have no or very little effect on Cactus RNAi-
inducedDrosomycin luciferase activity. Conversely, RNAi targeting
dorsal, the Drosophila NF-kB homolog in the Toll pathway
(downstream of Cactus), blocks this induction completely (Fig. 2E).
Results indicate that CG31660 appears to act upstream of Cactus,
whereas pannier, CG15737, Spt6, Gprk2, CG4325, u-shaped,
CG32133, and achaete appear to act downstream or independently
of Cactus. Relish also acts downstream of Cactus.
Gprk2, CG15737/Toll pathway activation mediating protein,
and u-shaped RNAi flies have reduced Drosomycin expression
in Drosophila in vivo
To investigate whether the identified nine genes are important for the
Toll pathway signaling in vivo, we carried out in vivo RNAi
experiments with fly lines carrying UAS-RNAi constructs targeting
these genes. RNAi flies (Supplemental Table I) were crossedwith the
C564-GAL4 driver line, which drives expression of the dsRNA in the
fatbody. Fly strains without the driver (i.e., RNAi strains over w1118
flies) were used as controls. The Toll pathway was activated by
M. luteus septic injury for 24 h, after which total RNAswere isolated.
Relative Drosomycin expression in RNA samples was measured by
qRT-PCR (Fig. 3).MyD88RNAi crossedwithC564-GAL4flieswere
used as positive controls (Fig. 3A). Two Gprk2 RNAi fly lines,
namelyGprk2 R-1 andGprk2 R-3, crossed withC564-GAL4 showed
a significant decrease in Drosomycin expression (Fig. 3B, 3C).
Moreover, the fly line expressing the CG15737 RNAi construct
showed a statistically significant reduction inDrosomycin expression
compared with control flies, so we decided to name the CG15737
gene TAMP (Fig. 3D). Also, flies expressing the u-shaped RNAi
construct showed a statistically significant reduction in Drosomycin
expression compared with control flies (Fig. 3E). In vivo RNAi
targeting other identified Toll pathway candidate genes did not sig-
nificantly decrease Drosomycin expression (Supplemental Fig. 1).
Drosophila Gprk2 is homologous to GRK5 from other
organisms
Because of the strong phenotype obtained in both in vitro and in vivo
Drosophila RNAi assays and its evolutionary conservation, we de-
cided to subject Gprk2 to further studies. Drosophila Gprk2
(CG17998) is well conserved and has high sequence similarity with
human, mouse, and zebrafish GRK5 (Supplemental Fig. 2). Gprk2
codes for a 714-aa protein that has three known domain structures:
a regulator of G protein signaling (RGS) domain, a serine/threonine
protein kinase catalytic domain, and an extension to kinase domain
(Fig. 4A). It belongs to a protein family, the members of which are
multifunctional, GTPase-accelerating proteins (38). When the
Gprk2-GFP construct was overexpressed in Drosophila S2 cells, it
was shown that Gprk2 is localized on the cell membrane or cyto-
plasm (Supplemental Fig. 3A). Similarly, the human GRK5-GFP
construct was located on the cell membrane or cytoplasm when
overexpressed in HeLa cells (Supplemental Fig. 3B).
Gprk2/GRK5 has an evolutionarily conserved role in NF-kB
signaling
To investigate whether Gprk2/GRK5 has an evolutionarily con-
served role in NF-kB signaling, we examined the role of GRK5 in
NF-kB signaling in human HeLa cells in vitro. HeLa cells were
transfected with NF-kB luciferase and CMV–b-galactosidase re-
porters and GRK5 or control siRNAs. Six hours prior to meas-
urements, NF-kB signaling was induced with TNF-a. When HeLa
cells are treated with GRK5 siRNA, the relative NF-kB-luc ac-
tivity is reduced .60% (Fig. 4B). This indicates that GRK5 is an
important regulator of human NF-kB signaling in vitro.
To study the role of Gprk2/GRK5 for vertebrate innate immune
response in vivo, we silenced the zebrafish GRK5 in embryos with
a translation-blocking morpholino. E. coli was injected into GRK5
morphant zebrafish larvae at 48 h postfertilization and proin-
flammatory cytokine levels weremonitored 18 h postinfection. TNF-
a mRNA expression was induced ∼600-fold and IL-1b 300-fold
(data not shown). In larvae lacking GRK5, the relative TNF-a ex-
pression (Fig. 4C) and IL-1b (Fig. 4D) was significantly reduced
from that of control morpholino-treated larvae. Blocking the trans-
lation of MyD88 also resulted in reduction of TNF-a and IL-1b
expression levels (Fig. 4C, 4D). These results indicate that GRK5 is
essential for NF-kB signaling in vertebrate immune system in vivo.
Gprk2 interacts with Cactus but is not required for its
degradation upon signaling
Because Gprk2 acts at the level or downstream Cactus in the cactus
dsRNA epistasis experiment (Fig. 2E), and because of reports of
mammalian GRK5 interaction with members of the IkB family (39–
41), we decided to investigate the interaction of Gprk2 with Cactus
and Dorsal. V5-tagged full-length Gprk2 and deletion constructs
were coimmunoprecipitated with myc-tagged Cactus and Dorsal in
S2 cells. The full-length Gprk2, Calmodulin (CaM) binding-site
deletion (DCaM1), and RGS-domain deletion (DRGS) constructs
interact withCactus protein, indicating that RGS andCaM1domains
are not needed in Gprk2 and Cactus interaction. In the kinase de-
letion (Dkinase) construct, this interaction is virtually not detectable
anymore, which suggests that the kinase domain is important for the
interaction, or that the protein, lacking a large domain, is not cor-
rectly folded anymore, resulting in loss of the interaction (Fig. 5A,
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Supplemental Fig. 4). V5-tagged Gprk2 proteins did not coimmu-
noprecipitate with Dorsal-myc (data not shown).
To investigate the functional significance of Cactus-Gprk2 in-
teraction, we used an established EGFR-Toll pathway induction
system (32) to monitor Cactus degradation. S2 cells expressing
a chimeric EGFR-Toll construct were treated with GFP, Gprk2, and
MyD88 dsRNAs and Cactus degradation was monitored on a West-
ern blot (Fig. 5B). Also, a loading control was carried out with anti-
GM130 Ab (Abcam) targeting aDrosophilaGolgi protein (Fig. 5B).
Cactus band intensities were quantified from three separate Western
blots with Adobe Photoshop 7 software (Adobe Systems) and nor-
malized to the loading control GM130 band intensities (Fig. 5C).
Gprk2 RNAi did not affect degradation of Cactus. Furthermore, we
carried out kinase experiments with coimmunoprecipitated Cactus
and Gprk2, but were not able to show Gprk2-mediated phosphory-
lation of the Cactus protein (data not shown). We conclude that
Gprk2 interacts directly or indirectly with Cactus, but is not required
for Cactus degradation upon signaling.
Gprk2 RNAi flies infected with B. bassiana have reduced
expression of the Toll pathway target genes in Drosophila
in vivo
To investigate the role of Gprk2 on Toll pathway-mediated im-
munity in vivo, we carried out an experiment in whichGrpk2 RNAi
flies and controls were subjected to natural fungal infection with
an insect pathogen B. bassiana at +29˚C for 48 h, after which total
RNAs were isolated. RNAs from noninfected flies were isolated as
a control for the infection. Expression of Toll pathway target
genes, namely Drosomycin, IM1, and IM2 was measured by qRT-
PCR (Fig. 6A–C, respectively). Results were normalized to Act5C
FIGURE 3. RNAi targeting Gprk2, CG15737/TAMP, and u-shaped re-
duces Drosomycin expression in Drosophila in vivo. Fly lines containing
indicated UAS-RNAi constructs crossed over the C564-GAL4-driver flies,
and controls were infected with M. luteus by pricking and collected 24 h
later. Total RNAs were extracted and Drosomycin expression levels mea-
sured by qRT-PCR. Results were normalized to Act5C expression values.
In each experiment, the relative Drosomycin expression value of the con-
trol flies was set to 1. A,MyD88 RNAi flies were used as a positive control.
Gprk2 (B, C), TAMP (D), and u-shaped (E) RNAi flies show impaired
Drosomycin expression (p , 0.05) compared with controls without the
driver. Data are shown as mean 6 SD.
FIGURE 4. Gprk2/GRK5 has an evolutionarily conserved role in NF-kB–
mediated immune signaling in human HeLa cells in vitro and in zebrafish
embryos in vivo. A, Schematic diagram of Drosophila Gprk2, Homo sapiens
GRK5, and Danio rerio GRK5 proteins. B, GRK5 is required for TNF-a–
triggered NF-kB signaling in HeLa cells. HeLa cells were transfected with
NF-kB–luciferase and CMV–b-galactosidase reporters and with GRK5 or
control siRNAs. Cells were inducedwith TNF-a 6 h prior to luciferase andb-
galactosidase measurements. C and D, GRK5 is required for E. coli-induced
activation of NF-kB signaling in zebrafish embryos. Zebrafish embryos were
injected with GRK5 and control morpholinos, and 24 h later, embryos were
infected by E. coli injection. After 18 h incubation, embryos were collected
and total RNAs extracted. Relative expression of TNF-a (C) or IL-1b (D) in
infected and control embryos was analyzed by qRT-PCR. Data are shown as
mean6 SD; n$ 5. C, CaM binding site; EXT, extension to kinase domain;
kinase, kinase domain.
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expression values. Both Gprk2 R-1 and Gprk2 R-3 RNAi lines
crossed with the driver C564-GAL4 showed a reduced expression
of Toll pathway target genes. w1118 flies over the C564-GAL4
driver and MyD88 RNAi flies over the C564-GAL4 driver were
used as negative and positive controls, respectively. These results
indicate that in Gprk2-silenced flies, Toll pathway-induced genes
are poorly activated after fungal infection.
Gprk2 RNAi flies are susceptible to infection with
Gram-positive bacteria E. faecalis
To examine whether the effect of Gprk2 silencing on Toll path-
way is sufficient to impair the fly’s survival, we used septic injury
with Gram-positive bacteria. The Toll pathway-mediated immune
response was first induced by pricking flies with a needle dipped
into a culture of M. luteus. M. luteus infection activates the Toll
pathway response including Drosomycin expression. Twenty-four
hours later, the flies were infected with E. faecalis by pricking as
above. Both Gprk2 RNAi lines crossed with the C564-GAL4
driver show a statistically significant reduction in survival com-
pared with the control line without the driver (Fig. 7A, 7B). When
infected with the Gram-negative bacterium E. cloacae, there was
no difference between the Gprk2 RNAi flies and controls (Sup-
plemental Fig. 5A, 5B). In conclusion, Gprk2 is needed for normal
defense against Gram-positive bacteria E. faecalis.
Gprk2 RNAi construct can rescue UAS-Toll10b blood cell
activation in Drosophila larvae in vivo
To examine if Gprk2 RNAi can inhibit blood cell activation caused
by a constitutively activated Toll pathway in vivo, transgenic RNAi
fly lines of Gprk2 R-3, and MyD88 as a control, were combined
with blood cell-specific hmlD-GAL4, UAS-GFP driver. Males origi-
nating from these stocks were crossed to females of theUAS-Toll10b
FIGURE 5. Gprk2 interacts with Cactus, but is not required for Cactus degradation upon signaling. A, The full-length Gprk2, CaM binding site deletion
(DCaM1) and RGS-domain deletion (DRGS) constructs interact with Cactus protein. In the kinase deletion (Dkinase) construct, this interaction is virtually
nondetectable. Protein expression was induced with CuSO4 (250 mM). Proteins were coimmunoprecipitated with anti-myc Ab and detected with anti-V5
Ab. B, Expression of pMT-Gprk2-V5 and pMT-Cactus-myc constructs in S2 cells induced with CuSO4 (250 mM) detected with anti-V5 and anti-myc Abs,
respectively. C, Gprk2 RNAi does not affect Cactus degradation upon signaling. S2 cells expressing a chimeric EGFR-Toll construct were treated with GFP,
Gprk2, and MyD88 dsRNAs. Toll pathway was activated with EGF, and Cactus protein in cytoplasmic extracts was detected by SDS-PAGE and Western
blotting with anti-Cactus Ab. Gel loading was controlled using anti-GM130 Ab targeting a Drosophila Golgi protein. D, Cactus band intensities were
quantified from three separate Western blots and normalized to the loading control GM130 band intensities. Data are shown as mean 6 SD; n = 3.
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line. Males from the original driver line were crossed to females
of either the UAS-Toll10b line (negative control) or w1118 (treatment
control). Progeny third-instar larvae were graded for the percentage
of their segments showing bands formed by islets of sessile hemo-
cytes under the epidermis. Offspring of the treatment control showed
bands of sessile cells in all segments, indicating that larval handling
had little effect on the blood cell distribution (Fig. 7Ci). In contrast,
larvae of the negative control showed a largely disturbed sessile
hemocyte banding pattern caused by the constitutive activation of
the Toll signaling pathway in blood cells (Fig. 7Cii) (27). This dif-
ference is reproducible and reflected in the average grades calcu-
lated, with significantly higher average grades for crosses of the
negative control compared with the treatment control (Fig. 7D). The
loss of sessile hemocyte banding pattern could be rescued by in-
troducing theRNAi constructs targetingGprk2orMyD88 (Fig. 7Ciii,
7Civ, 7D). These results indicate that RNAi targeting Gprk2 can
inhibit hemocyte activation caused by UAS-Toll10b.
Discussion
Large-scale in vitro RNAi screening has become a commonly used
method to identify gene products involved in numerous cellular
processes. In this study, we used a luciferase-based reporter assay,
withwhichwewereable tomonitorboth theToll and the Imdpathway
activities simultaneously. Based on careful setup of the assay, bi-
ologically meaningful cutoffs and assessment of the general well-
being of the cells usingAct5C–b-gal reporter, we obtained a sensible
hit list of 23 genes. These included 5 known components of the Toll
signaling pathway, 8 known components of the Imd pathway, and 10
previously uncharacterized novel regulators of Drosophila NF-kB
signaling. Noteworthy, only one new regulator (MED25) strongly
affected the Imd pathway, whereas there were nine dsRNA treat-
ments that primarily decreased the Toll pathway activity. This is in
accordance with the notion that several RNAi screens have already
been carried out for the Imd pathway, whereas the Toll pathway is
less thoroughly studied using RNAi. The results related to Toll
pathway activity were further confirmed by secondary (SpzC106
-based) and tertiary (qRT-PCR for endogenousDrosomycin) assays.
After these confirmation and validation steps, we ended up with
a solid hit list of nine novel modifiers of the Toll signaling pathway,
namely u-shaped, pannier, achaete, TAMP, CG4325, CG32133,
CG31660, Spt6, and Gprk2.
Our screen failed to identify one known positive regulator of the
Toll pathway downstreamof Toll receptor (Dif) and two components
of the Imd pathway (PGRP-LC and Dredd). Targeted RNAi for Dif
did not decrease the Drosomycin luciferase reporter activity either
when induced by Toll10b or Toll10b together with E. coli. This sug-
gests that in S2 cells, dorsal has a more important role in Toll
pathway-mediated signaling than Dif. As for PGRP-LC and Dredd,
we conclude that these two were not successfully targeted by our
dsRNA libraries. In fact, there were several instances in which there
was more than one PCR product, occasionally none of them corre-
sponding to the indicated gene, in a single well of the MRC Gene-
service PCR product library. Therefore, we found it imperative to
TA-clone and sequence every PCR template corresponding to in-
teresting RNAi phenotypes, to design gene-specific primers, and to
carry out independent RNAi with targeted dsRNAs. If there were
multiple PCR products, all corresponding targeted dsRNAs were
tested to identify the one that caused the observed phenotype.
U-shaped is the Drosophila Friend of GATA homolog with
a known important role in hemocytes. U-shaped has been shown to
interact with and negatively regulate pannier, a Drosophila GATA
transcription factor (42). U-shaped and pannier together with
achaete (and scute) also regulate the bristle formation inDrosophila
(43). This suggests that u-shaped, pannier, and achaete may act to-
gether in the process of Toll pathway regulation. TAMP (CG15737)
encodes a protein with an N-terminal domain homologous to poly
(A) polymerase proteins. CG4325 is a small protein with a RING
finger domain, which is likely to bear E3 ubiquitin-protein ligase
activity and is often involved in mediating protein-protein inter-
actions. CG32133 is a large protein with postulated molecular
functions in transcription factor binding, but the biological processes
it mediates are unknown. Drosophila Spt6 has homology to Sac-
charomyces cerevisiae Spt6p, which has been implicated in tran-
scription initiation and maintaining normal chromatin structure
during transcription elongation (44). CG31660 bears homology to
human G protein-coupled receptor 158, and it contains a domain
typical for a metabotropic glutamate family. Metabotropic gluta-
mate receptors are coupled to G proteins and stimulate the inositol
phosphate/Ca2+ intracellular signaling pathway (45). It is likely that
understanding the exact molecular functions of these genes will
reveal novel levels and means to delicately control NF-kB pathway-
mediated immune response.
Drosophila RNAi fly collections, namely the VDRC (Vienna,
Austria) and NIG-FLY (Kyoto, Japan), provide a tool to study the
importance of a selected gene product to a chosen function in the
whole organism scale. Crossing RNAi flies with an appropriate
FIGURE 6. Gprk2 RNAi flies have impaired expression of Toll pathway
target genes when subjected to B. bassiana natural fungal infection. Gprk2
RNAi flies crossed with C564-GAL4 driver and controls were infected with
B. bassiana, incubated for 48 h at 29˚C, and collected. Total RNAs extracted
from flies were subjected to qRT-PCR analysis. The relative Drosomycin,
IM1, or IM2 value of the control flies (w1118/C564) was set to 1. A, Relative
Drosomycin expression. Relative IM1 expression (B) and relative IM2 ex-
pression (C) in infected flies. Data are shown as mean 6 SD, n = 3.
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GAL4 driver fly line results in silencing of the targeted gene in
the chosen tissue in the progeny. However, it is recognized that as
much as 35–40% of fly lines may give a false-negative result, which
may be due to multiple reasons related to RNAi, driver GAL4 strain,
and/or the assay chosen (34). In our in vivo infection assays, we
found a phenotype with a statistical difference to controls in 5 out of
11 strains (Fig. 3, Supplemental Fig. 1). In addition, two other strains
(Spt6 and pannier RNAi strains; Supplemental Fig. 1) showed
a similar but nonsignificant trend. Therefore, our results are in line
with the estimates presented by Dietzl and coworkers (34). Of note,
the false-positive rate is estimated to be,2%, which means that it is
very likely the reduction in Drosomycin expression in our driver-
induced strains is due to silencing of the gene in question (34).
Importantly, we identified a novel, evolutionarily conserved
regulator of NF-kB signaling, Gprk2, in our screen in S2 cells.
Gprk2 is very well conserved and has high sequence similarity at
the amino acid level with vertebrate GRK5. GRKs are known to
phosphorylate G proteins, thus causing receptor desensitization
and switching off of the G protein-coupled receptor signaling
pathway (38). In addition to G proteins, GRKs are known to
phosphorylate various other substrates and to modulate cellular
responses in a phosphorylation-independent manner (46). Al-
though mostly membrane-bound, GRK5 has been shown to con-
tain a functional nuclear localization sequence (47), and a function
as a histone deacetylase kinase in the nucleus of cardiomyocytes
has been reported (48).
Recently, there have been implications as to the involvement of the
human GRK5 to NF-kB–mediated immunity: in a recent report, the
human GRK5 has been shown to participate in TNF-a–induced NF-
kB signaling via direct interaction with and phosphorylation of
IkBa (39). Also, effects on LPS-induced ERK1/2 signaling (40) and
NF-kB transcriptional activity (41) have been proposed. In Dro-
sophila, Gprk2 has been shown to regulate hedgehog signaling (49),
but no involvement in innate immunity has previously been reported.
In this study, we have shown that Gprk2 is an evolutionarily con-
served regulator of innate immune signaling. Furthermore, we were
able to show that Gprk2 is required for normal microbial resistance
in vivo. Interestingly, although Gprk2 physically interacts with
Cactus, it is not required for signal-induced Cactus degradation. It
will be of great interest in the future to investigate the exact role of
the Gprk2-Cactus interactions.
NF-kB signaling is of paramount importance for regulating
immune response both in flies and vertebrates. The power of the
Drosophila model includes the possibility of combining large-
scale RNAi screening with sophisticated in vivo tools. In this
study, we carried out a genome-wide RNAi screen in cultured
Drosophila cells and identified 10 novel regulators of Drosophila
NF-kB signaling. The evolutionarily conserved role for Gprk2/
GRK5 in NF-kB pathway activation was shown using human
HeLa cells in vitro and zebrafish embryos in vivo. Finally, the
importance of Gprk2 for Drosophila NF-kB signaling was dem-
onstrated both in vitro and in vivo.
FIGURE 7. Gprk2 RNAi flies are susceptible to infection with E. faecalis, and Gprk2 RNAi rescues Toll10b-induced blood cell activation in Drosophila
larvae in vivo. A and B, The Toll pathway was activated by pricking flies with M. luteus, and 24 h later, the flies were pricked with E. faecalis. The survival
of the flies was monitored for 24 h.MyD88 RNAi flies were used as a positive control. Both Gprk2 RNAi lines (Gprk2 R-1 and Gprk2 R-3) crossed over the
C564-GAL4 driver show a statistically significant reduction in survival compared with controls. Gprk2 R-1 3 C564-GAL4 (n = 132); Gprk2 R-1 control
without the driver (n = 117); Gprk2 R-3 3 C564-GAL4 (n = 105); Gprk2 R-3 control without the driver (n = 99). C, Sessile hemocyte banding pattern (i),
lost upon constitutive activation of the Toll signaling pathway in blood cells (ii), could be rescued by Gprk2 (iii) or MyD88 RNAi (iv). D, The average
grades of three independent crosses. n = 20 larvae per cross, 6 SEM. Grade 1, sessile hemocyte bands in 100% of segments; grade 2, bands in ,75% of
segments; grade 3, bands in ,50% of segments; and grade 4, no bands or bands only in the most posterior 25% of segments.
The Journal of Immunology 6197
 o
n
 O
ctober 28, 2010 
w
w
w
.jimmunol.org
D
ow
nloaded from
 
Acknowledgments
We thank othermembers of our laboratory for help and insightful discussions,
L. Ma¨kinen for technical help with Drosophila lines and zebrafish work, and
M. Ovaska for creation of the cDNA library and dsRNA synthesis. We also
thank J.-L. Imler, J.-M. Reichhart, and S. Sto¨ven for reporter, Toll10b, SpzC106,
and Relish plasmid constructs, S. Wasserman and P. Towb for the Cactus Ab
and the EGFR-Toll construct, B. Lemaitre for C564-GAL4 driver flies and
B. bassiana, and P. Wedegaertner for theGRK5-GFP construct. The P{UAS-
Tl10b:11} stock was a kind gift of J.-M. Reichhart. We also thank S. Sinenko
for the hmlD-GAL4, UAS-GFP fly stock and Kyoto NIG-FLY (Kyoto, Japan)
and VDRC (Vienna, Austria) for RNAi fly lines.
Disclosures
The authors have no financial conflicts of interest.
References
1. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18:
2195–2224.
2. Lemaitre, B., and J. Hoffmann. 2007. The host defense of Drosophila mela-
nogaster. Annu. Rev. Immunol. 25: 697–743.
3. Lemaitre, B., E. Nicolas, L. Michaut, J. M. Reichhart, and J. A. Hoffmann. 1996.
The dorsoventral regulatory gene cassette spa¨tzle/Toll/cactus controls the potent
antifungal response in Drosophila adults. Cell 86: 973–983.
4. Lemaitre, B., J. M. Reichhart, and J. A. Hoffmann. 1997. Drosophila host defense:
differential inductionof antimicrobial peptide genes after infectionbyvarious classes
of microorganisms. Proc. Natl. Acad. Sci. U.S.A. 94: 14614–14619.
5. Irving, P., L. Troxler, T. S. Heuer, M. Belvin, C. Kopczynski, J. M. Reichhart,
J. A. Hoffmann, and C. Hetru. 2001. A genome-wide analysis of immune re-
sponses in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 98: 15119–15124.
6. Ra¨met, M., P. Manfruelli, A. Pearson, B. Mathey-Prevot, and R. A. Ezekowitz.
2002. Functional genomic analysis of phagocytosis and identification of a Dro-
sophila receptor for E. coli. Nature 416: 644–648.
7. Choe, K. M., T. Werner, S. Sto¨ven, D. Hultmark, and K. V. Anderson. 2002.
Requirement for a peptidoglycan recognition protein (PGRP) in Relish activation
and antibacterial immune responses in Drosophila. Science 296: 359–362.
8. Gottar,M., V. Gobert, T.Michel,M.Belvin, G.Duyk, J. A.Hoffmann, D. Ferrandon,
and J.Royet. 2002.TheDrosophila immune responseagainstGram-negativebacteria
is mediated by a peptidoglycan recognition protein. Nature 416: 640–644.
9. Georgel, P., S. Naitza, C. Kappler, D. Ferrandon, D. Zachary, C. Swimmer,
C. Kopczynski, G. Duyk, J. M. Reichhart, and J. A. Hoffmann. 2001. Drosophila
immune deficiency (IMD) is a death domain protein that activates antibacterial
defense and can promote apoptosis. Dev. Cell 1: 503–514.
10. Vidal, S., R. S. Khush, F. Leulier, P. Tzou, M. Nakamura, and B. Lemaitre. 2001.
Mutations in the Drosophila dTAK1 gene reveal a conserved function for
MAPKKKs in the control of rel/NF-kappaB-dependent innate immune re-
sponses. Genes Dev. 15: 1900–1912.
11. Leulier, F., S. Vidal, K. Saigo, R. Ueda, and B. Lemaitre. 2002. Inducible ex-
pression of double-stranded RNA reveals a role for dFADD in the regulation of
the antibacterial response in Drosophila adults. Curr. Biol. 12: 996–1000.
12. Rutschmann, S., A. C. Jung, R. Zhou, N. Silverman, J. A. Hoffmann, and
D. Ferrandon. 2000. Role of Drosophila IKK gamma in a toll-independent an-
tibacterial immune response. Nat. Immunol. 1: 342–347.
13. Silverman, N., R. Zhou, S. Sto¨ven, N. Pandey, D. Hultmark, and T. A. Maniatis.
2000. A Drosophila IkappaB kinase complex required for Relish cleavage and
antibacterial immunity. Genes Dev. 14: 2461–2471.
14. Sto¨ven, S., I. Ando, L. Kadalayil, Y. Engstro¨m, and D. Hultmark. 2000. Acti-
vation of the Drosophila NF-kappaB factor Relish by rapid endoproteolytic
cleavage. EMBO Rep. 1: 347–352.
15. Sto¨ven, S., N. Silverman, A. Junell, M. Hedengren-Olcott, D. Erturk, Y. Engstro¨m,
T.Maniatis, andD.Hultmark. 2003. Caspase-mediated processing of the Drosophila
NF-kappaB factor Relish. Proc. Natl. Acad. Sci. U.S.A. 100: 5991–5996.
16. Leulier, F., A. Rodriguez, R. S. Khush, J. M. Abrams, and B. Lemaitre. 2000.
The Drosophila caspase Dredd is required to resist gram-negative bacterial in-
fection. EMBO Rep. 1: 353–358.
17. Kleino, A., S. Valanne, J. Ulvila, J. Kallio, H. Myllyma¨ki, H. Enwald, S. Sto¨ven,
M. Poidevin, R. Ueda, D. Hultmark, et al. 2005. Inhibitor of apoptosis 2 and
TAK1-binding protein are components of the Drosophila Imd pathway. EMBO J.
24: 3423–3434.
18. Gesellchen, V., D. Kuttenkeuler, M. Steckel, N. Pelte, and M. Boutros. 2005. An
RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator
of innate immune signalling in Drosophila. EMBO Rep. 6: 979–984.
19. Leulier, F., N. Lhocine, B. Lemaitre, and P. Meier. 2006. The Drosophila in-
hibitor of apoptosis protein DIAP2 functions in innate immunity and is essential
to resist gram-negative bacterial infection. Mol. Cell. Biol. 26: 7821–7831.
20. Valanne, S., A. Kleino, H. Myllyma¨ki, J. Vuoristo, and M. Ra¨met. 2007. Iap2 is
required for a sustained response in the Drosophila Imd pathway. Dev. Comp.
Immunol. 31: 991–1001.
21. Michel, T., J. M. Reichhart, J. A. Hoffmann, and J. Royet. 2001. Drosophila Toll
is activated by Gram-positive bacteria through a circulating peptidoglycan rec-
ognition protein. Nature 414: 756–759.
22. Weber, A. N., S. Tauszig-Delamasure, J. A. Hoffmann, E. Lelie`vre, H. Gascan,
K. P. Ray, M. A. Morse, J. L. Imler, and N. J. Gay. 2003. Binding of the Dro-
sophila cytokine Spa¨tzle to Toll is direct and establishes signaling. Nat. Im-
munol. 4: 794–800.
23. Rosetto,M.,Y. Engstro¨m,C. T.Baldari, J. L.Telford, andD.Hultmark. 1995. Signals
from the IL-1 receptor homolog, Toll, can activate an immune response in a Dro-
sophila hemocyte cell line. Biochem. Biophys. Res. Commun. 209: 111–116.
24. Horng, T., and R. Medzhitov. 2001. Drosophila MyD88 is an adapter in the Toll
signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 98: 12654–12658.
25. Tanji, T., and Y. T. Ip. 2005. Regulators of the Toll and Imd pathways in the
Drosophila innate immune response. Trends Immunol. 26: 193–198.
26. Sorrentino, R. P., J. P. Melk, and S. Govind. 2004. Genetic analysis of con-
tributions of dorsal group and JAK-Stat92E pathway genes to larval hemocyte
concentration and the egg encapsulation response in Drosophila. Genetics 166:
1343–1356.
27. Zettervall, C. J., I. Anderl, M. J. Williams, R. Palmer, E. Kurucz, I. Ando, and
D. Hultmark. 2004. A directed screen for genes involved in Drosophila blood
cell activation. Proc. Natl. Acad. Sci. U.S.A. 101: 14192–14197.
28. Kallio, J., A. Leinonen, J. Ulvila, S. Valanne, R. A. Ezekowitz, and M. Ra¨met.
2005. Functional analysis of immune response genes in Drosophila identifies
JNK pathway as a regulator of antimicrobial peptide gene expression in S2 cells.
Microbes Infect. 7: 811–819.
29. Tauszig, S., E. Jouanguy, J. A. Hoffmann, and J. L. Imler. 2000. Toll-related
receptors and the control of antimicrobial peptide expression in Drosophila.
Proc. Natl. Acad. Sci. U.S.A. 97: 10520–10525.
30. Kleino, A., H. Myllyma¨ki, J. Kallio, L. M. Vanha-aho, K. Oksanen, J. Ulvila,
D. Hultmark, S. Valanne, and M. Ra¨met. 2008. Pirk is a negative regulator of the
Drosophila Imd pathway. J. Immunol. 180: 5413–5422.
31. Nu¨sslein-Volhard, C., and R. Dahm. 2002. Zebrafish, A Practical Approach.
Oxford University Press, New York.
32. Sun, H., P. Towb, D. N. Chiem, B. A. Foster, and S. A. Wasserman. 2004.
Regulated assembly of the Toll signaling complex drives Drosophila dorso-
ventral patterning. EMBO J. 23: 100–110.
33. Sinenko, S. A., and B. Mathey-Prevot. 2004. Increased expression of Drosophila
tetraspanin, Tsp68C, suppresses the abnormal proliferation of ytr-deficient and
Ras/Raf-activated hemocytes. Oncogene 23: 9120–9128.
34. Dietzl, G., D. Chen, F. Schnorrer, K. C. Su, Y. Barinova, M. Fellner, B. Gasser,
K. Kinsey, S. Oppel, S. Scheiblauer, et al. 2007. A genome-wide transgenic RNAi
library for conditional gene inactivation in Drosophila. Nature 448: 151–156.
35. Romeo, Y., and B. Lemaitre. 2008. Drosophila immunity: methods for moni-
toring the activity of Toll and Imd signaling pathways. Methods Mol. Biol. 415:
379–394.
36. Tanji, T., X. Hu, A. N. Weber, and Y. T. Ip. 2007. Toll and IMD pathways
synergistically activate an innate immune response in Drosophila melanogaster.
Mol. Cell. Biol. 27: 4578–4588.
37. Ulvila, J., M. Parikka, A. Kleino, R. Sormunen, R. A. Ezekowitz, C. Kocks, and
M. Ra¨met. 2006. Double-stranded RNA is internalized by scavenger receptor-
mediated endocytosis in Drosophila S2 cells. J. Biol. Chem. 281: 14370–14375.
38. De Vries, L., B. Zheng, T. Fischer, E. Elenko, and M. G. Farquhar. 2000.
The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40:
235–271.
39. Patial, S., J. Luo, K. J. Porter, J. L. Benovic, and N. Parameswaran. 2009.
G-protein-coupled-receptor kinases mediate TNFalpha-induced NF-kappaB
signalling via direct interaction with and phosphorylation of IkappaBalpha.
Biochem. J. 425: 169–178.
40. Parameswaran, N., C. S. Pao, K. S. Leonhard, D. S. Kang, M. Kratz, S. C. Ley, and
J. L. Benovic. 2006. Arrestin-2 andG protein-coupled receptor kinase 5 interact with
NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2
activation in macrophages. J. Biol. Chem. 281: 34159–34170.
41. Sorriento, D., M. Ciccarelli, G. Santulli, A. Campanile, G. G. Altobelli,
V. Cimini, G. Galasso, D. Astone, F. Piscione, L. Pastore, et al. 2008. The
G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity
by inducing nuclear accumulation of IkappaB alpha. Proc. Natl. Acad. Sci. U.S.
A. 105: 17818–17823.
42. Sorrentino, R. P., K. M. Gajewski, and R. A. Schulz. 2005. GATA factors in Dro-
sophila heart and blood cell development. Semin. Cell Dev. Biol. 16: 107–116.
43. Cubadda, Y., P. Heitzler, R. P. Ray, M. Bourouis, P. Ramain, W. Gelbart,
P. Simpson, and M. Haenlin. 1997. u-shaped encodes a zinc finger protein that
regulates the proneural genes achaete and scute during the formation of bristles
in Drosophila. Genes Dev. 11: 3083–3095.
44. Kaplan, C. D., L. Laprade, and F. Winston. 2003. Transcription elongation factors
repress transcription initiation from cryptic sites. Science 301: 1096–1099.
45. Masu,M., Y. Tanabe, K. Tsuchida, R. Shigemoto, and S. Nakanishi. 1991. Sequence
and expression of a metabotropic glutamate receptor. Nature 349: 760–765.
46. Ribas, C., P. Penela, C. Murga, A. Salcedo, C. Garcı´a-Hoz, M. Jurado-Pueyo,
I. Aymerich, and F. Mayor, Jr. 2007. The G protein-coupled receptor kinase
(GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim.
Biophys. Acta 1768: 913–922.
47. Johnson, L. R., M. G. Scott, and J. A. Pitcher. 2004. G protein-coupled receptor
kinase 5 contains a DNA-binding nuclear localization sequence. Mol. Cell. Biol.
24: 10169–10179.
48. Martini, J. S., P. Raake, L. E. Vinge, B. R. DeGeorge, Jr., B. DeGeorge, Jr.,
J. K. Chuprun, D. M. Harris, E. Gao, A. D. Eckhart, J. A. Pitcher, and W. J. Koch.
2008. Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase
kinase in the nucleus of cardiomyocytes. Proc. Natl. Acad. Sci. U.S.A. 105:
12457–12462.
49. Molnar, C., H.Holguin, F.Mayor, Jr.,A.Ruiz-Gomez, and J. F. deCelis. 2007. TheG
protein-coupled receptor regulatory kinase GPRK2 participates in Hedgehog sig-
naling in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 104: 7963–7968.
6198 Drosophila Gprk2 IN NF-kB SIGNALING
 o
n
 O
ctober 28, 2010 
w
w
w
.jimmunol.org
D
ow
nloaded from
 
The FASEB Journal • Research Communication
Eye transformer is a negative regulator of Drosophila
JAK/STAT signaling
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ABSTRACT JAK/STAT signaling pathway is evolu-
tionarily conserved and tightly regulated. We carried
out a reporter-based genome-wide RNAi in vitro screen
to identify genes that regulate Drosophila JAK/STAT
pathway and found 5 novel regulators. Of these,
CG14225 is a negative regulator structurally related to
the Drosophila JAK/STAT pathway receptor Domeless,
especially in the extracellular domain, and to the mam-
malian IL-6 receptor and the signal transducer gp130.
CG14225 coimmunoprecipitates with Domeless and its
associated kinase hopscotch in S2 cells. CG14225 RNAi
caused hyperphosphorylation of the transcription fac-
tor Stat92E in S2 cells on stimulation with the Drosoph-
ila JAK/STAT pathway ligand unpaired. CG14225 RNAi
in vivo hyperactivated JAK/STAT target genes on septic
injury and enhanced unpaired-induced eye overgrowth,
and was thus named the eye transformer (ET). In the
gastrointestinal infection model, where JAK/STAT sig-
naling is important for stem cell renewal, CG14225/ET
RNAi was protective in vivo. In conclusion, we have
identified ET as a novel negative regulator of the
Drosophila JAK/STAT pathway both in vitro and in vivo,
and it functions in regulating Stat92E phosphoryla-
tion.—Kallio, J., Myllyma¨ki, H., Gro¨nholm, J., Arm-
strong, M., Vanha-aho, L.-M., Ma¨kinen, L., Silven-
noinen, O., Valanne, S., Ra¨met, M. Eye transformer is a
negative regulator of Drosophila JAK/STAT signaling.
FASEB J. 24, 000–000 (2010). www.fasebj.org
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The evolutionarily conserved janus tyrosine ki-
nase/signal transducer and activator of transcription
(JAK/STAT) pathway controls responses to hematopoi-
etic cytokines that orchestrate inflammatory and im-
mune responses in mammals (1). In humans, selective
utilization of 4 different Janus kinases (JAKs) and 7
STAT transcription factors leads to specific changes in
the activity of a set of target genes providing complexity
for JAK/STAT-mediated responses. Disturbances in
JAK/STAT signaling may cause serious human diseases,
including cancer, polycytemia vera, severe immune
deficiencies such as SCID, autoimmunity, allergies, and
neurological defects (1–5).
Drosophila has been widely used as a model for
JAK/STAT signaling. The core signaling pathway is
conserved in evolution from flies to humans, but Dro-
sophila has only 1 JAK, hopscotch (6, 7), and a single
STAT transcription factor, Stat92E (8, 9), making the
pathway simpler and less redundant. Like in mammals,
the Drosophila JAK/STAT pathway is also involved in
multiple processes, which include embryonic segmen-
tation, larval hematopoiesis and development of vari-
ous organs, regulation of stem cell maintenance, and
cellular proliferation. In addition, Drosophila JAK/
STAT signaling is required to control immune and
stress responses (7, 10; reviewed in refs. 11–14). After
septic injury, the activation of JAK/STAT pathway leads
to the expression of a number of genes, including
Turandot (Tot) stress genes in the fatbody (15–17).
JAK/STAT pathway activation is mediated by se-
creted cytokine-like molecules unpaired (upd), upd2,
and upd3 (18–20), which bind to the transmembrane
receptor Domeless (Dome) (21, 22). Dome shares
homology with members of the interleukin 6 (IL-6)
receptor family and, like the mammalian cytokine
receptors, forms dimers (22, 23). In the canonical
model of JAK/STAT signaling cascade, ligand binding
induces a conformational change in the receptor lead-
ing to activation of associated JAKs by auto- and/or
trans-phosphorylation. Activated JAKs phosphorylate
tyrosine residues in the receptors, thereby creating
docking sites for STATs, which subsequently become
phosphorylated by JAKs too. Activated STATs dimerize
and translocate in the nucleus, where they bind their
target sites in DNA and act as transcriptional activators
(8, 24). In Drosophila, the Socs36E (suppressor of cyto-
kine signaling 36E) gene is known to be a target gene
of the JAK/STAT pathway, forming a negative feedback
loop by inhibiting hop activity (25, 26). Drosophila
protein inhibitor of activated stat (dPIAS) is shown to
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be a negative regulator of the Drosophila JAK/STAT
pathway too, but the mechanism remains elusive (27)
compared to humans, where, for example, hPias1 is
shown to promote sumoylation of hStat1 (28).
JAK/STAT signaling has been studied in the Drosoph-
ila system because of its importance in human diseases.
S2 cell-based large-scale RNAi screening provides a
powerful tool to identify theoretically all genes re-
quired for given cellular function (29, 30). Two Dro-
sophila in vitro RNAi screens have been carried out to
find genes involved in JAK/STAT signaling (31, 32),
and several new modifiers of this pathway have been
identified. Curiously, however, there were differences
between the sets of identified genes. To study regula-
tion of the Drosophila JAK/STAT signaling and to
elucidate the events involved in the signaling, we car-
ried out a genome-wide RNAi based in vitro screen in
Drosophila S2 cells. As the intracellular part of the
JAK/STAT pathway downstream of the JAK kinase is
particularly well conserved, we chose to activate the sig-
naling using the constitutively active form of the Drosophila
JAK kinase hopscotch (hopTum-l) (33, 34). Activity of the
pathway was monitored using a Stat92E responsive TotM-
luciferase (TotM-luc) reporter-based assay. We screened
16,025 dsRNAs for their effect on TotM reporter activity.
In addition to the known JAK/STAT signaling pathway
components, we identified 5 genes that regulated TotM
response in S2 cells. Of these, the CG14225 gene we call
eye transformer (ET) was identified as a negative regulator of
JAK/STAT signaling both in vitro and in vivo.
MATERIALS AND METHODS
dsRNA synthesis
The dsRNAs used in the RNAi screen were produced from a
commercial Drosophila genome RNAi library consisting of a
set of 13,625 PCR products with dual T7 promoter sequences
[Medical Research Council (MRC) Geneservice Ltd., Cam-
bridge, UK]. An additional 2400 dsRNAs were transcribed
from the S2 cell-derived cDNA library (35). Targeted dsRNAs
were synthesized from S2 cDNA essentially as described in ref.
36. pMT/BiP/V5-His/GFP plasmid (Invitrogen, Carlsbad,
CA, USA) was used as a template for the production of the
negative control GFP dsRNA. Primers used for targeted
dsRNAs were GFP 5-T7GCTCGGGAGATCTCC-3 and 5-
T7CTAGACTCGAGCGGC-3; Stat92E 5-T7CCGATT-
AGCCAACGC-3 and 5-T7GGACCCCAGTGATCT-3; hop
5-T7GGAGCAGCAGATAGC-3 and 5-T7GGCGGTAG-
AGGAACT-3;Dome 5-T7TAACGGCAAGAGCGC-3 and 5-T7
AGGTTCTGGCCAGGT-3; ET dsRNA1 5 -T7TGC-
GAAGGCAGGGCACAATAGAATC-3 and 5-T7CAAGT-
CTGGTTGGGCGTTTGTATCA-3; ET dsRNA2 5-T7CG-
GAGAATGCGTTGC-3 and 5-T7AGTTGGGCAGCTT-
GG-3; ET dsRNA3 5-T7GACATCCGGGATCGACG-3 and
5-T7CGTGGGCTCCTCTTCCG-3. Additional information
related to primers is presented in Supplemental Table S1.
Cell culture, transfections, dsRNA treatments, and
overexpression constructs
Drosophila S2 cells were cultured in Schneider medium (Sigma-
Aldrich, St. Louis, MO, USA) with 10% FBS, 100 U/ml
penicillin, and 100 g/ml streptomycin at 25°C. Transfec-
tions and dsRNA treatments were performed essentially as
described previously (37). We transfected 1.0  106 S2 cells
with 0.2 g of a constitutively active form of the Janus kinase
hopTum-l together with TotM-luc reporter plasmid for activating
the JAK/STAT pathway and for quantifying TotM expression,
respectively. Cells were also transfected with 0.2 g Act5C--
gal reporter plasmid for monitoring cell viability and trans-
fection effiency. We used 0.5 g of control and experimental
dsRNAs for RNAi. Reporter activities were measured 72 h
after transfection. Transfections with other reporters were
carried out similarly. CG14225 was cloned from S2 cell cDNA
to EcoRI and NotI sites of Drosophila expression vector pMT-
HisA. Protein production was induced by addition of CuSO4
to a final concentration of 500 M 24 h prior to cell lysis.
Quantitative RT-PCR
Quantitative RT-PCR for TotM, TotA, and CG14225 and Act5C
levels was carried out using the QuantiTect SYBR Green
RT-PCR Kit (Qiagen, Valencia, CA, USA) and the ABI7000
instrument (Applied Biosystems, Foster City, CA, USA) ac-
cording to the manufacturers’ instructions. Primers used for
qRT-PCR were Act5C 5-CGAAGAAGTTGCTGCTCTGG-3
and AGAACGATACCGGTGGTACG; TotM 5-ACCGGAACA-
TCGACAGCC-3 and 5-CCAGAATCCGCCTTGTGC-3; TotA
5-CCCAGTTTGACCCCTGAG-3 and 5-GCCCTTCACACCTG-
GAGA-3; ET 5-CGGAGAAAGGAGCACCCA-3 and 5-GG-
GACTGCATCTCGCAGT-3.
Sequence analysis
Sequences were analyzed with the National Center for Bio-
technology Information (NCBI) Basic Local Alignment
Search Tool (BLAST; http://www.ncbi.nlm.nih.gov/). ClustalW
alignments (http://www.ebi.ac.uk/Tools/clustalw2/index.
html) were carried out in order to identify similar regions
between ET, Dome, and gp130.
Coimmunoprecipitation
S2 cells were transfected with constructs of cDNAs cloned in
the pMT/V5/HisA vector (Invitrogen). Protein production
was induced with CuSO4. The following tagged full-length
constructs were used: hopscotch-V5, Dome-myc, ET-myc, ET-
V5, and Dome-V5. Constructs were cotransfected in the
combinations shown and immunoprecipitated with Protein G
Sepharose beads (GE Healthcare, Little Chalfont, UK) or
Protein G Dynabeads (Invitrogen), separated, transferred to
nitrocellulose membrane, and detected essentially as de-
scribed previously (38).
Immunodetection
We transfected 5.0 106 S2 cells with a total amount of 3.0 g
of dsRNA and 1.0 g of pMT-upd plasmid or 1.0 g of empty
pMT-V5-HisA using Fugene6 reagent (Roche, Basel, Switzer-
land) according to the manufacturer’s instructions. Then
48 h after transfection, cells were treated with 500 M CuSO4
for 24 h. Cells were lysed in Triton-X lysis buffer. The protein
amounts were determined by a Dc protein assay kit (Bio-Rad
Laboratories, Hercules, CA, USA). The proteins were sepa-
rated by SDS-PAGE and transferred to a nitrocellulose mem-
brane (Protran; Schleicher & Schuell, Dassel, Germany).
Membranes were blocked with 5% milk in TBS-0.1% Tween
20, incubated with anti-Stat92E-N-terminal antibody (dN-17;
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Santa Cruz Biotechnology, Santa Cruz, CA, USA) or with
anti-phospho-Tyrosine antibody (PY99; Santa Cruz Biotech-
nology) and with a biotinylated anti-goat or anti-mouse
secondary antibody (DakoCytomation, Copenhagen, Den-
mark). Immunodetection was performed with the enhanced
chemiluminescence method (GE Healthcare). TBS buffer
containing 1% -mercapthoethanol and 0.2% SDS was used
for stripping. Phospho-Stat92E bands were quantified by
ImageQuant TL image analysis software (GE Healthcare) and
analyzed after background subtraction.
Fly stocks and maintenance
Drosophila stocks were kept on a standard mashed potato diet
at RT or at 25°C. The RNAi transgenic fly stocks were
obtained from the Vienna Drosophila RNAi Center [VDRC;
Vienna, Austria; VDRC transformants 19756 (ET IR1), 100881
(ET IR2), and 43866 (Stat92E IR)]. UAS-RNAi flies were
crossed over a fatbody-specific C564-GAL4 or ubiquitous
GeneSwitch-GAL4 driver flies or to w1118 flies for controls. In
flies crossed over the GeneSwitch-GAL4 driver, the GAL4
construct was induced with Mifepristone (200 M). Week-old
offspring were used for experiments.
To study the eye phenotype, flies carrying GMR-upd3
were first crossed over ET IR1/CyO flies. The F1 flies with 1
copy of GMR-upd3 and 1 copy of ET IR1 were then crossed
over eye-specific driver ey-GAL4 to induce ET RNAi. The
offspring from the first cross without the ET RNAi construct
were used as controls.
Fly infections
For Enterobacter cloacae infection, week-old flies were pricked
with a thin tungsten needle dipped in a concentrated culture
of bacteria. Serratia marcescens feeding infection experiment
was performed as described previously (39, 40). Survival of
the flies was recorded daily.
Data analysis
Statistical analyses of reporter assays and qRT-PCR results
were carried out using 1-way ANOVA. Statistical analysis of fly
survival experiments was carried out using the log-rank (Man-
tel-Cox) test. Values of P  0.05 were considered to be
statistically significant.
RESULTS
Luciferase-based reporter assay to monitor
JAK/STAT signaling pathway activity in Drosophila S2
cells
Under stressful conditions, including septic injury, sev-
eral Tot genes are expressed in the Drosophila fatbody,
the functional equivalent of mammalian liver (15, 16).
It has been shown that the activation of TotA is JAK/
STAT pathway dependent but is also partly regulated by
the Imd pathway and requires MAPKKK Mekk1 (17,
41). As shown in Fig. 1A, TotM-luc reporter activity is
induced by a constitutively active form of Janus kinase
hopscotch (hopTum-l) in Drosophila S2 cells. This induction
is STAT dependent, as RNAi targeting the transcription
factor Stat92E blocks the TotM expression. On the other
hand, RNAi targeting the Imd pathway transcription
factor Relish has no effect on hopTum-l-induced TotM
expression, demonstrating the specificity of our assay to
JAK/STAT signaling (data not shown). These results
indicate that hopTum-l-induced TotM-luc reporter activity
can be used to study the regulation of the JAK/STAT
pathway in Drosophila S2 cells.
Genome-wide RNAi analysis of the Drosophila JAK/
STAT pathway in Drosophila S2 cells
To identify all regulators of the JAK/STAT pathway
downstream of hop, we carried out a genome-wide
RNAi screen and monitored the effects of 16,025
dsRNA treatments on hopTum-l-induced TotM-luc re-
porter activity in S2 cells. The dsRNAs were produced
by in vitro transcription from a commercial Drosophila
genome-wide library (MRC Geneservice; 13,625 PCR
products), and an additional 2400 dsRNAs were tran-
scribed from S2 cell-derived cDNA library (35). S2 cells
were transfected with a hopTum-l expression vector and
TotM-luc-reporter together with experimental or con-
trol dsRNAs. Act5C--gal reporter was used to control
cell viability. The luciferase and -galactosidase activi-
ties were measured 72 h after transfection. dsRNA
targeting Stat92E and dsRNA targeting a gene encoding
Green Fluorescence Protein (GFP), which is not expressed
in S2 cells, were used as positive and negative controls
in each experiment, respectively. The luciferase and
-galactosidase values for GFP dsRNA-treated cells were
used as reference values for experimental dsRNAs. As
shown in Fig. 1B, most dsRNA treatments had little or
no effect on TotM-luc or Act5C--gal activity. Notably,
there were 7 dsRNA treatments that repeatedly de-
creased TotM-luc activity by more than 50% without
significantly affecting Act5C--gal activity. These tar-
geted 2 known JAK/STAT pathway components
(Stat92E and hop), one gene previously shown to be
involved in JAK/STAT pathway regulation (enok) (31,
32), and 4 novel regulators (Taf1, CG31716, CG14225,
and Med27). Corresponding templates from the origi-
nal library were TA-cloned and sequenced. Based on
the sequencing results, we designed gene-specific prim-
ers and synthesized targeted independent dsRNAs
against these novel regulators to confirm that the RNAi
phenotype had been due to presumed dsRNA and not
due to contaminating dsRNAs or any off-target effect.
As shown in Fig. 1C, all 5 targeted dsRNA treatments
decreased TotM-luc reporter activity comparably to the
library dsRNAs.
To ensure that the obtained results were not caused
by an artifact related to the reporter assay, we studied
the endogenous TotM and Act5C expression levels of
hopTum-l-transfected and dsRNA-treated S2 cells using
qRT-PCR (Fig. 1D). RNAi targeting any of the identi-
fied genes resulted in at least a 50% reduction in
relative TotM expression level, indicating that these
genes are required for normal hopTum-l -induced TotM
response in S2 cells. Based on these results, enok, Taf1,
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CG31716, CG14225, and Med27 are potential regulators
of Drosophila JAK/STAT signaling, and these 5 genes
were subjected to further studies.
CG31716 and CG14225 are general modifiers of
JAK/STAT signaling, whereas enok, Med27, and Taf1
are more context sensitive
To assess the role of identified genes in JAK/STAT
signaling in more physiological context, we activated
the JAK/STAT signaling in S2 cells by overexpressing
the ligand upd, and we used TotM-luc reporter to
measure the pathway activity. As shown in Fig. 2A,
dsRNA treatments targeting enok, Taf1, and CG31716
reduced upd-induced TotM expression in a similar
manner compared to hopTum-l-induced TotM re-
sponse, whereas RNAi against Med27 showed no
effect. Intriguingly, RNAi targeting CG14225 caused
strong hyperactivation of the TotM reporter activity
in this setting.
Figure 1. Genome-wide RNAi screen to identify gene products required for
Drosophila JAK/STAT signaling. A) TotM-luc reporter activity is induced by hopTum-l
in a Stat92E-dependent manner in S2 cells. Expression of hopTum-l caused more
than 5-fold induction in the TotM-luc activity, which was blocked by RNAi targeting
Stat92E. S2 cells were transfected with TotM-luc reporter plasmid together with
hopTum-l and Act5C--gal reporter. ***P  0.001. B) Results of the genome-wide
RNAi screen of the Drosophila JAK/STAT signaling. Luciferase and -galactosidase
values are plotted on a log-scale. Light blue dots represent GFP dsRNA-treated
negative control samples, and Stat92E dsRNA-treated positive controls are shown in
purple. Samples located near the purple dots in the top left corner of the plot
represent most potential positive regulators of JAK/STAT signaling. S2 cells were
transfected with hopTum-l, TotM-luc, and Act5C--gal plasmids together with experi-
mental or control dsRNAs. In total, 16,025 independent dsRNAs for their effect on
TotM-luc reporter activity induced by hopTum-l were analyzed. C) Targeted dsRNA-
treatments against potential regulators of the Drosophila JAK/STAT pathway. To
confirm the initial findings of the screen, independent dsRNAs targeting indicated genes were designed and tested for their
effect on hopTum-l-induced TotM-reporter activity as in panel A. All targeted dsRNAs decrease hopTum-l-induced TotM-luc
reporter activity by more than 50% in S2 cells as compared to GFP dsRNA-treated cells. D) Endogenous TotM expression
is reduced by dsRNA treatments targeting any of the 5 novel regulators of the Drosophila JAK/STAT pathway. dsRNAs
targeting indicated genes were transfected into S2 cells together with hopTum-l. Endogenous TotM expression levels were
measured by qRT-PCR and results normalized to Act5C expression values. All data are shown as means  sd, n  4. Values
of P  0.05 unless indicated otherwise.
Figure 2. CG31716 and CG14225 are general
modifiers of JAK/STAT signaling, whereas enok,
Med27, and Taf1 are more context sensitive. A)
RNAi targeting enok, CG31716, and Taf1 decreases
upd-induced TotM-luc activity in S2 cells, whereas
CG14225 dsRNA strongly enhances TotM-luc re-
sponse. B) RNAi targeting Med27 and CG31716
decreases upd-induced 10xStat92E-luc activity in S2
cells, whereas CG14225 and Taf1 RNAi enhances
the response. S2 cells were transfected with TotM-luc
(A) or 10xStat92E-luc (B) and Act5C--gal reporter
constructs together with indicated dsRNAs and upd
to induce the pathway. Data are shown as means
sd, n  4, *P  0.05; **P  0.01; ***P  0.001.
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Next, we tested whether these novel regulators are
specific for regulating TotM expression, or whether
they affect JAK/STAT target genes in a more general
manner. To this end, we induced JAK/STAT signaling
by expressing upd, and we used 10xStat92E-luc reporter
consisting of a sequence containing a double Stat92E
binding site from a SOCS36E enhancer region multi-
plied 10 times, to measure the JAK/STAT pathway
activity (31). As shown in Fig. 2B, upd expression caused
3.1-fold induction in 10xStat92E-luc reporter activity.
This induction is strongly inhibited by dsRNA treat-
ments targeting CG31716 and Med27, suggesting that
these genes are required for Stat92E-dependent activa-
tion of target genes in Drosophila S2 cells. Interestingly,
RNAi targeting enok or Taf1 increased upd-induced
10xStat92E reporter activity, indicating that these gene
products have a more specific effect on regulating TotM
expression. Of note, as enok also had been identified
earlier as a negative regulator of Drosophila JAK/STAT
signaling (31, 32), our results with 10xStat92E-luc
reporter are in line with the earlier reports. CG14225
RNAi caused clear hyperactivation of 10xStat92E-luc
reporter also in this setting. Furthermore, CG14225
dsRNA treatment caused a strong increase in another
Stat92E-responsive reporter, 3  2xDraf-luciferase ac-
tivity (32) in response to upd expression in S2 cells
(more than 10-fold induction compared to GFP
dsRNA-treated controls, data not shown). These re-
sults related to the role of CG14425 in upd-induced
JAK/STAT signaling are in striking contrast com-
pared to our results with hopTum-l induction and
prompted us to study this gene in more detail.
CG14225/ET is a Dome-related gene that negatively
regulates the JAK/STAT signaling in Drosophila S2
cells
CG14225/ET is a 3.3 kb gene comprising 3 separate
coding sequences (Fig. 3A). It is located next to the
Figure 3. ET is a negative regulator of the Drosophila JAK/STAT pathway and is structurally related to Dome. A) Schematic
representation of gene and protein structures of CG14225/ET. The ET gene consists of 3 exons and has no UTR regions.
Sequence regions where ET dsRNAs (dsRNA1–3) were designed are shown. Domain structure of ET protein is illustrated and
compared to domain structure of Dome in the bottom panel. N-terminal fibronectin-type III domain of the cytokine-binding
module (CBM N) and C-terminal fibronectin-type III domain of the cytokine-binding module (CBM C) are highly conserved
in both proteins. The fibronectin-type III (FnIII) domain triplet near the transmembrane domain in Dome is absent in ET. B,
C) RNAi targeting different regions of ET has a similar effect on both hopTum-l- and upd-induced 10xStat92E-luc activity. S2 cells
were transfected with 10xStat92E-luc reporter plasmid together with hopTum-l or upd constructs for induction of the pathway.
Two dsRNAs targeting different parts of the ET gene decrease hopTum-l-induced 10xStat92E-luc activity (B) and increase
upd-induced 10xStat92E-luc activity (C), compared to GFP dsRNA-treated controls in S2 cells. D) RNAi targeting ET strongly
decreases the amount of ET transcripts in S2 cells compared to GFP dsRNA-treated controls. Endogenous ET mRNA levels after
dsRNA treatments were measured using qRT-PCR. E) Overexpression of ET blocks upd-induced 10xStat92E-luc activity in S2
cells, but enhances hopTum-l-induced 10xStat92E-luc response. S2 cells were transfected with an ET overexpression construct or
an empty vector together with hopTum-l or upd to induce the pathway. All data are shown as means sd, n 4. *P 0.05; **P
0.01; ***P  0.001.
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Drosophila JAK/STAT pathway receptor Dome in the
genome. Furthermore, the ET gene encodes a 713 amino
acid type-I transmembrane protein that shares structural
similarities with Dome (11). Like Dome, ET has a cytokine
binding module (CBM) in the N terminus but lacks 3 FnIII
domains near the transmembrane domain. The CBM do-
main of vertebrate interleukin receptors is composed of 2
FnIII domains, containing 4 conserved cysteine residues in
the N-terminal domain and a conserved WSXWS motif in
the C-terminal domain (42). CBM in Dome and
CG14225/ET share these features, but the WSXWS motif is
incomplete in both (NTLWS/GSPWS). Intriguingly, al-
though Dome shares similarities with the mammalian inter-
leukin-6 (IL-6) receptor family members, ET’s closest hu-
man homologue is the signal transducing protein gp130
with 12.7% identity, mostly found in the extracellular region.
In mammalian IL-6 signaling, gp130 associates with IL-6
receptors that have bound their ligand and dimerizes, there-
fore allowing transduction of the signal to activate target
molecules, including JAKs and STATs (43). Thus, ET shares
structural similarities with Dome and mammalian gp130,
which plays an important role in regulation of JAK/STAT
signaling. The structure of the ET gene product explains in
part why we observed opposing results with ET RNAi de-
pending on what level the JAK/STAT pathway was activated
at, because with the transmembrane domain, ET is likely to
function at the level of Dome, thus epistatically between upd
and hop.
To verify that the observed ET RNAi phenotype was
not due to off-target effects, we generated another
dsRNA targeting the third exon of ET (the 3 different
dsRNAs targeting ET are shown schematically in Fig.
3A). As shown in Fig. 3B, both targeted dsRNAs
(dsRNA2 and dsRNA3) caused strong inhibition of
hopTum-l-induced 10xStat92E-luc reporter activity. Fur-
thermore, both targeted dsRNAs caused hyperactiva-
tion of the upd-induced 10xStat92E-luc reporter activity
(Fig. 3C), indicating that independent dsRNAs target-
ing ET cause similar phenotypes. Furthermore, hyper-
activation of 10xStat92E-luc reporter was also observed
when upd-conditioned medium (32) was added on ET
dsRNA-treated cells (data not shown). To confirm
efficiency of RNAi on the ET mRNA level, we treated S2
cells with both targeted dsRNAs against ET and ana-
lyzed mRNA levels using qRT-PCR (Fig. 3D). Both
dsRNAs resulted in strongly decreased ET mRNA levels
compared to GFP dsRNA-treated control cells, indicat-
ing that these treatments effectively suppress ET expres-
sion in S2 cells. Taken together, these results indicate
that ET RNAi causes hyperactivation of upd-induced
JAK/STAT response in S2 cells.
To test whether overexpression of ET has an effect on
JAK/STAT signaling in S2 cells, we cloned ET to a
Drosophila expression vector. As shown in Fig. 3E,
overexpression of ET caused a marked decrease in
upd-induced 10xStat92E-luc reporter activity in S2 cells
and consistently with the RNAi phenotype results,
1.6-fold increase in hopTum-l-induced TotM-luc activity.
Of note, ET mRNA contains no UTR regions, and thus
it was not possible to carry out a rescue experiment
where endogenous ET would be knocked down by
dsRNA targeting the UTR regions and the resulting
phenotype would then be rescued by overexpression of
ET construct.
To analyze whether ET RNAi affects signaling cas-
cades in S2 cells in a more general manner, we inves-
tigated the Toll and the Imd pathway signaling in ET
dsRNA-treated S2 cells. ET RNAi did not significantly
affect the heat-killed E. coli-induced Attacin (Imd path-
way target gene) reporter activity, and had only a minor
effect on Toll10b-induced Drosomycin (Toll pathway tar-
get gene) reporter activity in S2 cells (data not shown).
These results indicate that ET is not a general regulator
of signaling pathways in S2 cells, but its function is
more specific to the JAK/STAT pathway.
ET is an intrinsic component of the Dome receptor
complex, and it functions as a regulator of Stat92E
phosphorylation
Curiously, RNAi targeting ET caused different pheno-
types in TotM-luc and 10xStat92E-luc reporter assays
depending on whether hopTum-l or upd was used to
trigger the JAK/STAT pathway signaling. To investi-
gate the function of ET, we tested whether ET RNAi
phenotype can be suppressed by dual RNAi treat-
ments targeting known regulators of Drosophila JAK/
STAT signaling in S2 cells. S2 cells were treated with
ET dsRNA and with dsRNA targeting known compo-
nents of the JAK/STAT pathway, hop, Stat92E, or
Dome. The JAK/STAT pathway activity was measured
using TotM-luc reporter. ET RNAi caused a subtle
activation of the TotM-luc reporter activity (Fig. 4A),
suggesting that ET acts as a constitutive negative
regulator of the JAK/STAT pathway in S2 cells. RNAi
targeting any of the known Drosophila JAK/STAT
pathway components (Dome, hop, or Stat92E) pre-
vented this activation, which suggests that ET func-
tion is dependent on these components and that ET
acts upstream or at their level in S2 cells.
To gain a more mechanistic insight about ET-
mediated inhibition of JAK/STAT signaling, we co-
immunoprecipitated overexpressed V5-tagged com-
ponents of the Drosophila JAK/STAT signalosome
with myc-tagged ET in S2 cells (Fig. 4B). At first, we
confirmed the method by hop and Dome coimmu-
noprecipitation, and as expected, hop-V5 coimmuno-
precipitated with Dome-myc (Fig. 4B). Notably, both
hop-V5 and Dome-V5 coimmunoprecipitated with
ET-myc, suggesting that overexpressed ET interacts
directly with key regulators of the Drosophila JAK/
STAT signalosome in S2 cells. Of note, we were
unable to coimmunoprecipitate upd or Stat92E with
ET (data not shown).
To gain further insight to the molecular function of
ET, we analyzed whether ET suppresses JAK/STAT
signaling by affecting the dimerization of Dome. As
shown in Fig. 5A, Dome-Dome interaction, as analyzed
by immunoprecipitating V5-tagged Dome with myc-
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tagged Dome, was not affected by overexpression of ET
(or ET RNAi). Similarly, overexpression of ET (or ET
RNAi) did not alter the interaction between hop-V5 and
Dome-myc (Fig. 5A). These results indicate that ET is not
likely to function by preventing dimerization of Dome, or
by disrupting Dome-hop interaction in S2 cells.
Next, we studied whether ET affects the kinase
activity of the Drosophila JAK/STAT signalosome by
investigating Stat92E phosphorylation upon upd induc-
tion in S2 cells (Fig. 5B). S2 cells were transfected with
indicated dsRNAs and upd to activate signaling leading
to Stat92E phosphorylation. Then 72 h after transfec-
tion, S2 cell protein lysates were separated by SDS-
PAGE and analyzed by Western blotting with anti-
Stat92E N-terminal antibody. RNAi targeting ET caused
Stat92E band shift upon activation with upd compared
to GFP dsRNA-treated controls, suggesting hyperphos-
phorylation of Stat92E. To ensure that this upper band
represents a phosphorylated form of the protein,
Stat92E was immunoprecipitated from S2 cell lysates
with anti-Stat92E N-terminal antibody and detected
with phospho-tyrosine-specific antibody (Fig. 5B). Hy-
perphosphorylation of Stat92E was abolished when
Dome or hop dsRNA was cotransfected with ET dsRNA
(Fig. 5B), indicating that ET function is dependent on
these factors. Stat92E dsRNA strongly decreases the
signal demonstrating the specificity of the antibody.
Taking these data together, we see that ET is a
negative regulator of the JAK/STAT pathway in Dro-
sophila S2 cells. ET functions as a regulator of Stat92E
phosphorylation and is located functionally at the level
or upstream of the receptor Dome. Furthermore, ET
appears as an intrinsic component of the Dome recep-
tor complex as it coimmunoprecipitates with both hop
and Dome when overexpressed in S2 cells, but it does
not affect Dome dimerization or Dome-hop interac-
tion. The mechanistic function of ET is shown schemat-
ically in Fig. 5C.
ET negatively regulates Tot gene expression in vivo
ET functions as a negative regulator of JAK/STAT
signaling in vitro. JAK/STAT pathway is required for Tot
gene expression under stressful conditions in Drosophila
in vivo (17, 41). To investigate the role of ET in
JAK/STAT signaling in vivo, we crossed fly lines carry-
ing UAS-RNAi constructs targeting ET (ET IR1 and ET
IR2) (44) over C564-GAL4 flies, which drive GAL4
expression in the adult fatbody. Thereafter the relative
expression levels of both TotM and TotA in response to
septic injury with E. cloacae were measured in experi-
mental and control progeny flies by qRT-PCR (Fig. 6A,
B). As expected, C564-GAL4-driven expression of UAS-
Stat92E RNAi strongly impaired both TotM and TotA
response to E. cloacae compared to controls crossed
over w1118 (Fig. 6A, B). On the contrary, C564-GAL4-
driven UAS-ET RNAi markedly enhanced both TotM
and TotA expression. These results are in agreement
with the results obtained using S2 cells and indicate
that ET negatively regulates Tot gene expression in
adult Drosophila. Of note, infection with E. cloacae did
not affect the level of ET expression, which suggests
that ET expression is not regulated by the JAK/STAT
(or the Imd) pathway (data not shown).
Genetic background may affect gene expression lev-
els under experimental conditions. To avoid bias
caused by genetic background, we analyzed the in vivo
ET RNAi phenotype using a drug-inducible ubiquitous
driver GeneSwitch-GAL4, which activates the expression
of the RNAi construct when Mifepristone is added to
the food vials. This enables monitoring the offspring
from each cross with and without expression of the
RNAi construct, therefore providing a genetically rele-
vant control. Figure 6C, D shows that in Mifepristone-
induced ET RNAi flies, both TotM and TotA expression
in response to septic injury with E. cloacae are hyperac-
Figure 4. ET functions at the level or upstream of Dome and
coimmunoprecipitates with hop and Dome. A) ET functions
at the level or upstream of Dome. TotM-luc reporter was
activated by RNAi targeting ET. RNAi targeting known com-
ponents (hop, Stat92E, Dome) of the Drosophila JAK/STAT
pathway abolishes ET RNAi -induced TotM activity, indicating
that these components are located functionally downstream
of ET. Data are shown as means sd, n 4. *P 0.05. B) ET
coimmunoprecipitates with both hop and Dome. S2 cells
were transfected with either ET-myc or Dome-myc and
hop-V5 or Dome-V5. Immunoprecipitation (IP) was done
with anti-myc (	 myc) antibody and immunoblotting (IB)
with anti-V5 (	 V5) antibody. CuSO4 was used to induce the
expression of the constructs.
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tivated compared to control flies with a drug-free diet.
As expected, Stat92E RNAi strongly inhibits both TotM
and TotA induction under these conditions, demon-
strating that the GeneSwitch-GAL4 driver was operative.
Tot gene expression is controlled jointly by the
JAK/STAT and by the Imd pathway on septic injury in
Drosophila (17, 41). By crossing UAS-ET RNAi flies
over C564-GAL4 flies and measuring Attacin B expres-
sion on E. cloacae septic injury in the offspring, we
confirmed that the effect of ET RNAi on Tot gene
expression is not mediated by the Imd pathway (data
not shown).
ET RNAi is protective in a gastrointestinal infection
model with Serratia marcescens
Recently, the Drosophila JAK/STAT signaling has been
shown to be important for survival of the flies after
intestinal bacterial infection (45, 46). In response to
infection or damage, enterocytes in the Drosophila mid-
gut produce upd, upd2, and upd3, which activate
JAK/STAT signaling in intestinal stem cells, leading to
cell division and regeneration of the gut epithelium
(45). Serratia marcescens is an entomopathogenic bacte-
rium that can infect Drosophila through the digestive
tract. It was shown that despite the local immune
response induced, S. marcescens infection causes disrup-
tion of the gut morphology, which contributes to death
of the flies that follows in a few days (40). Thus, we used
the S. marcescens intestinal infection assay to study the role
of ET in microbial resistance in vivo (39, 40, 46). ET RNAi
lines (ET IR1 and ET IR2) were crossed over the Gene-
Switch-GAL4 driver line, and w1118 and Stat92E over Gene-
Switch-GAL4 were used as controls. As shown in Fig. 7, ET
RNAi flies survived better in food contaminated with
S. marcescens than flies in which RNAi was not induced by
Mifepristone. In contrast, flies with induced Stat92E RNAi
were more susceptible than flies with no RNAi induction
(Fig. 7A, B). These data support previous reports suggest-
ing that JAK/STAT signaling is involved in survival of the
flies from S. marcescens infection in vivo, and that ET RNAi
enhances their resistance to S. marcescens. The enhanced
resistance against gastrointestinal infection may be due to
improved stem cell renewal caused by hyperactivated
JAK/STAT pathway (45), although it is plausible that the
protective effect of ET RNAi is caused by mechanisms
independent of JAK/STAT signaling.
Figure 5. ET RNAi causes hyperphosphorylation of Stat92E in response to upd expression in S2 cells. A) ET does not affect the
interaction between hop and Dome (top panel) or homodimerization of Dome (bottom panel). The effect of ET overexpression
or RNAi was studied by transfecting S2 cells with Dome-myc and hop-V5 or Dome-myc and ET-V5 or treated with ET dsRNA.
Immunoprecipitation (IP) was done with antimyc (	-myc) antibody and immunoblotting (IB) with anti-V5 (	 V5) antibody.
B) ET RNAi causes Stat92E hyperphosphorylation in response to activation of JAK/STAT signaling with upd (3 top panels). The
intensity of the phosphorylation bands of Stat92E is significantly increased in ET dsRNA-treated samples compared to GFP
dsRNA-treated controls. Hyperphosphorylation of Stat92E is abolished when Dome or hop dsRNA is cotransfected with ET dsRNA
(bottom panel), indicating that function of ET is dependent on these factors. S2 cells were transfected with dsRNAs as indicated
with or without upd to activate the JAK/STAT pathway. Cells were lyzed 72 h after transfection, and proteins were separated by
SDS-PAGE and analyzed by Western blotting with anti-Stat92E N-terminal antibody. IP was done with anti-Stat92E N-terminal
antibody followed by SDS-PAGE and IB with antiphospho-Tyrosine antibody. After stripping, the same membrane was reprobed
with anti-Stat92E N-terminal antibody showing equal amounts of protein in the immunoprecipitates (middle panels).
C) Schematic representation of the canonical Drosophila JAK/STAT signaling (left) and the inhibitory function of ET (right).
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ET RNAi causes eye overgrowth in adult flies
To gain more direct evidence that ET negatively regu-
lates JAK/STAT signaling in vivo, we investigated
whether ET RNAi affects upd-induced eye overgrowth.
JAK/STAT signaling has been shown to be important in
regulation of Drosophila eye imaginal disc development
(47, 48). This is demonstrated by the fact that hyperac-
tivation of the pathway by ectopic overexpression of the
ligand upd in the developing eye leads to distinct
overgrowth (48; Fig. 7C). Furthermore, the overgrowth
phenotype has been shown to be modulated by overex-
pression or removal of several JAK/STAT pathway
components and regulators (e.g., refs. 32, 48–50). To
this end, we tested whether ET RNAi affects eye devel-
opment. Expressing the ET RNAi construct under an
eye-specific driver (ey-GAL4) alone did not affect eye
development (Supplemental Fig. S1). However, when
these flies were further crossed to GMR-upd3 flies
that overexpress upd in the eye, the resulting offspring
had more severe eye overgrowth than flies from the
same cross without ET RNAi (Fig. 7C and Supplemental
Fig. S1). To evaluate the eye phenotypes objectively, we
created a scoring system to quantify the observations.
Pictures of each fly’s eyes were independently evaluated
by 5 experienced researchers from our group as a blind
test, and the eye phenotypes were given scores 0–5, 0
representing wild type and 5 the most severe pheno-
type. The results in Fig. 7D show that the eye phenotype
of flies carrying both GMR-upd3 and ET RNAi con-
struct together with the ey-GAL4 driver is more severe
than that of flies with only GMR-upd3. These results
suggest that ET regulates JAK/STAT pathway-mediated
eye overgrowth in Drosophila.
DISCUSSION
JAK/STAT signaling is involved in a variety of processes
in both Drosophila and mammals. To identify gene
products involved in regulation of Drosophila JAK/
STAT signaling, we carried out a genome-wide reporter
assay-based RNAi screen in S2 cells. A constantly active
form of hop (hopTum-l) was chosen for pathway activa-
tion in order to focus on the more evolutionarily
Figure 6. ET in vivo RNAi increases JAK/STAT pathway response. A, B) ET RNAi strongly increases TotM (A) and TotA (B)
expression in response to septic injury in Drosophila in vivo, whereas Stat92E RNAi abolishes Tot gene expression. Flies carrying
the UAS-RNAi constructs ET IR 1, ET IR2, or Stat92E IR (positive control) were crossed over either C564-GAL4 driver or w1118
flies (negative control). The offspring were infected with E. cloacae to induce JAK/STAT signaling. TotM and TotA expression
levels were measured from extracted total RNAs by qRT-PCR. C, D) ET RNAi also dramatically increases TotM (C) and TotA (D)
expression with an inducible ubiquitous GeneSwicth-GAL4 driver as compared to flies with the same genetic background with no
RNAi induction. In the positive control (Stat92E RNAi flies), induction of RNAi abolished Tot gene expression, whereas in the
negative control (w1118) Tot gene expression was not affected by induction. In flies crossed over GeneSwitch-GAL4 driver, RNAi
was induced by adding the drug Mifepristone to food vials, and flies with a drug-free diet (uninduced) were used as controls.
All data are shown as means  sd, n  4. *P  0.05; **P  0.01; ***P  0.001.
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conserved intracellular part of the signaling cascade.
To identify the most important regulators, we subjected
the genes, whose RNAi repeatedly caused 
50% de-
crease on the luciferase activity, to further studies. The
original findings of the screen were confirmed in vitro
by several means using different dsRNAs, different
reporters, and different ways to induce the JAK/STAT
signaling. In this way, we identified 5 novel putative
regulators of Drosophila JAK/STAT signaling. This is a
reasonable number of gene products that can be di-
rectly involved in JAK/STAT pathway regulation and
probably excludes factors that affect JAK/STAT path-
way activity indirectly via crosstalk with other signaling
pathways. In addition, our screen found 2 previously
known intracellular components of the pathway, hop
and Stat92E, confirming the validity of our screen.
Notably, we identified the gp130/IL-6R related trans-
membrane protein ET as a novel negative regulator of
Drosophila JAK/STAT pathway.
ET is a negative regulator of Drosophila JAK/STAT
signaling
Our RNAi screen was originally set out to identify novel
positive regulators of Drosophila JAK/STAT pathway. ET
RNAi caused strong decrease in hopTum-l-induced
TotM-luc activity in our primary screen. Curiously, when
the JAK/STAT signaling was induced using upd, the
ligand of the pathway, the phenotype of ET RNAi was
the exact opposite. In this setting, ET RNAi increased
the activity of all reporters tested (TotM-luc, 10xStat92E-
luc, and 32xDraf-luc) by at least 5-fold, indicating that
the RNAi phenotype was not reporter sensitive, and
therefore not likely to be highly context-dependent or
due to an artifact. Furthermore, overexpression of ET
in S2 cells also produced opposite luciferase assay
phenotypes with different activating molecules. Even
though these results are consistent with the RNAi
phenotypes observed, the reason for different pheno-
types of ET knockdown or overexpression observed
depending on the activating molecule remains specu-
lative. However, several pieces of evidence suggest
partial explanations for this phenomenon.
In the Drosophila genome, the sequence coding for
ET is located next to that of Drosophila JAK/STAT
pathway receptor Dome. ET polypeptide carries a puta-
tive transmembrane domain and shares sequence sim-
ilarity to Dome, especially in the extracellular domain
(11); therefore, ET is likely a result of gene duplication.
Both the proposed protein structure of ET and our
experimental data from double-RNAi and coimmuno-
precipitation assays suggest that ET functions on the
cell membrane, epistatically at the level upd and hop.
hopTum-l causes strong activation of Drosophila JAK/
STAT signaling, but this induction appears to take a
somehow pathological form. Interestingly, Dome was
not among the known components identified in our
screen for positive regulators. We therefore tested the
Figure 7. ET in vivo RNAi is
protective in a gastrointestinal in-
fection model and enhances eye
overgrowth phenotype caused by
ectopic upd expression. A, B) ET
RNAi protects the flies from S.
marcescens infection. Two strains of
ET RNAi flies, ET IR1 (A) and IR2
(B), show enhanced survival from
gastrointestinal infection caused by
S. marcescens as compared to flies
with the same genetic background
with no RNAi induction. Flies with
induced Stat92ERNAi show decreased survival, as well as eatermutant flies, which were used as controls.ETRNAi flies were crossed over
the drug-inducible driver GeneSwitch-GAL4. Mifepristone was used to induce the expression of the RNAi construct. w1118 and Stat92E
RNAi flies crossed over GeneSwitch-GAL4 flies were used as an additional control. C) ET RNAi enhances upd-induced eye overgrowth.
Eye overgrowth phenotype caused by overexpression of upd in the developing eye (GMR-upd3) is more severe in flies that also
express an ET RNAi construct with an eye-specific driver (ey-GAL4). D) The eye phenotype in flies with ectopic expression of both upd
and ET RNAi in their eyes was significantly more severe than in flies with upd alone. Grades: 0  wild-type, 5  most severe eye
phenotype. n  8 for CantonS flies and n  16 for GMR-upd3 and GMR-upd3  ET IR1 flies. Data are shown as means  sd.
***P  0.001 vs. GMR-upd3.
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RNAi phenotype for Dome with both upd and hopTum-l-
induction in S2 cells. As expected, when upd was used,
Dome RNAi abolished reporter activity. In line with our
ET results, when hopTum-l was used to activate JAK/
STAT signaling, the phenotype for Dome RNAi was the
opposite, the reporter activity being doubled (data not
shown). These results implicate that the mutant hop is
likely to behave abnormally in Drosophila cells acting
independently of Dome, perhaps by using ET’s short
cytoplasmic tail as a docking site: This results in consti-
tutive activation of JAK/STAT signaling and may ex-
plain the hopTum-l-mutant phenotype. Using ectopic
expression of upd as an inducer of JAK/STAT pathway
provides more physiological information about ET’s
function, and thus we conclude that ET is a negative
regulator of the Drosophila JAK/STAT signaling.
ET’s exact molecular function in regulation of
Drosophila JAK/STAT signaling remains to be stud-
ied, but since it has putative cytokine binding motifs
in the ectodomain, it could function as a decoy
receptor that captures upd ligands from Dome. ET
could also inhibit Dome activation by forming a
nonsignaling heterodimer with Dome, or by inhibit-
ing Dome homodimer-hop signalosome in some
other manner. Since ET coimmunoprecipitated with
Dome but did not affect Dome homodimerization, or
interaction of hop with Dome, the latter statement
appears more likely.
Regulation of JAK/STAT signaling in Drosophila and
mammals: common mechanisms
The core JAK/STAT signaling pathway is evolutionarily
conserved. Because of its role in diverse cellular pro-
cesses, the JAK/STAT pathway needs to be strictly
controlled at different levels of the cascade. Several
regulatory mechanisms appear to be conserved from
flies to humans, as many of the positive and negative
regulators of Drosophila JAK/STAT signaling have been
identified based on their homology with the mamma-
lian counterparts. The Drosophila model has also pro-
vided important information about regulation of the
JAK/STAT pathway. For example, the first evidence for
the critical role of the JH2 pseudokinase domain in
regulation of JAK activity and hematopoietic homeosta-
sis was obtained in Drosophila (51). Of the known
conserved negative regulators of the JAK/STAT path-
way, SOCS36E is strongly induced by Stat92E, forming a
negative feedback loop. dPIAS, on the other hand,
interacts directly with Stat92E and affects its nuclear
functions. According to our results, ET negatively reg-
ulates pathway at the level or upstream to Dome and is
not induced via a negative feedback loop.
Both Dome and ET show homology with mammalian
IL-6 receptor family members and the signal transducer
gp130. In mammals, gp130 is able to form functional
signaling complexes with several cytokine receptors,
such as interleukin-6, leukemia inhibitory factor, ciliary
neurotrophic factor, oncostatin M, cardiotrophin-1, the
granulocyte colony-stimulating factor, IL-11, and IL-27
(43, 52–56). In these ligand-induced receptor com-
plexes gp130 mediates the activation signal to multiple
cytoplasmic signaling molecules via activation of JAKs
that are constitutively associated with gp130 cytoplas-
mic domain. In Drosophila, the signaling cascade is
simpler, and Dome is the only characterized JAK/STAT
pathway receptor (22, 23). Dome homodimerization is
needed for a proper upd-induced signal transduction
and Stat92E activation (23), but it is still unclear if
Dome participates in larger multisubunit receptor com-
plexes resembling those seen in mammals.
The role of ET in Drosophila in vivo
Notably, we also assessed ET’s role in Drosophila JAK/
STAT signaling in vivo. Two ET RNAi strains crossed
over a driver expressed in the fatbody and lymph glands
(C564-GAL4) or a ubiquitous drug-inducible driver
(GeneSwitch-GAL4) were tested by qRT-PCR for their
effect on JAK/STAT pathway target gene expression in
response to septic injury with E. cloacae. Both ET RNAi
lines showed a significant increase in JAK/STAT path-
way-dependent stress response compared to controls,
indicating hyperactivation of JAK/STAT signaling.
More direct in vivo model to study JAK/STAT activity in
Drosophila is overexpression of upd in the developing
eye, which leads to eye overgrowth due to hyperacti-
vated JAK/STAT signaling (48). The eye overgrowth
phenotype is shown to be modified by overexpression
and removal of several JAK/STAT pathway components
and regulators (32, 48–50). Notably, overexpression of
upd together with ET RNAi construct under an eye-
specific driver ey-GAL4 lead to a significantly more
severe eye overgrowth than overexpression of upd
alone. In addition, ET RNAi appears to have a protec-
tive role in an S. marcescens gastrointestinal infection
model. Enhanced JAK/STAT signaling activity may be
advantageous in S. marcescens-infected flies for renewal
of the injured gut wall (45). Accordingly, Stat92E RNAi
flies were more susceptible to infection in this assay. It
is possible, however, that the protective effect of ET
RNAi is due to another mechanism unrelated to JAK/
STAT signaling.
In summary, we identified 5 putative novel regulators
of Drosophila JAK/STAT signaling in this study. Of
these, ET is a negative regulator of JAK/STAT pathway
signaling both in vitro and in vivo. ET is involved in
Stat92E phosphorylation and coimmunoprecipitates
with Dome and hop. The exact molecular mechanisms
of how ET regulates Stat92E phosphorylation remains
to be studied.
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